Publications: Prof Paolo Pozzilli

Pozzilli P, Sormani M ( 2024 ) . Financial incentives and public health with a focus on obesity: Turning point or dead end? . Diabetes Obesity and Metabolism

Feliziani E, Caterina Chios M, Pozzilli P ( 2024 ) . Beyond the insulin pump: Unraveling diabetes tech dependency . Diabetes Research and Clinical Practice vol. 217 ,

Lee Jia Jia I, Zampetti S, Pozzilli P, Buzzetti R ( 2024 ) . Type 2 diabetes in children and adolescents: Challenges for treatment and potential solutions . Diabetes Research and Clinical Practice vol. 217 ,

Paviglianiti A, Bianchessi A, Avenoso D, Radici V, Domingo MP, Pozzilli P, Sureda A ( 2024 ) . Modern views of nutritional support in patients undergoing allogeneic stem cell transplantation . Clinical Nutrition ESPEN vol. 63 , 400 - 408 .

JIA X, POZZILLI P, NISSIM A, STROLLO R, YU L ( 2024 ) . 1178-P: Autoantibodies Specifically Targeting Oxidative Post-translationally Modified Insulin in Type 1 Diabetes . Diabetes vol. 73 , ( Supplement_1 )

Jia ILJ, Buzzetti R, Leslie RD, Pozzilli P ( 2024 ) . LADA 30th anniversary: A growing form of diabetes with persistent unresolved questions . Diabetes/Metabolism Research and Reviews vol. 40 , ( 4 )

Carbone S, Pozzilli P ( 2024 ) . Chrononutrition in cardiometabolic diseases: Current evidence and future perspectives . Diabetes/Metabolism Research and Reviews vol. 40 , ( 2 )

Weston CS, Boehm BO, Pozzilli P ( 2024 ) . Type 1 diabetes: A new vision of the disease based on endotypes . Diabetes/Metabolism Research and Reviews vol. 40 , ( 2 )

Pozzilli P ( 2024 ) . Chronicles of progress: Celebrating 40 years of scientific excellence in diabetes . Diabetes/Metabolism Research and Reviews vol. 40 , ( 2 )

Maddaloni E, Naciu AM, Mignogna C, Galiero R, Amendolara R, Fogolari M, Satta C, Serafini C et al. ( 2024 ) . Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: A 12‐month, randomized, comparator‐controlled pilot study . Diabetes Obesity and Metabolism vol. 26 , ( 5 ) 1670 - 1677 .

Ibrahim M, Ba‐Essa EM, Baker J, Cahn A, Ceriello A, Cosentino F, Davies MJ, Eckel RH et al. ( 2023 ) . Cardio‐renal‐metabolic disease in primary care setting . Diabetes/Metabolism Research and Reviews vol. 40 , ( 3 )

Ricottini E, Gatto L, Nusca A, Melfi R, Mangiacapra F, Albano M, Cavallaro C, Pozzilli P et al. ( 2023 ) . Leptin as predictor of cardiovascular events and high platelet reactivity in patients undergoing percutaneous coronary intervention . Clinical Nutrition ESPEN vol. 58 , 104 - 110 .

Nazari P, Pozzilli P ( 2023 ) . Type 2 diabetes and Covid-19: Lessons learnt, unanswered questions and hints for the future . Diabetes Research and Clinical Practice vol. 204 ,

Maddaloni E, Carlone A, Pitocco D, Leanza G, Suraci C, Altomare M, Cavallo MG, Barchetta I et al. ( 2023 ) . Glycated haemoglobin in the first year after diagnosis of type 1 diabetes is an independent risk factor for diabetic retinopathy: The IMDIAB 25 years follow‐up study . Diabetes Obesity and Metabolism vol. 25 , ( 11 ) 3415 - 3419 .

ALHAMAR G, FALLUCCA S, PIERALICE S, VALENTE L, POZZILLI P ( 2023 ) . 1492-P: IL-8/CXCL8 May Identify a New Type 1 Diabetes Endotype . Diabetes vol. 72 , ( Supplement_1 )

POZZILLI P, FALLUCCA S, PIERALICE S, MARELLI M, MANCINI L ( 2023 ) . 297-OR: Systematic Review of Immune Interventions Trials in Recent Onset Type 1 and Effect on HbA1c . Diabetes vol. 72 , ( Supplement_1 )

Sordi V, Monti P, Lampasona V, Melzi R, Pellegrini S, Keymeulen B, Gillard P, Linn T et al. ( 2023 ) . Post hoc analysis of a randomized, double-blind, prospective trial evaluating a CXCR1/2 inhibitor in new-onset type 1 diabetes: endo-metabolic features at baseline identify a subgroup of responders . Frontiers in Endocrinology vol. 14 ,

D’Souza F, Buzzetti R, Pozzilli P ( 2023 ) . Diabetes, COVID‐19, and questions unsolved . Diabetes/Metabolism Research and Reviews vol. 39 , ( 5 )

Paolo P ( 2023 ) . What does publishing a paper mean for you? . Diabetes/Metabolism Research and Reviews vol. 39 , ( 4 )

D’Antoni F, Petrosino L, Marchetti A, Bacco L, Pieralice S, Vollero L, Pozzilli P, Piemonte V et al. ( 2023 ) . Layered Meta-Learning Algorithm for Predicting Adverse Events in Type 1 Diabetes . IEEE Access vol. 11 , 9074 - 9094 .

Alhamar G, Briganti S, Maggi D, Viola V, Faraj M, Zannella C, Galdiero M, Franci G et al. ( 2023 ) . Prevaccination Glucose Time in Range Correlates With Antibody Response to SARS-CoV-2 Vaccine in Type 1 Diabetes . The Journal of Clinical Endocrinology & Metabolism vol. 108 , ( 7 ) e474 - e479 .

Alhamar G, Briganti SI, Viola V, Faraj M, Zannella C, Franci G, Fusco C, Isgro C et al. ( 2023 ) . PRE-VACCCINATION GLUCOSE TIME IN RANGE POSITIVELY CORRELATES WITH ANTIBODY RESPONSE AFTER SARS-COV2 MRNA VACCINE BNT162B2 IN PATIENTS WITH TYPE 1 DIABETES . DIABETES TECHNOLOGY & THERAPEUTICS . vol. 25 , A81 - A81 .

Leanza G, Cannata F, Faraj M, Viola V, Tramontana F, Pedone C, Piccoli A, Strollo R et al. ( 2023 ) . Wnt Signaling Regulation in Bone of Postmenopausal Women With Type 2 Diabetes . JOURNAL OF BONE AND MINERAL RESEARCH . vol. 38 , 331 - 331 .

Bruttomesso D, Irace C, Pozzilli P, group TSS, Anichini R, Magiar A, Baggiore CM, Disoteo O et al. ( 2022 ) . A sub-analysis of the SAGE study in Italy indicates good glycemic control in type 1 diabetes . Nutrition Metabolism and Cardiovascular Diseases vol. 33 , ( 3 ) 631 - 639 .

Strollo R, Vinci C, Man YKS, Bruzzaniti S, Piemonte E, Alhamar G, Briganti SI, Malandrucco I et al. ( 2022 ) . Autoantibody and T cell responses to oxidative post-translationally modified insulin neoantigenic peptides in type 1 diabetes . Diabetologia vol. 66 , ( 1 ) 132 - 146 .

Messina MV, Pozzilli P, Palermo A ( 2022 ) . An Investigation Through Time: What Hides Behind the Neck of This Ancient Roman Woman? . Thyroid vol. 32 , ( 9 ) 1007 - 1009 .

Defeudis G, Maddaloni E, Rossini G, Di Tommaso AM, Mazzilli R, Di Palma P, Pozzilli P, Napoli N ( 2022 ) . Glycemic Variability in Subjects with Diabetes and Hypogonadism during Testosterone Replacement Treatment: A Pilot Study . Journal of Clinical Medicine vol. 11 , ( 18 )

Di Mario C, Genovese S, Lanza GA, Mannucci E, Marenzi G, Sciatti E, Pitocco D ( 2022 ) . Role of continuous glucose monitoring in diabetic patients at high cardiovascular risk: an expert-based multidisciplinary Delphi consensus . Cardiovascular Diabetology vol. 21 , ( 1 )

Pozzilli P, Villa Giovanni CF ( 2022 ) . A beautiful image of the thyroid in an apparently healthy young boy . Journal of Endocrinological Investigation vol. 46 , ( 4 ) 851 - 852 .

Chandrashekhar Joshi S, Pozzilli P ( 2022 ) . COVID-19 induced Diabetes: A novel presentation . Diabetes Research and Clinical Practice vol. 191 ,

Piemonti L, Keymeulen B, Gillard P, Linn T, Bosi E, Rose L, Pozzilli P, Giorgino F et al. ( 2022 ) . Ladarixin, an inhibitor of the interleukin‐8 receptors CXCR1 and CXCR2, in new‐onset type 1 diabetes: A multicentre, randomized, double‐blind, placebo‐controlled trial . Diabetes Obesity and Metabolism vol. 24 , ( 9 ) 1840 - 1849 .

Maddaloni E, Bolli GB, Frier BM, Little RR, Leslie RD, Pozzilli P, Buzzetti R ( 2022 ) . C‐peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective . Diabetes Obesity and Metabolism vol. 24 , ( 10 ) 1912 - 1926 .

Pofi R, Giannetta E, Feola T, Galea N, Barbagallo F, Campolo F, Badagliacca R, Barbano B et al. ( 2022 ) . Sex-specific effects of daily tadalafil on diabetic heart kinetics in RECOGITO, a randomized, double-blind, placebo-controlled trial . Science Translational Medicine vol. 14 , ( 649 )

MONTE L, TUCCINARDI D, ROSSINI G, WATANABE M, POZZILLI P, NAPOLI N, MANFRINI S ( 2022 ) . 242-LB: Roux-en-Y Gastric Bypass and Vertical Sleeve Gastrectomy Showed Similar Efficacy in Achieving Cardiometabolic Composite Target in Subject with Type 2 Diabetes Undergoing Bariatric Surgery . Diabetes vol. 71 , ( Supplement_1 )

MADDALONI E, CARLONE A, PITOCCO D, LEANZA G, SURACI C, ALTOMARE M, CAVALLO MG, BARCHETTA I et al. ( 2022 ) . 471-P: Glycated Haemoglobin in the First Year after Diagnosis of Type 1 Diabetes Is an Independent Risk Factor for Diabetic Retinopathy: The IMDIAB 25 Years Follow-Up Study . Diabetes vol. 71 , ( Supplement_1 )

PIERALICE S, MONTE L, DEFEUDIS G, TABACCO G, NAPOLI N, POZZILLI P ( 2022 ) . 677-P: Impact of Third Dose COVID-Vaccination on Glycaemic Control in Individuals with Type 1 Diabetes Using Flash Glucose Monitoring . Diabetes vol. 71 , ( Supplement_1 )

De Ridder F, Ledeganck KJ, De Winter B, Braspenning R, Delbeke D, Renard E, Pozzilli P, Pieralice S et al. ( 2022 ) . Trends of glucose, lactate and ketones during anaerobic and aerobic exercise in subjects with type 1 diabetes: The ACTION‐1 study . Diabetes/Metabolism Research and Reviews . vol. 38 ,

Fiorina P, Pozzilli P ( 2022 ) . Unveiling a novel type 1 diabetes endotype: Opportunities for intervention . Diabetes/Metabolism Research and Reviews vol. 38 , ( 5 )

Briganti SI, Strollo R, Maggi D, Kyanvash S, Lanza O, Manfrini S, Pozzilli P ( 2022 ) . Effect of a novel-app based strategy for carbohydrate counting on glucose control in type 1 diabetes . Endocrine Abstracts

Monte L, Tuccinardi D, Strollo R, Briganti S, Rausa D, Pozzilli P, Napoli N, Manfrini S ( 2022 ) . Primary hyperparathyroidism in the setting of previous roux-en-Y gastric bypass: a case report . Endocrine Abstracts

Monte L, Tuccinardi D, Rossini G, Watanabe M, Pozzilli P, Napoli N, Manfrini S ( 2022 ) . Roux-en-Y gastric bypass and vertical sleeve gastrectomy showed similar efficacy in achieving cardiometabolic composite target in subject with type 2 diabetes undergoing bariatric surgery . Endocrine Abstracts

Rossini G, Tommaso AMD, Rausa D, Palermo A, Tuccinardi D, Pozzilli P, Napoli N, Manfrini S ( 2022 ) . Severe refractory nonislet cell tumor hypoglycemia and paraneoplastic hypercalcemia in a patient with pancreatic adenocarcinoma with neuroendocrine differentiation: a case report . Endocrine Abstracts

Pozzilli P ( 2022 ) . Type 1 diabetes remission: who, how and when . Endocrine Abstracts

Irina BS, Maggi D, Strollo R, Kyanvash S, Lanza O, Pozzilli P, Manfrini S ( 2022 ) . Type 1 diabetes technology and quality of life: glucose control and beyond . Endocrine Abstracts

Pieralice S, D’Onofrio L, Pozzilli P, Buzzetti R ( 2022 ) . Third dose of COVID‐19 vaccine in diabetes: Relevance of good metabolic control to improve its efficacy . Diabetes/Metabolism Research and Reviews vol. 38 , ( 5 )

Pezzilli S, Tohidirad M, Biagini T, Scarale MG, Alberico F, Mercuri L, Mannino GC, Garofolo M et al. ( 2022 ) . Contribution of rare variants in monogenic diabetes-genes to early-onset type 2 diabetes . Diabetes & Metabolism vol. 48 , ( 5 )

Tavaglione F, Jamialahmadi O, De Vincentis A, Qadri S, Mowlaei ME, Mancina RM, Ciociola E, Carotti S et al. ( 2022 ) . Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis . Clinical Gastroenterology and Hepatology vol. 21 , ( PLoS Med 12 2015 ) 1523 - 1532.e1 .

Alhamar G, Maddaloni E, Al Shukry A, Al‐Sabah S, Al‐Haddad M, Al‐Youha S, Jamal M, Almazeedi S et al. ( 2022 ) . Development of a clinical risk score to predict death in patients with COVID‐19 . Diabetes/Metabolism Research and Reviews vol. 38 , ( 5 )

Pezzilli S, Mazza T, Scarale MG, Tang Y, Andreozzi F, Baroni MG, Buzzetti R, Cavallo MG et al. ( 2022 ) . Pathogenic variants of MODY-genes in adult patients with early-onset type 2 diabetes . Acta Diabetologica vol. 59 , ( 5 ) 747 - 750 .

Catriona C, Paolo P ( 2022 ) . SARS‐CoV‐2 induced post‐translational protein modifications: A trigger for developing autoimmune diabetes? . Diabetes/Metabolism Research and Reviews vol. 38 , ( 1 )

Briganti SI, Strollo R, Maggi D, Kyanvash S, Pozzilli P, Manfrini S ( 2022 ) . A MOBILE-APP ASSISTED CARBOHYDRATE COUNTING STRATEGY IMPROVES GLUCOSE CONTROL IN TYPE 1 DIABETES . DIABETES TECHNOLOGY & THERAPEUTICS . vol. 24 , A154 - A154 .

Naciu AM, Vescini F, Sanson G, Incognito GG, Falchetti A, Bosco D, Santonati A, Pozzilli P et al. ( 2022 ) . Efficacy of calcium citrate versus calcium carbonate for the management of chronic hypoparathyroidism . JOURNAL OF BONE AND MINERAL RESEARCH . vol. 37 , 164 - 164 .

Briganti SI, Strollo R, Maggi D, Kyanvash S, Egiddi S, Pozzilli P, Manfrini S, Lanza O ( 2022 ) . IMPACT OF NEW TECHNOLOGIES ON QUALITY OF LIFE AND GLUCOSE CONTROL IN PATIENTS WITH TYPE 1 DIABETES . DIABETES TECHNOLOGY & THERAPEUTICS . vol. 24 , A175 - A176 .

Briganti S, Alhamar G, Viola V, Faraj M, Zannella C, Franci G, Fusco C, Isgro C et al. ( 2022 ) . Pre-vaccination glucose time in range positively correlates with antibody response to SARs-CoV2 mRNA vaccine BNT162b2 in patients with type 1 diabetes . DIABETOLOGIA . vol. 65 , S163 - S163 .

Tavaglione F, Jamialahmadi O, De Vincentis A, Qadri S, Bruni V, Carotti S, Perrone G, Tuccinardi D et al. ( 2022 ) . The fibrotic NASH index: a simple non-invasive score to screen for liver disease in individuals with metabolic risk factors . DIABETOLOGIA . vol. 65 , S50 - S51 .

Leanza G, Tramontana F, Cannata F, Piccoli A, Faraj M, Viola V, Strollo R, Beeve A et al. ( 2022 ) . Wnt Regulation in Bone of Type 2 Diabetes Patients . JOURNAL OF BONE AND MINERAL RESEARCH . vol. 37 , 37 - 37 .

Tavaglione F, De Vincentis A, Bruni V, Gallo IF, Carotti S, Tuccinardi D, Spagnolo G, Ciociola E et al. ( 2021 ) . Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery . Liver International vol. 42 , ( 2 ) 374 - 383 .

Bosi E, Gregori G, Cruciani C, Irace C, Pozzilli P, Buzzetti R ( 2021 ) . The use of flash glucose monitoring significantly improves glycemic control in type 2 diabetes managed with basal bolus insulin therapy compared to self-monitoring of blood glucose: A prospective observational cohort study . Diabetes Research and Clinical Practice vol. 183 ,

Feriozzi S, Buzzetti R, Pozzilli P ( 2021 ) . Comparsa di diabete mellito dopo trapianto di rene (NODAT) . L'Endocrinologo vol. 22 , ( 6 ) 576 - 577 .

Cavallari I, Maddaloni E, Nusca A, Tuccinardi D, Buzzetti R, Pozzilli P, Grigioni F ( 2021 ) . SGLT-2 Inhibitors on Top of Current Pharmacological Treatments for Heart Failure: A Comparative Review on Outcomes and Cost Effectiveness . American Journal of Cardiovascular Drugs vol. 22 , ( 3 ) 263 - 270 .

Pozzilli P, Pieralice S ( 2021 ) . Early Diagnosis of Type 1 Diabetes – Useful or a Pyrrhic Victory? . Clinical Dilemmas in Diabetes , Wiley

Tuccinardi D, Di Mauro A, Lattanzi G, Rossini G, Monte L, Beato I, Spiezia C, Bravo M et al. ( 2021 ) . An extra virgin olive oil‐enriched chocolate spread positively modulates insulin‐resistance markers compared with a palm oil‐enriched one in healthy young adults: A double‐blind, cross‐over, randomised controlled trial . Diabetes/Metabolism Research and Reviews vol. 38 , ( 2 )

Defeudis G, Mazzilli R, Tenuta M, Rossini G, Zamponi V, Olana S, Faggiano A, Pozzilli P et al. ( 2021 ) . Erectile dysfunction and diabetes: A melting pot of circumstances and treatments . Diabetes/Metabolism Research and Reviews vol. 38 , ( 2 )

Ludvigsson J, Cuthbertson D, Becker DJ, Kordonouri O, Aschemeier B, Pacaud D, Clarson C, Krischer JP et al. ( 2021 ) . Increasing plasma glucose before the development of type 1 diabetes—the TRIGR study . Pediatric Diabetes vol. 22 , ( 7 ) 974 - 981 .

Pofi R, Giannetta E, Feola T, Galea N, Campolo F, Barbagallo F, Badagliacca R, Barbano B et al. ( 2021 ) . Sex-specific cardioprotection of daily tadalafil in patients with type-2 diabetes. The RECOGITO, randomized, double-blind, placebo-controlled trial . Endocrine Abstracts

Gu Y, Jia X, Vartak T, Miao D, Dong F, Jerram ST, Rewers M, Ferrara A et al. ( 2021 ) . Improving clinical utility of GAD65 autoantibodies by electrochemiluminescence assay and clinical phenotype when identifying autoimmune adult-onset diabetes . Diabetologia vol. 64 , ( 9 ) 2052 - 2060 .

Pozzilli P, Nicolai L ( 2021 ) . Cosimo I de Medici and his Merseburg triad of Graves’ disease . Journal of Endocrinological Investigation vol. 44 , ( 12 ) 2853 - 2854 .

LEANZA G, TRAMONTANA F, CANNATA F, PICCOLI A, FARAJ M, VIOLA V, STROLLO R, NAPOLI N et al. ( 2021 ) . 1031-P: Wnt Regulation and Collagen Gene Expression in the Bone of Type 2 Diabetes Patients . Diabetes vol. 70 , ( Supplement_1 )

De Paoli B, D’Antoni F, Merone M, Pieralice S, Piemonte V, Pozzilli P ( 2021 ) . Blood Glucose Level Forecasting on Type-1-Diabetes Subjects during Physical Activity: A Comparative Analysis of Different Learning Techniques . Bioengineering vol. 8 , ( 6 )

Cesareo R, Manfrini S, Pasqualini V, Ambrogi C, Sanson G, Gallo A, Pozzilli P, Pedone C et al. ( 2021 ) . Laser ablation versus radiofrequency ablation for benign non-functioning thyroid nodules: twelve-month results of a randomized, parallel-arm, open-label trial . Endocrine Abstracts

Del Toro R, Cavallari I, Tramontana F, Park K, Strollo R, Valente L, De Pascalis M, Grigioni F et al. ( 2021 ) . Association of bone biomarkers with advanced atherosclerotic disease in people with overweight/obesity . Endocrine vol. 73 , ( 2 ) 339 - 346 .

Pozzilli P, Napoli N ( 2021 ) . Medical congresses at the click of a mouse . Diabetes Research and Clinical Practice vol. 175 ,

Renard E, Ikegami H, Vianna AGD, Pozzilli P, Brette S, Bosnyak Z, Lauand F, Peters A et al. ( 2021 ) . The SAGE study: Global observational analysis of glycaemic control, hypoglycaemia and diabetes management in T1DM . Diabetes/Metabolism Research and Reviews vol. 37 , ( 7 )

Cesareo R, Manfrini S, Pasqualini V, Ambrogi C, Sanson G, Gallo A, Pozzilli P, Pedone C et al. ( 2021 ) . Laser Ablation Versus Radiofrequency Ablation for Thyroid Nodules: 12-Month Results of a Randomized Trial (LARA II Study) . The Journal of Clinical Endocrinology & Metabolism vol. 106 , ( 6 ) 1692 - 1701 .

Jendle JH, Ampudia-Blasco FJ, Fuchtenbusch M, Pozzilli P ( 2021 ) . Dapagliflozin as an Adjunct Therapy to Insulin in Patients with Type 1 Diabetes Mellitus: Efficacy and Safety of this Combination . touchREVIEWS in Endocrinology vol. 1 , ( 1 )

Bosi E, Gregori G, Cruciani C, Irace C, Pozzilli P, Buzzetti R ( 2021 ) . EFFECT OF FLASH GLUCOSE MONITORING ON GLYCAEMIC CONTROL IN TYPE 2 DIABETES COMPARED TO SMBG; A PROSPECTIVE OBSERVATIONAL STUDY FROM ITALY . DIABETES TECHNOLOGY & THERAPEUTICS . vol. 23 , A40 - A41 .

Palermo A, Tabacco G, Vescini F, Sanson G, Incognito GG, Falchetti A, Bosco D, Santonati A et al. ( 2021 ) . EFFECTIVENESS OF CALCIUM CITRATE IN COMPARISON WITH CALCIUM CARBONATE FOR THE MANAGEMENT OF CHRONIC HYPOPARATHYROIDISM . OSTEOPOROSIS INTERNATIONAL . vol. 32 , S334 - S335 .

Peters A, Ampudia-Blasco FJ, Gagliardino J, Bigot G, Westerbacka J, Pozzilli P ( 2021 ) . REGIONAL DIFFERENCES IN GLYCAEMIC CONTROL BY RECOMMENDED METHOD OF INSULIN TITRATION IN ADULTS WITH TYPE 1 DIABETES (T1D) IN THE SAGE STUDY . DIABETES TECHNOLOGY & THERAPEUTICS . vol. 23 , A88 - A88 .

Briganti SI, Strollo R, Maggi D, Kyanvash S, Pozzilli P, Manfrini S ( 2021 ) . TIME IN RANGE AND GLUCOSE CONTROL IN PATIENTS WITH TYPE 1 DIABETES USING A MOBILE APP-ASSISTED CARBOHYDRATE COUNTING . DIABETES TECHNOLOGY & THERAPEUTICS . vol. 23 , A29 - A29 .

Leanza G, Tramontana F, Cannata F, Piccoli A, Viola V, Faraj M, Strollo R, Pozzilli P et al. ( 2021 ) . Wnt regulation and collagen gene expression in the bone of type 2 diabetes elderly women . DIABETOLOGIA . vol. 64 , 89 - 89 .

Forst T, Choudhary P, Schneider D, Linetzky B, Pozzilli P ( 2020 ) . A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetes . Diabetes/Metabolism Research and Reviews vol. 37 , ( 6 )

Maddaloni E, Moretti C, Del Toro R, Sterpetti S, Ievolella MV, Arnesano G, Strollo R, Briganti SI et al. ( 2020 ) . Risk of cardiac autonomic neuropathy in latent autoimmune diabetes in adults is similar to type 1 diabetes and lower compared to type 2 diabetes: A cross‐sectional study . Diabetic Medicine vol. 38 , ( 2 )

Dario T, Riccardo G, Silvia P, Mikiko W, Daria M, Andrea P, Giuseppe D, Elvira F et al. ( 2020 ) . The utility of assessing C-peptide in patients with insulin-treated type 2 diabetes: a cross-sectional study . Acta Diabetologica vol. 58 , ( 4 ) 411 - 417 .

Cannata F, Vadalà G, Ambrosio L, Napoli N, Papalia R, Denaro V, Pozzilli P ( 2020 ) . The impact of type 2 diabetes on the development of tendinopathy . Diabetes/Metabolism Research and Reviews vol. 37 , ( 6 )

Maddaloni E, D’Onofrio L, Alessandri F, Mignogna C, Leto G, Pascarella G, Mezzaroma I, Lichtner M et al. ( 2020 ) . Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II) . Cardiovascular Diabetology vol. 19 , ( 1 )

Di Mauro A, Tuccinardi D, Watanabe M, Del Toro R, Monte L, Giorgino R, Rampa L, Rossini G et al. ( 2020 ) . The Mediterranean diet increases glucagon‐like peptide 1 and oxyntomodulin compared with a vegetarian diet in patients with type 2 diabetes: A randomized controlled cross‐over trial . Diabetes/Metabolism Research and Reviews vol. 37 , ( 6 )

Maddaloni E, D'Onofrio L, Alessandri F, Mignogna C, Leto G, Coraggio L, Sterpetti S, Pascarella G et al. ( 2020 ) . Clinical features of patients with type 2 diabetes with and without Covid-19: A case control study (CoViDiab I) . Diabetes Research and Clinical Practice vol. 169 ,

Strollo R, Maddaloni E, Dauriz M, Pedone C, Buzzetti R, Pozzilli P ( 2020 ) . Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths . Diabetes Research and Clinical Practice vol. 171 ,

Battisti S, Pedone C, Napoli N, Russo E, Agnoletti V, Nigra SG, Dengo C, Mughetti M et al. ( 2020 ) . Computed Tomography Highlights Increased Visceral Adiposity Associated With Critical Illness in COVID-19 . Diabetes Care vol. 43 , ( 10 ) e129 - e130 .

Cannata F, Vadalà G, Russo F, Papalia R, Napoli N, Pozzilli P ( 2020 ) . Beneficial Effects of Physical Activity in Diabetic Patients . Journal of Functional Morphology and Kinesiology vol. 5 , ( 3 )

Buzzetti R, Tuomi T, Mauricio D, Pietropaolo M, Zhou Z, Pozzilli P, Leslie RD ( 2020 ) . Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel . Diabetes vol. 69 , ( 10 ) 2037 - 2047 .

Cesareo R, Maurizio PC, Pasqualini V, Campagna G, Lauria PA, Pozzilli P, Cianni R, Manfrini S et al. ( 2020 ) . Llaser ablation vs radiofrequency ablation for benign non-functioning thyroid nodules: six-month results of a randomised, parallel, open-label, trial (LARA trial) . Endocrine Abstracts

Maddaloni E, Briganti SI, Crescenzi A, Anguissola GB, Perrella E, Taffon C, Palermo A, Manfrini S et al. ( 2020 ) . Usefulness of Color Doppler Ultrasonography in the Risk Stratification of Thyroid Nodules . European Thyroid Journal vol. 10 , ( 4 ) 339 - 344 .

Piccoli A, Cannata F, Strollo R, Pedone C, Leanza G, Russo F, Greto V, Isgrò C et al. ( 2020 ) . Sclerostin Regulation, Microarchitecture, and Advanced Glycation End‐Products in the Bone of Elderly Women With Type 2 Diabetes . Journal of Bone and Mineral Research vol. 35 , ( 12 ) 2415 - 2422 .

Alhamar GE, Strollo R, Pozzilli P ( 2020 ) . Comment on So et al. Autoantibody Reversion: Changing Risk Categories in Multiple-Autoantibody–Positive Individuals. Diabetes Care 2020;43:913–917 . Diabetes Care vol. 43 , ( 8 ) e102 - e102 .

Cavallari I, Maddaloni E, Pieralice S, Mulè MT, Buzzetti R, Ussia GP, Pozzilli P, Grigioni F ( 2020 ) . The Vicious Circle of Left Ventricular Dysfunction and Diabetes: From Pathophysiology to Emerging Treatments . The Journal of Clinical Endocrinology & Metabolism vol. 105 , ( 9 )

Maddaloni E, Coraggio L, Pieralice S, Carlone A, Pozzilli P, Buzzetti R ( 2020 ) . Effects of COVID-19 Lockdown on Glucose Control: Continuous Glucose Monitoring Data From People With Diabetes on Intensive Insulin Therapy . Diabetes Care vol. 43 , ( 8 ) e86 - e87 .

Strollo R, Pozzilli P ( 2020 ) . DPP4 inhibition: Preventing SARS‐CoV‐2 infection and/or progression of COVID‐19? . Diabetes/Metabolism Research and Reviews vol. 36 , ( 8 )

PIERALICE S, TUCCINARDI D, KYANVASH S, MAGGI D, MONTE L, BRIGANTI SI, MANFRINI S, POZZILLI P ( 2020 ) . 1124-P: SGLT2 Inhibitors as Adjuvant Therapy for Type 1 Diabetes: An Italian Center Experience . Diabetes vol. 69 , ( Supplement_1 )

PIERALICE S, MADDALONI E, MORETTI C, MAURIZI AR, MIGNOGNA C, DINATALE S, POZZILLI P, BUZZETTI R ( 2020 ) . 1217-P: Improvement of Metabolic Control in Type 1 Diabetes after Transition Is Independent from Referral Center and Insulin Regimen . Diabetes vol. 69 , ( Supplement_1 )

RENARD E, BOSNYAK Z, LAUAND F, POZZILLI P, IKEGAMI H, KESAVADEV J, VIANNA AG ( 2020 ) . 1514-P: Suboptimal Glycemic Control and High Prevalence of Diabetes Complications in Adults with Type 1 Diabetes (T1D) in the SAGE Study . Diabetes vol. 69 , ( Supplement_1 )

MAURO AD, TUCCINARDI D, TORO RD, MONTE L, GIORGINO R, RAMPA L, ROSSINI G, KYANVASH S et al. ( 2020 ) . 226-OR: The Mediterranean Diet Increases GLP-1 and Oxyntomodulin Compared with Vegetarian Diet in Type 2 Diabetes Subjects . Diabetes vol. 69 , ( Supplement_1 )

TRAMONTANA F, MADDALONI E, GRECI S, DEFEUDIS G, STROLLO R, POZZILLI P, NAPOLI N ( 2020 ) . 227-OR: The Effect of Dietary Fiber in Combination with Metformin Therapy in Type 2 Diabetes . Diabetes vol. 69 , ( Supplement_1 )

BOSI E, POZZILLI P, GIORGINO F, COSSU E, LINN T, ROSE L, KEYMEULEN B, GILLARD P et al. ( 2020 ) . 249-OR: A Randomized, Double-Blind Phase 2 Trial of the CXCR1/2 Inhibitor Ladarixin in Adult Patients with New-Onset Type 1 Diabetes . Diabetes vol. 69 , ( Supplement_1 )

MADDALONI E, PARK K, GUIDA MD, CORAGGIO L, LUORDI C, D’ONOFRIO L, BARONI MG, CAVALLO MG et al. ( 2020 ) . 570-P: Osteoprotegerin Induces Endothelial Dysfunction and Is Associated with Vascular Complications In Type 2 Diabetes . Diabetes vol. 69 , ( Supplement_1 )

Ibrahim M, Baker J, Cahn A, Eckel RH, Sayed NAE, Fischl AH, Gaede P, Leslie RD et al. ( 2020 ) . Hypoglycaemia and its management in primary care setting . Diabetes/Metabolism Research and Reviews vol. 36 , ( 8 )

Cesareo R, Pacella CM, Pasqualini V, Campagna G, Iozzino M, Gallo A, Pantano AL, Cianni R et al. ( 2020 ) . OR18-07 Laser Ablation Versus Radiofrequency Ablation for Benign Non-Functioning Thyroid Nodules: Six-Month Results of a Randomised, Parallel, Open-Label, Trial (Lara Trial) . Journal of the Endocrine Society vol. 4 , ( Supplement_1 ) or18 - or07 .

Pozzilli P, Lenzi A ( 2020 ) . Commentary: Testosterone, a key hormone in the context of COVID-19 pandemic . Metabolism vol. 108 ,

Vinci C, Infantino M, Raturi S, Tindell A, Topping L, Strollo R, Amital H, Shoenfeld Y et al. ( 2020 ) . Immunoglobulin A antibodies to oxidized collagen type II as a potential biomarker for the stratification of spondyloarthritis from rheumatoid arthritis . Scandinavian Journal of Rheumatology vol. 49 , ( 4 ) 281 - 291 .

Palermo A, Naciu AM, Tabacco G, Falcone S, Santonati A, Maggi D, D’Onofrio L, Briganti SI et al. ( 2020 ) . Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism . The Journal of Clinical Endocrinology & Metabolism vol. 105 , ( 7 )

Pozzilli P, Bosi E, Cirkel D, Harris J, Leech N, Tinahones FJ, Vantyghem M-C, Vlasakakis G et al. ( 2020 ) . Randomized 52-week Phase 2 Trial of Albiglutide Versus Placebo in Adult Patients With Newly Diagnosed Type 1 Diabetes . The Journal of Clinical Endocrinology & Metabolism vol. 105 , ( 6 )

Buzzetti R, Zampetti S, Pozzilli P ( 2020 ) . Impact of obesity on the increasing incidence of type 1 diabetes . Diabetes Obesity and Metabolism vol. 22 , ( 7 ) 1009 - 1013 .

Cesareo R, Pacella CM, Pasqualini V, Campagna G, Iozzino M, Gallo A, Pantano AL, Cianni R et al. ( 2020 ) . Laser Ablation Versus Radiofrequency Ablation for Benign Non-Functioning Thyroid Nodules: Six-Month Results of a Randomized, Parallel, Open-Label, Trial (LARA Trial) . Thyroid vol. 30 , ( 6 ) 847 - 856 .

Amisi CA, Ciccozzi M, Pozzilli P ( 2020 ) . Wrist circumference: A new marker for insulin resistance in African women with polycystic ovary syndrome . World Journal of Diabetes vol. 11 , ( 2 ) 42 - 51 .

Pozzilli P, Lazzeri D ( 2020 ) . Our Lady of Carmel and Saints of Pietro Novelli (1603–1647) . Journal of Endocrinological Investigation vol. 43 , ( 7 ) 1045 - 1046 .

Leanza G, Fontana F, Strollo R, Pozzilli P, Napoli N, Civitelli R ( 2020 ) . Linagliptin Does Not Alter Bone Mass but Reduces Body Weight and White Adipose Tissue . JOURNAL OF BONE AND MINERAL RESEARCH . vol. 35 , 123 - 123 .

Piemonti L, Lampasona V, Marzinotto I, Bosi E, Pozzilli P, Giorgino F, Cossu E, Linn T et al. ( 2020 ) . MiR-375 levels in newly diagnosed type 1 diabetes: results from a phase 2, multicentre, randomised, placebo controlled trial (MEX0114) . DIABETOLOGIA . vol. 63 , S183 - S184 .

Tramontana F, Maddaloni E, Greci S, Defeudis G, Strollo R, Pozzilli P, Napoli N ( 2020 ) . The effect of dietary fiber on glycaemic control in patients with type 2 diabetes on metformin monotherapy . DIABETOLOGIA . vol. 63 , S105 - S105 .

Creta A, Providência R, Adragão P, de Asmundis C, Chun J, Chierchia G, Defaye P, Schmidt B et al. ( 2019 ) . Impact of Type-2 Diabetes Mellitus on the Outcomes of Catheter Ablation of Atrial Fibrillation (European Observational Multicentre Study) . The American Journal of Cardiology vol. 125 , ( 6 ) 901 - 906 .

Cannata F, Vadalà G, Ambrosio L, Napoli N, Papalia R, Denaro V, Pozzilli P ( 2019 ) . Osteoarthritis and type 2 diabetes: From pathogenetic factors to therapeutic intervention . Diabetes/Metabolism Research and Reviews vol. 36 , ( 3 )

Cannata F, Vadalà G, Ambrosio L, Fallucca S, Napoli N, Papalia R, Pozzilli P, Denaro V ( 2019 ) . Intervertebral disc degeneration: A focus on obesity and type 2 diabetes . Diabetes/Metabolism Research and Reviews vol. 36 , ( 1 )

Nusca A, Tuccinardi D, Proscia C, Melfi R, Manfrini S, Nicolucci A, Ceriello A, Pozzilli P et al. ( 2019 ) . Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention . Cardiovascular Diabetology vol. 18 , ( 1 )

Tabacco G, Naciu AM, Cesareo R, Maggi D, Pedone C, Lelli D, Santonati A, Bosco D et al. ( 2019 ) . Cardiovascular autonomic neuropathy as a cause of fatigue in chronic hypoparathyroidism . Endocrine vol. 67 , ( 1 ) 198 - 203 .

Gentilella R, Sesti G, Vazquez L, Sapin H, Reed V, Romera I, Pozzilli P ( 2019 ) . Dulaglutide is an effective treatment for lowering HbA1c in patients with type 2 diabetes regardless of body mass index . Diabetes Obesity and Metabolism vol. 21 , ( 12 ) 2660 - 2666 .

D'Antoni F, Merone M, Piemonte V, Pozzilli P, Iannello G, Soda P ( 2019 ) . Early Experience in Forecasting Blood Glucose Levels Using a Delayed and Auto-Regressive Jump Neural Network . Conference: 2019 IEEE 18th International Conference on Cognitive Informatics & Cognitive Computing (ICCI*CC) vol. 00 , 394 - 402 .

Maddaloni E, Coleman RL, Pozzilli P, Holman RR ( 2019 ) . Long‐term risk of cardiovascular disease in individuals with latent autoimmune diabetes in adults (UKPDS 85) . Diabetes Obesity and Metabolism vol. 21 , ( 9 ) 2115 - 2122 .

Pozzilli P, Vollero L, Colao A ( 2019 ) . Venus by Botticelli and Her Pituitary Adenoma . Endocrine Practice vol. 25 , ( 10 ) 1067 - 1073 .

PIERALICE S, TORO RD, KHAZRAI YM, MADDALONI E, MAURIZI AR, MANFRINI S, POZZILLI P ( 2019 ) . 1581-P: Increase of Diabetes and Obesity among Descendants of First-Generation Filipino Immigrants to Italy . Diabetes . vol. 68 ,

LEANZA G, ALIPPE Y, LEE S-Y, STROLLO R, POZZILLI P, CIVITELLI R, NAPOLI N ( 2019 ) . 1964-P: Type 1 Diabetes: Sclerostin Resistance Improves Glucose Metabolism and Protects Bone Mass . Diabetes . vol. 68 ,

PICCOLI A, CANNATA F, RUSSO F, GRETO VL, ISGRÒ C, LEANZA G, STROLLO R, MASSARONI C et al. ( 2019 ) . 1983-P: WNT Pathway and Bone Fragility in Postmenopausal Women with Type 2 Diabetes . Diabetes . vol. 68 ,

TUCCINARDI D, ROSSINI G, MADDALONI E, MAGGI D, MONTE L, FIORITI E, KYANVASH S, POZZILLI P et al. ( 2019 ) . 2069-P: Energy Expenditure during Sleep Is an Independent Marker of Prediabetes—A Cross-Sectional Study of Overweight/Obese Subjects . Diabetes . vol. 68 ,

Pozzilli P, Lazzeri D ( 2019 ) . The Altarpiece of Saint Joseph’s Church in Scicli (Sicily) . Journal of Endocrinological Investigation vol. 43 , ( 1 ) 121 - 122 .

Leanza G, Maddaloni E, Pitocco D, Conte C, Palermo A, Maurizi AR, Pantano AL, Suraci C et al. ( 2019 ) . Risk factors for fragility fractures in type 1 diabetes . Bone . vol. 125 , 194 - 199 .

Naciu AM, Tabacco G, Falcone S, Santonati A, Maggi D, D'Onofrio L, Briganti SI, Castellitto D et al. . Clinical, biochemical and radiological profile of normocalcaemic hyperparathyroidism: a multicentric cross-sectional evaluation . Endocrine Abstracts .

Tabacco G, Naciu A, Maggi D, Pedone C, Lelli D, Santonati A, Bosco D, Cesareo R et al. ( 2019 ) . MON-527 Cardiovascular Autonomic Neuropathy As A Cause Of Quality Of Life Impairment In Subjects With Chronic Hypoparathyroidism . Journal of the Endocrine Society vol. 3 , ( Supplement_1 ) mon - 527 .

Rosenson RS, Daviglus ML, Handelsman Y, Pozzilli P, Bays H, Monsalvo ML, Elliott-Davey M, Somaratne R et al. ( 2019 ) . Efficacy and safety of evolocumab in individuals with type 2 diabetes mellitus: primary results of the randomised controlled BANTING study . Diabetologia vol. 62 , ( 6 ) 948 - 958 .

Pieralice S, Vari R, Minutolo A, Maurizi AR, Fioriti E, Napoli N, Pozzilli P, Manfrini S et al. ( 2019 ) . Biomarkers of response to alpha-lipoic acid ± palmitoiletanolamide treatment in patients with diabetes and symptoms of peripheral neuropathy . Endocrine vol. 66 , ( 2 ) 178 - 184 .

Verma S, Wanner C, Zwiener I, Ofstad AP, George JT, Fitchett D, Zinman B, Investigators E-RO ( 2019 ) . Influence of Microvascular Disease on Cardiovascular Events in Type 2 Diabetes . Journal of the American College of Cardiology vol. 73 , ( 21 ) 2780 - 2782 .

Pozzilli P, Signore A ( 2019 ) . The reconstructed natural history of type 1 diabetes mellitus . Nature Reviews Endocrinology vol. 15 , ( 5 ) 256 - 257 .

Pozzilli P ( 2019 ) . A tribute to Professor Domenico Andreani . Diabetes/Metabolism Research and Reviews vol. 35 , ( 3 )

Strollo R, Vinci C, Napoli N, Fioriti E, Maddaloni E, Åkerman L, Casas R, Pozzilli P et al. ( 2019 ) . Antibodies to oxidized insulin improve prediction of type 1 diabetes in children with positive standard islet autoantibodies . Diabetes/Metabolism Research and Reviews vol. 35 , ( 4 )

Pugliese G, Pozzilli P ( 2019 ) . Domenico Andreani (1925–2018) . L'Endocrinologo vol. 20 , ( 1 ) 2 - 3 .

Maurizi AR, Pieralice S, Pozzilli P ( 2019 ) . Il trattamento del diabete di tipo 1: dalle nuove insuline ai farmaci orali . L'Endocrinologo vol. 20 , ( 1 ) 21 - 26 .

Tabacco G, Naciu AM, Maggi D, Pedone C, Lelli D, Cesareo R, Santonati A, Bosco D et al. ( 2019 ) . CARDIOVASCULAR AUTONOMIC NEUROPATHY CAUSES AN IMPAIRMENT OF QUALITY OF LIFE IN SUBJECTS WITH CHRONIC HYPOPARATHYROIDISM . OSTEOPOROSIS INTERNATIONAL . vol. 30 , S293 - S293 .

Naciu AM, Tabacco G, Falcone S, Santonati A, Maggi D, D'Onofrio L, Briganti SI, Castellitto D et al. ( 2019 ) . CLINICAL, BIOCHEMICAL AND RADIOLOGICAL PROFILE OF NORMOCALCAEMIC HYPERPARATHYROIDISM: A MULTICENTRIC CROSS-SECTIONAL EVALUATION . OSTEOPOROSIS INTERNATIONAL . vol. 30 , S412 - S412 .

Leanza G, Fontana F, Alippe Y, Lee S-Y, Remedi M, Napoli N, Civitelli R, Strollo R et al. ( 2019 ) . Resistance to Lrp5 Inhibitors Protects Bone Mass and Improves Glucose Metabolism in Type 1 Diabetes . JOURNAL OF BONE AND MINERAL RESEARCH . vol. 34 , 19 - 19 .

Leanza G, Fontana F, Alippe Y, Lee S-Y, Strollo R, Pozzilli P, Remedi M, Civitelli R et al. ( 2019 ) . Sclerostin resistance improves glucose metabolism and protects bone mass in a mouse model of type 1 diabetes . DIABETOLOGIA . vol. 62 , S270 - S270 .

Renard E, Pozzilli P, Wilmot EG, Peters A, Bosnyak Z, Castro R, Lauand F, Pilorget V et al. ( 2019 ) . Suboptimal glycaemic control globally in all age groups of adults with type 1 diabetes: results of a multinational, observational study (SAGE) . DIABETOLOGIA . vol. 62 , S8 - S9 .

Tramontana F, Maddaloni E, Pozzilli P, Napoli N ( 2019 ) . The effect of high-fiber diet in combination with metformin therapy in type 2 diabetes . DIABETOLOGIA . vol. 62 , S338 - S338 .

Piccoli A, Cannata F, Russo F, Greto V, Isgro C, Strollo R, Massaroni C, Pedone C et al. ( 2019 ) . Wnt Signaling and Bone Fragility in Elderly Postmenopausal Women with Type 2 Diabetes . JOURNAL OF BONE AND MINERAL RESEARCH . vol. 34 , 357 - 357 .

Pieralice S, Pozzilli P ( 2018 ) . Latent Autoimmune Diabetes in Adults: A Review on Clinical Implications and Management . Diabetes & Metabolism Journal vol. 42 , ( 6 ) 451 - 464 .

Tabacco G, Naciu AM, Maggi D, Santonati A, Pedone C, Cesareo R, Bosco D, Gaspa G et al. ( 2018 ) . Cardiovascular Autonomic Neuropathy as a New Complication of Postsurgical Chronic Hypoparathyroidism . Journal of Bone and Mineral Research vol. 34 , ( 3 ) 475 - 481 .

Cavallari I, Delli Veneri A, Maddaloni E, Melfi R, Patti G, Napoli N, Pozzilli P, Di Sciascio G ( 2018 ) . Comparison of Lipid-Lowering Medications and Risk for Cardiovascular Disease in Diabetes . Current Diabetes Reports vol. 18 , ( 12 )

Wanner C, Heerspink HJL, Zinman B, Inzucchi SE, Koitka-Weber A, Mattheus M, Hantel S, Woerle H-J et al. ( 2018 ) . Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial . Journal of the American Society of Nephrology vol. 29 , ( 11 ) 2755 - 2769 .

Lazzeri D, Pozzilli P ( 2018 ) . Exophthalmos or pseudo-exophthalmos in the Last Judgement (1535–1541) by Michelangelo Buonarroti (1475–1564) . Journal of Endocrinological Investigation vol. 41 , ( 12 ) 1485 - 1486 .

Writing GFTTSG, M K, HK Å, E AT, D B, J B, L C, T D et al. ( 2018 ) . Effect of hydrolyzed infant formula vs conventional formula on risk of T1DM. The TRIGR randomized clinical trial .

Ricottini E, Gatto L, Melfi R, Nusca A, Cavallaro C, Albano M, Giannone S, Patti G et al. ( 2018 ) . P4766Hyperleptinemia as risk factor for high platelet reactivity and cardiovascular events in patients undergoing percutaneous coronary intervention . European Heart Journal vol. 39 , ( suppl_1 )

Nusca A, Tuccinardi D, Albano M, Cavallaro C, Ricottini E, Manfrini S, Pozzilli P, Di Sciascio G ( 2018 ) . Glycemic variability in the development of cardiovascular complications in diabetes . Diabetes/Metabolism Research and Reviews vol. 34 , ( 8 )

Palermo A, Capoluongo E, Del Toro R, Manfrini S, Pozzilli P, Maggi D, Defeudis G, Pantano F et al. ( 2018 ) . A novel germline mutation at exon 10 of MEN1 gene: a clinical survey and positive genotype-phenotype analysis of a MEN1 Italian family, including monozygotic twins . Hormones vol. 17 , ( 3 ) 427 - 435 .

( 2018 ) . Addendum . Diabetes/Metabolism Research and Reviews vol. 34 , ( 5 )

ROSENSON RS, DAVIGLUS ML, REAVEN P, POZZILLI P, BAYS H, MONSALVO ML, ELLIOTT M, SOMARATNE R et al. ( 2018 ) . Efficacy and Safety of Evolocumab in Patients with Type 2 Diabetes Mellitus and Hypercholesterolemia or Mixed Dyslipidemia . Diabetes . vol. 67 ,

TUCCINARDI D, MADDALONI E, CAPASSO I, RAMPA L, SOARE A, MAGGI D, DEFEUDIS G, KYANVASH S et al. ( 2018 ) . Energy Expenditure during Sleep Is an Independent Marker of Insulin-Resistance—A Cross-Sectional Study of Overweight/Obese Subjects . Diabetes . vol. 67 ,

MADDALONI E, MAURIZI AR, MINUTOLO A, FIORITI E, TORO RD, NACIU AM, PIERALICE S, ROSATI MM et al. ( 2018 ) . Palmitoylethanolamide in Add-On to Alpha Lipoic Acid for Control of Symptoms of Diabetic Peripheral Neuropathy . Diabetes . vol. 67 ,

MAURIZI AR, PIERALICE S, TUCCINARDI D, GUGLIELMI C, LAURIA A, MADDALONI E, FIORITI E, MANFRINI S et al. ( 2018 ) . Rapid Improvement of Metabolic Control in Type 1 Diabetes after Transition from Paediatric Clinics to an Adult Diabetes Center . Diabetes . vol. 67 ,

LEANZA G, STROLLO R, POZZILLI P, CIVITELLI R, NAPOLI N ( 2018 ) . Sclerostin Resistance Protects Bone Mass and Retards the Onset of Metabolic Abnormalities in a Mouse Model of Type 1 Diabetes . Diabetes . vol. 67 ,

Pozzilli P, Pieralice S ( 2018 ) . Latent Autoimmune Diabetes in Adults: Current Status and New Horizons . Endocrinology and Metabolism vol. 33 , ( 2 ) 147 - 159 .

Leslie RD, Pozzilli P, Peters AL, Buzzetti R, Shankar SS, Milicevic Z, Pavo I, Lebrec J et al. ( 2018 ) . Response to the comment on: “Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post‐hoc analysis of the AWARD‐2, ‐4 and ‐5 trials” . Diabetes Obesity and Metabolism vol. 20 , ( 9 ) 2319 - 2320 .

Ibrahim M, Tuomilehto J, Aschner P, Beseler L, Cahn A, Eckel RH, Fischl AH, Guthrie G et al. ( 2018 ) . Global status of diabetes prevention and prospects for action: A consensus statement . Diabetes - Metabolism: Research and Reviews vol. 34 , ( 6 )

Defeudis G, Fioriti E, Palermo A, Tuccinardi D, Minucci A, Capoluongo E, Pozzilli P, Manfrini S ( 2018 ) . A case of pheochromocytoma with negative MIBG scintigraphy, PET-CT and genetic tests (VHL included) and a rare case of post-operative erectile dysfunction . Hormones vol. 17 , ( 2 ) 279 - 284 .

Zinman B, Inzucchi SE, Wanner C, Hehnke U, George JT, Johansen OE, Fitchett D, on behalf of the EMPA-REG OUTCOME® investigators ( 2018 ) . Empagliflozin in women with type 2 diabetes and cardiovascular disease – an analysis of EMPA-REG OUTCOME® . Diabetologia vol. 61 , ( 7 ) 1522 - 1527 .

Garg S, Henry R, Banks P, Buse J, Davies M, Fulcher G, Pozzilli P, Gesty-Palmer D et al. ( 2018 ) . Efficacy of sotagliflozin 400 mg/day in 1402 patients with type 1 diabetes treated with any insulin regimen (inTandem 3) . Diabetologie und Stoffwechsel . Conference: „Wissenschaft und klinischer Fortschritt – gemeinsam in die Zukunft“ – www.diabeteskongress.de vol. 13 , s29 - s29 .

Pozzilli P, Leslie R, Peters A, Buzzetti R, Shankar S, Milicevic Z, Pavo I, Lebrec J et al. ( 2018 ) . Reduction of HbA1c with dulaglutide in type 2 diabetes (T2D) patients negative, low positive or high positive for GAD antibodies (GADA): a post hoc analysis of AWARD -2, -4 and -5 . Diabetologie und Stoffwechsel . Conference: „Wissenschaft und klinischer Fortschritt – gemeinsam in die Zukunft“ – www.diabeteskongress.de vol. 13 , s50 - s51 .

Defeudis G, Khazrai YM, Di Rosa C, Secchi C, Montedoro A, Maurizi AR, Palermo A, Pozzilli P et al. ( 2018 ) . Conversation Maps™, an effective tool for the management of males and females with type 2 diabetes and mildly impaired glycemic control . Hormones vol. 17 , ( 1 ) 113 - 117 .

Pantano AL, Maddaloni E, Briganti SI, Anguissola GB, Perrella E, Taffon C, Palermo A, Pozzilli P et al. ( 2018 ) . Differences between ATA, AACE/ACE/AME and ACR TI-RADS ultrasound classifications performance in identifying cytological high-risk thyroid nodules . European Journal of Endocrinology vol. 178 , ( 6 ) 595 - 603 .

Guglielmi C, Leslie RD, Pozzilli P ( 2018 ) . Epidemiology and Risk Factors of Type 1 Diabetes . Diabetes. Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment , Springer Nature

Napoli N, Strollo R, Defeudis G, Leto G, Moretti C, Zampetti S, D’Onofrio L, Campagna G et al. ( 2018 ) . Serum Sclerostin and Bone Turnover in Latent Autoimmune Diabetes in Adults . The Journal of Clinical Endocrinology & Metabolism vol. 103 , ( 5 ) 1921 - 1928 .

Pozzilli P, Leslie RD, Peters AL, Buzzetti R, Shankar SS, Milicevic Z, Pavo I, Lebrec J et al. ( 2018 ) . Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post‐hoc analysis of the AWARD‐2, ‐4 and ‐5 Trials . Diabetes Obesity and Metabolism vol. 20 , ( 6 ) 1490 - 1498 .

Naciu AM, Pozzilli P ( 2018 ) . Novel blood glucose lowering therapies for managing type 1 diabetes in paediatric patients . Expert Opinion on Pharmacotherapy vol. 19 , ( 4 ) 355 - 364 .

Maurizi AR, Piemonte V, Pozzilli P ( 2018 ) . Diabetes on demand and novel technologies . Diabetes/Metabolism Research and Reviews vol. 34 , ( 2 )

Capocelli M, De Santis L, Maurizi A, Pozzilli P, Piemonte V ( 2018 ) . Model Predictive Control for the Artificial Pancreas . Biomedical Engineering Challenges , Wiley

Lazzeri D, Pozzilli P ( 2018 ) . “Madonna of the carnation”: Leonardo da Vinci (1452–1519) . Journal of Endocrinological Investigation vol. 41 , ( 7 ) 879 - 880 .

Ricottini E, Mangiacapra F, Nusca A, Melfi R, Cavallari I, Miglionico M, Gallo P, Pozzilli P et al. ( 2018 ) . Relation of Platelet Indexes to Platelet Reactivity and Periprocedural Myocardial Infarction in Patients Who Underwent Percutaneous Coronary Angioplasty . The American Journal of Cardiology vol. 121 , ( 9 ) 1027 - 1031 .

Pozzilli P ( 2018 ) . Fast publication, a must for a journal . Diabetes/Metabolism Research and Reviews vol. 34 , ( 1 )

Pozzilli P ( 2018 ) . In memoriam . Diabetes/Metabolism Research and Reviews vol. 34 , ( 1 )

Grieco D, Palamà Z, Borrelli A, De Ruvo E, Sciarra L, Scarà A, Goanta E, Calabrese V et al. ( 2018 ) . Diabetes mellitus and atrial remodelling in patients with paroxysmal atrial fibrillation: Role of electroanatomical mapping and catheter ablation . Diabetes and Vascular Disease Research vol. 15 , ( 3 ) 185 - 195 .

Knip M, Åkerblom HK, Al Taji E, Becker D, Bruining J, Castano L, Danne T, de Beaufort C et al. ( 2018 ) . Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes: The TRIGR Randomized Clinical Trial . JAMA vol. 319 , ( 1 ) 38 - 48 .

Strollo R, Vinci C, Napoli N, Fioriti E, Maddaloni E, Akerman L, Casas R, Pozzilli P et al. ( 2018 ) . Antibodies to oxidised insulin improve prediction of type 1 diabetes in children with positive standard islet-autoantibodies . DIABETOLOGIA . vol. 61 , S105 - S106 .

Tabacco G, Naciu AM, Cesareo R, Pedone C, Gaspa G, Santonati A, Bosco D, Maggi D et al. ( 2018 ) . Cardiovascular Autonomic Neuropathy as a new complication of chronic hypoparathyroidism . JOURNAL OF BONE AND MINERAL RESEARCH . vol. 33 , 203 - 203 .

Piccoli A, Bisogno T, Maccarrone M, Pozzilli P, Napoli N, Strollo R ( 2018 ) . Effects of glycated insulin on adipogenic differentiation . DIABETOLOGIA . vol. 61 , S277 - S278 .

Maurizi A, Pieralice S, Del Toro R, Tuccinardi D, Pantano AL, Guglielmi C, Maddaloni E, Fioriti E et al. ( 2018 ) . Fast improvement of glycaemic control during transition of young adults with type 1 diabetes . DIABETOLOGIA . vol. 61 , S415 - S416 .

Ricottini E, Gatto L, Melfi R, Nusca A, Cavallaro C, Albano M, Giannone S, Patti G et al. ( 2018 ) . Hyperleptinemia as risk factor for high platelet reactivity and cardiovascular events in patients undergoing percutaneous coronary intervention . EUROPEAN HEART JOURNAL . vol. 39 , 997 - 997 .

Pieralice S, Del Toro R, Pesce G, Jansen K, Khazrai M, Maurizi A, Manfrini S, Pozzilli P ( 2018 ) . Integration increases the risk of diabetes and obesity in the Filipino population resident in Rome . DIABETOLOGIA . vol. 61 , S184 - S184 .

Maddaloni E, Coleman RL, Pozzilli P, Holman RR ( 2018 ) . Risk of cardiovascular disease in individuals with latent autoimmune diabetes of adults: results from the UKPDS . DIABETOLOGIA . vol. 61 , S574 - S575 .

Leanza G, Fontana F, Strollo R, Pozzilli P, Napoli N, Civitelli R ( 2018 ) . Sclerostin Resistance Protects Bone Mass and Improves Insulin Sensitivity in a Mouse Model of Type 1 Diabetes . JOURNAL OF BONE AND MINERAL RESEARCH . vol. 33 , 41 - 41 .

Palermo A, Fosca M, Tabacco G, Marini F, Graziani V, Santarsia MC, Longo F, Lauria A et al. ( 2017 ) . Raman Spectroscopy Applied to Parathyroid Tissues: A New Diagnostic Tool to Discriminate Normal Tissue from Adenoma . Analytical Chemistry vol. 90 , ( 1 ) 847 - 854 .

Lepore G, Bonfanti R, Bozzetto L, Di Blasi V, Girelli A, Grassi G, Iafusco D, Laviola L et al. ( 2017 ) . Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion . Nutrition Metabolism and Cardiovascular Diseases vol. 28 , ( 4 ) 335 - 342 .

Rau JV, Fosca M, Graziani V, Taffon C, Rocchia M, Caricato M, Pozzilli P, Onetti Muda A et al. ( 2017 ) . Proof-of-concept Raman spectroscopy study aimed to differentiate thyroid follicular patterned lesions . Sci Rep vol. 7 , ( 1 ) 14970 - 14970 .

Maddaloni E, Pozzilli P ( 2017 ) . Diabetes: the disease of the 10 D . Endocrine vol. 61 , ( 2 ) 353 - 354 .

Quercia S, Turroni S, Fiori J, Soverini M, Rampelli S, Biagi E, Castagnetti A, Consolandi C et al. ( 2017 ) . Gut microbiome response to short‐term dietary interventions in reactive hypoglycemia subjects . Diabetes/Metabolism Research and Reviews vol. 33 , ( 8 )

Garg SK, Henry RR, Banks P, Buse JB, Davies MJ, Fulcher GR, Pozzilli P, Gesty-Palmer D et al. ( 2017 ) . Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes . New England Journal of Medicine vol. 377 , ( 24 ) 2337 - 2348 .

Wanner C, Lachin JM, Inzucchi SE, Fitchett D, Mattheus M, George J, Woerle HJ, Broedl UC et al. ( 2017 ) . Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease . Circulation vol. 137 , ( 2 ) 119 - 129 .

Maddaloni E, Pastore G, Del Buono MG, Porcari A, Fittipaldi M, Garilli F, Tiberti C, Angeletti S et al. ( 2017 ) . High Prevalence of Autoimmune Diabetes and Poor Glycaemic Control among Adults in Madagascar: A Brief Report from a Humanitarian Health Campaign in Ambanja . J Diabetes Res vol. 2017 , 3860674 - 3860674 .

Nusca A, Albano M, Cavallaro C, Borrelli E, Palumo M, Proscia C, Pantano AL, Manfrini S et al. ( 2017 ) . 2870Glycemic variability assessed by continuous glucose monitoring and antiplatelet responsiveness in patients undergoing coronary stenting: results from the observational GLYVAR study . European Heart Journal vol. 38 , ( suppl_1 )

Piemonte V, Capocelli M, De Santis L, Maurizi AR, Pozzilli P ( 2017 ) . A Novel Three‐Compartmental Model for Artificial Pancreas: Development and Validation . Artificial Organs vol. 41 , ( 12 ) e326 - e336 .

Fitchett D, Butler J, van de Borne P, Zinman B, Lachin JM, Wanner C, Woerle HJ, Hantel S et al. ( 2017 ) . Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial . European Heart Journal vol. 39 , ( 5 ) 363 - 370 .

Pozzilli P, Guglielmi C ( 2017 ) . Prevention of Type 1 Diabetes Mellitus . Principles of Diabetes Mellitus , Springer Nature

Napoli N, Strollo R, Paladini A, Briganti SI, Pozzilli P, Epstein S ( 2017 ) . Corrigendum to "The Alliance of Mesenchymal Stem Cells, Bone, and Diabetes" . Int J Endocrinol vol. 2017 , Article 5924671 , 5924671 - 5924671 .

Vinci C, Infantino M, Pozzilli P, Grossi V, Manfredi M, Bandinelli F, Gobbi FL, Damiani A et al. ( 2017 ) . FRI0423 Antibodies to type ii collagen: a novel tool for the spondyloarthritis diagnosis? . Annals of the Rheumatic Diseases . Conference: Poster Presentations vol. 76 ,

Gaetani L, Fanelli F, Riccucci I, Eusebi P, Sarchielli P, Pozzilli C, Calabresi P, Prosperini L et al. ( 2017 ) . High risk of early conversion to multiple sclerosis in clinically isolated syndromes with dissemination in space at baseline . Journal of the Neurological Sciences vol. 379 , 236 - 240 .

Strollo R, Vinci C, Napoli N, Pozzilli P, Ludvigsson J, Nissim A ( 2017 ) . Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children . Diabetologia vol. 60 , ( 8 ) 1467 - 1474 .

Guglielmi C, Del Toro R, Lauria A, Maurizi AR, Fallucca S, Cappelli A, Angeletti S, Lachin JM et al. ( 2017 ) . Effect of GLP‐1 and GIP on C‐peptide secretion after glucagon or mixed meal tests: Significance in assessing B‐cell function in diabetes . Diabetes/Metabolism Research and Reviews vol. 33 , ( 6 )

Maurizi AR, Pozzilli P ( 2017 ) . Ipoglicemia cronica e deficit di memoria . L'Endocrinologo vol. 18 , ( Suppl 1 ) 22 - 23 .

Pozzilli P, Cappa M ( 2017 ) . Sleeping Cupid by Caravaggio: What Diagnosis? . Endocrine Practice vol. 23 , ( 7 ) 881 - 884 .

Pozzilli P, Norwood P, Jódar E, Davies MJ, Ivanyi T, Jiang H, Woodward DB, Milicevic Z ( 2017 ) . Placebo‐controlled, randomized trial of the addition of once‐weekly glucagon‐like peptide‐1 receptor agonist dulaglutide to titrated daily insulin glargine in patients with type 2 diabetes (AWARD‐9) . Diabetes Obesity and Metabolism vol. 19 , ( 7 ) 1024 - 1031 .

Zinman B, Inzucchi SE, Lachin JM, Wanner C, Fitchett D, Kohler S, Mattheus M, Woerle HJ et al. ( 2017 ) . Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk . Stroke vol. 48 , ( 5 ) 1218 - 1225 .

Palermo A, Tuccinardi D, D'Onofrio L, Watanabe M, Maggi D, Maurizi AR, Greto V, Buzzetti R et al. ( 2017 ) . Vitamin K and osteoporosis: Myth or reality? . Metabolism vol. 70 , 57 - 71 .

Soare A, Khazrai YM, Fontana L, Del Toro R, Lazzaro MC, Di Rosa C, Buldo A, Fioriti E et al. ( 2017 ) . Treatment of reactive hypoglycemia with the macrobiotic Ma-pi 2 diet as assessed by continuous glucose monitoring: The MAHYP randomized crossover trial . Metabolism vol. 69 , 148 - 156 .

Maurizi AR, Maddaloni E, Del Toro R, Pieralice S, Fioriti E, Manfrini S, Pozzilli P ( 2017 ) . An Automated Bolus Calculator for the Control of Glucose Variability in Type 1 Diabetes . DIABETES . vol. 66 , A238 - A238 .

Strollo R, Vinci C, Napoli N, Pozzilli P, Ludvigsson J, Nissim A ( 2017 ) . Antibodies to Posttranslationally Modified Insulin for Prediction of Type 1 Diabetes in Children . DIABETES . vol. 66 , A58 - A58 .

Leanza G, Maddaloni E, Pitocco D, Strollo R, Pozzilli P, Napoli N ( 2017 ) . Association between Glycemic Control and the Occurrence of the First Fragility Fracture in Type 1 Diabetes . DIABETES . vol. 66 , A463 - A463 .

Maddaloni E, Del Toro R, Fioriti E, Tabacco G, Defeudis G, Caggiano C, Manfrini S, Pozzilli P ( 2017 ) . Cardiac Autonomic Neuropathy Is Efficiently Diagnosed by Valsalva Maneuver Alone . DIABETES . vol. 66 , A150 - A150 .

Saponaro F, Cetani F, Repaci A, Camozzi V, Minisola S, Scillitani A, Chiodini I, Romanelli F et al. ( 2017 ) . Clinical presentation and management of primary hyperparathyroidism in Italy . JOURNAL OF BONE AND MINERAL RESEARCH . vol. 32 , S299 - S300 .

Maddaloni E, Strollo R, Del Toro R, Pozzilli P, Napoli N ( 2017 ) . Effect of Calcidiol on Insulin Resistance and β-Cell Function in Subjects with Prediabetes . DIABETES . vol. 66 , A349 - A349 .

Maddaloni E, Strollo R, Pozzilli P, Napoli N ( 2017 ) . Effect of calcidiol on insulin resistance and beta cell function in subjects with pre-diabetes . DIABETOLOGIA . vol. 60 , S252 - S252 .

Pantano AL, Nusca A, Del Toro R, Maddaloni E, Borrelli E, Zappia L, Proscia C, Melfi R et al. ( 2017 ) . Glycemic Variability Assessed by Continuous Glucose Monitoring and Antiplatelet Responsiveness in Patients Undergoing Coronary Stenting: Results from the Observational Glyvar Study . DIABETES . vol. 66 , A243 - A243 .

Nusca A, Albano M, Cavallaro C, Borrelli E, Palumo M, Proscia C, Pantano AL, Manfrini S et al. ( 2017 ) . Glycemic variability assessed by continuous glucose monitoring and antiplatelet responsiveness in patients undergoing coronary stenting: results from the observational GLYVAR study . EUROPEAN HEART JOURNAL . vol. 38 , 614 - 614 .

Pozzilli P, Napoli N, Naciu AM, Soare A ( 2017 ) . PRESENT AND FUTURE OF THE RELATIONSHIP BETWEEN GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS AND INSULIN FOR THE TREATMENT OF TYPE 2 DIABETES . INTERDIAB 2017: DIABETES MELLITUS IN INTERNAL MEDICINE . 78 - 85 .

Khazrai YM, Fioriti E, Lattanzi G, Pozzilli P, Manfrini S ( 2017 ) . Person-Centered Approach: A Valuable Tool for the Management of Type 2 Diabetes . DIABETES . vol. 66 , A183 - A183 .

Pantano AL, Nusca A, Del Toro R, Maddaloni E, Borrelli E, Zappia L, Proscia C, Melfi R et al. ( 2017 ) . Pleiotropic Effects of Ranolazine in Diabetic Patients Undergoing Percutaneous Coronary Intervention: Preliminary Results of an Observational, Prospective Study . DIABETES . vol. 66 , A592 - A592 .

Pozzilli P, Leslie RD, Peters A, Buzzetti R, Shankar SS, Milicevic Z, Pavo I, Lebrec J et al. ( 2017 ) . Reduction of HbA1c with dulaglutide in type 2 diabetes (T2D) patients negative, low positive or high positive for GAD antibodies (GADA): a post hoc analysis of AWARD-2,-4 and-5 . DIABETOLOGIA . vol. 60 , S68 - S68 .

Del Toro R, Maddaloni E, Fioriti E, Tabacco G, Defeudis G, Caggiano C, Manfrini S, Pozzilli P ( 2017 ) . Valsalva test alone is the best and economically valued tool for diagnosing cardiac autonomic neuropathy . DIABETOLOGIA . vol. 60 , S458 - S458 .

Maurizi AR, Menduni M, Del Toro R, Kyanvash S, Maggi D, Guglielmi C, Pantano AL, Defeudis G et al. ( 2016 ) . A pilot study of d-chiro-inositol plus folic acid in overweight patients with type 1 diabetes . Acta Diabetologica vol. 54 , ( 4 ) 361 - 365 .

Kaku K, Lee J, Mattheus M, Kaspers S, George J, Woerle H-J, Investigators OBOTE-RO ( 2016 ) . Empagliflozin and Cardiovascular Outcomes in Asian Patients With Type 2 Diabetes and Established Cardiovascular Disease ― Results From EMPA-REG OUTCOME® ― . Circulation Journal vol. 81 , ( 2 )

Strollo R, Soare A, Manon Khazrai Y, Di Mauro A, Palermo A, Del Toro R, Fallucca S, Giovanna Belluomo M et al. ( 2016 ) . Increased sclerostin and bone turnover after diet-induced weight loss in type 2 diabetes: a post hoc analysis of the MADIAB trial . Endocrine vol. 56 , ( 3 ) 667 - 674 .

Pozzilli P, Lazzeri D ( 2016 ) . A Goiter in Christ in Crucifixion . Thyroid vol. 26 , ( 11 ) 1646 - 1647 .

Rau JV, Graziani V, Fosca M, Taffon C, Rocchia M, Crucitti P, Pozzilli P, Onetti Muda A et al. ( 2016 ) . RAMAN spectroscopy imaging improves the diagnosis of papillary thyroid carcinoma . Scientific Reports vol. 6 , ( 1 )

Veitenhansl M, Stegner K, Hierl F-X, Dieterle C, Feldmeier H, Gutt B, Landgraf R, Garrow AP et al. ( 2004 ) . 40th EASD Annual Meeting of the European Association for the Study of Diabetes . Diabetologia . vol. 47 , a1 - a464 .

Nucci AM, Virtanen SM, Sorkio S, Bärlund S, Cuthbertson D, Uusitalo U, Lawson ML, Salonen M et al. ( 2016 ) . Regional differences in milk and complementary feeding patterns in infants participating in an international nutritional type 1 diabetes prevention trial . Maternal and Child Nutrition vol. 13 , ( 3 )

Rizzo P, Pitocco D, Zaccardi F, Di Stasio E, Strollo R, Rizzi A, Scavone G, Costantini F et al. ( 2016 ) . Autoantibodies to post‐translationally modified type I and II collagen in Charcot neuroarthropathy in subjects with type 2 diabetes mellitus . Diabetes/Metabolism Research and Reviews vol. 33 , ( 2 )

Mangiacapra F, Panaioli E, Colaiori I, Ricottini E, Lauria Pantano A, Pozzilli P, Barbato E, Di Sciascio G ( 2016 ) . Clopidogrel Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients Treated With Percutaneous Coronary Intervention . Circulation vol. 134 , ( 11 ) 835 - 837 .

Schloot NC, Pham MN, Hawa MI, Pozzilli P, Scherbaum WA, Schott M, Kolb H, Hunter S et al. ( 2016 ) . Inverse Relationship Between Organ-Specific Autoantibodies and Systemic Immune Mediators in Type 1 Diabetes and Type 2 Diabetes: Action LADA 11 . Diabetes Care vol. 39 , ( 11 ) 1932 - 1939 .

Soare A, Del Toro R, Khazrai YM, Di Mauro A, Fallucca S, Angeletti S, Skrami E, Gesuita R et al. ( 2016 ) . A 6-month follow-up study of the randomized controlled Ma-Pi macrobiotic dietary intervention (MADIAB trial) in type 2 diabetes . Nutrition & Diabetes vol. 6 , ( 8 ) e222 - e222 .

Palermo A, Mangiameli G, Tabacco G, Longo F, Pedone C, Briganti SI, Maggi D, Vescini F et al. ( 2016 ) . PTH(1-34) for the Primary Prevention of Postthyroidectomy Hypocalcemia: The THYPOS Trial . J Clin Endocrinol Metab vol. 101 , ( 11 ) 4039 - 4045 .

Maddaloni E, Pozzilli P ( 2016 ) . Why China guidelines for type 2 diabetes represent an opportunity for treating this disease . Diabetes Metab Res Rev vol. 32 , ( 5 ) 438 - 439 .

Maddaloni E, Cavallari I, De Pascalis M, Keenan H, Park K, Manfrini S, Buzzetti R, Patti G et al. ( 2016 ) . Relation of Body Circumferences to Cardiometabolic Disease in Overweight-Obese Subjects . The American Journal of Cardiology vol. 118 , ( 6 ) 822 - 827 .

Wanner C, Inzucchi SE, Lachin JM, Fitchett D, von Eynatten M, Mattheus M, Johansen OE, Woerle HJ et al. ( 2016 ) . Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes . New England Journal of Medicine vol. 375 , ( 4 ) 323 - 334 .

Palermo A, Tuccinardi D, Defeudis G, Watanabe M, D’Onofrio L, Pantano AL, Napoli N, Pozzilli P et al. ( 2016 ) . BMI and BMD: The Potential Interplay between Obesity and Bone Fragility . International Journal of Environmental Research and Public Health vol. 13 , ( 6 )

Guglielmi C, Williams SR, Del Toro R, Pozzilli P ( 2016 ) . Efficacy and safety of otelixizumab use in new-onset type 1 diabetes mellitus . Expert Opin Biol Ther vol. 16 , ( 6 ) 841 - 846 .

Candela M, Biagi E, Soverini M, Consolandi C, Quercia S, Severgnini M, Peano C, Turroni S et al. ( 2016 ) . Modulation of gut microbiota dysbioses in type 2 diabetic patients by macrobiotic Ma-Pi 2 diet . Br J Nutr vol. 116 , ( 1 ) 80 - 93 .

Amed S, Pozzilli P ( 2016 ) . Diagnosis of diabetes type in children and young people: challenges and recommendations . The Lancet Diabetes & Endocrinology vol. 4 , ( 5 ) 385 - 386 .

Giorgino F, Bonadonna RC, Gentile S, Vettor R, Pozzilli P ( 2016 ) . Treatment intensification in patients with inadequate glycemic control on basal insulin: rationale and clinical evidence for the use of short‐acting and other glucagon‐like peptide‐1 receptor agonists . Diabetes/Metabolism Research and Reviews vol. 32 , ( 6 ) 497 - 511 .

Epstein S, Defeudis G, Manfrini S, Napoli N, Pozzilli P, on behalf of the Scientific Committee of the First International Symposium on Diabetes and Bone ( 2016 ) . Diabetes and disordered bone metabolism (diabetic osteodystrophy): time for recognition . Osteoporosis International vol. 27 , ( 6 ) 1931 - 1951 .

Modesti PA, Omboni S, Taddei S, Ghione S, Portaluppi F, Pozzilli P, Volpe M, Arca M et al. ( 2016 ) . Zofenopril or irbesartan plus hydrochlorothiazide in elderly patients with isolated systolic hypertension untreated or uncontrolled by previous treatment . Journal of Hypertension vol. 34 , ( 3 ) 567 - 587 .

Pozzilli P, Guglielmi C ( 2016 ) . Prevention of Type 1 Diabetes Mellitus . Principles of Diabetes Mellitus , Springer Nature

Nicoli F, Pozzilli P, Lazzeri D ( 2016 ) . “The Penitent Magdalene”: Tiziano Vecellio (1488/1490–1576) . Journal of Endocrinological Investigation vol. 39 , ( 7 ) 835 - 836 .

Nambam B, Bratina N, Schatz D ( 2016 ) . Immune Intervention in Type 1 Diabetes . Diabetes Technology & Therapeutics vol. 18 , ( S1 )

Fitchett D, Zinman B, Wanner C, Lachin JM, Hantel S, Salsali A, Johansen OE, Woerle HJ et al. ( 2016 ) . Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial . European Heart Journal vol. 37 , ( 19 ) 1526 - 1534 .

Dang MN, Bradford CM, Pozzilli P, Leslie RD ( 2016 ) . Methylation Analysis in Distinct Immune Cell Subsets in Type 1 Diabetes . Methods in Molecular Biology vol. 1433 , 143 - 151 .

Maurizi AR, Anda N, Del Toro R, Pantano AL, Fioriti E, Manfrini S, Pozzilli P ( 2016 ) . A Bolus Advisor System for the Management of Insulin Therapy in Type 1 Diabetes . DIABETES . vol. 65 , A227 - A228 .

Mangiacapra F, Panaioli E, Colaiori I, Ricottini E, Pantano AL, Pozzilli P, Barbato E, Di Sciascio G ( 2016 ) . CLOpidogrel versus TIcagreLor for antiplatelet maintenance in DIAbetic patients treated with percutaneous coronary intervention: results of the CLOTILDIA study . EUROPEAN HEART JOURNAL . vol. 37 , 385 - 385 .

Pozzilli P ( 2016 ) . CSII AND OTHER TECHNOLOGIES FOR PREVENTING BETA CELL FAILURE IN TYPE 2 DIABETES . DIABETES TECHNOLOGY & THERAPEUTICS . vol. 18 , A1 - A2 .

Zanoboni L, Leanza G, Pitocco D, Costantino F, Schwartz AV, Pozzilli P, Napoli N ( 2016 ) . Importance of Medical Nutrition Therapy on Long-Term Glycemic Control in Type 1 Diabetes Patients . DIABETES . vol. 65 , A559 - A560 .

Pozzilli P, Norwood P, Jodar E, Ivanyi T, Jiang H, Woodward B, Milicevic Z ( 2016 ) . Improved Glycemic Control and Weight Loss with Once-Weekly Dulaglutide vs. Placebo, Both Added to Titrated Daily Insulin Glargine, in Type 2 Diabetes Patients (AWARD-9) . DIABETES . vol. 65 , A62 - A62 .

Pozzilli P, Norwood P, Jodar E, Davies M, Ivanyi T, Jiang H, Woodward B, Milicevic Z ( 2016 ) . Improved glycaemic control and weight loss with once weekly dulaglutide versus placebo, both added to titrated daily insulin glargine in type 2 diabetes patients (AWARD-9) . DIABETOLOGIA . vol. 59 , S75 - S75 .

Khazrai YM, Maurizi AR, Piccirilli S, Pipolo G, Costantino F, Pozzilli P, Manfrini S ( 2016 ) . Person-Centred Approach Counselling: A Useful Tool to Reduce Burden of Care in Adolescents with Type 1 Diabetes . DIABETES . vol. 65 , A177 - A177 .

Del Toro R, Maddaloni E, Montedoro A, Lauria A, Maurizi AR, Guglielmi C, Manfrini S, Pozzilli P ( 2016 ) . Risk Factors for Cardiac Autonomic Neuropathy: The Role of HDL . DIABETES . vol. 65 , A149 - A149 .

Strollo R, Soare A, Khazrai YM, Del Toro R, Fallucca S, Di Mauro A, Pozzilli P, Napoli N ( 2016 ) . The Effect of Diet-induced Weight Loss on Bone Turnover in Patients with Type 2 Diabetes . DIABETES . vol. 65 , A195 - A195 .

Khazrai Y, Soare A, Fontana L, Del Toro R, Lazzaro M, Di Rosa C, Buldo A, Fioriti E et al. ( 2016 ) . Treatment of reactive hypoglycaemia with macrobiotic Ma-Pi 2 diet for prevention of type 2 diabetes: the MAHYP randomised crossover trial . DIABETOLOGIA . vol. 59 , S334 - S335 .

Weng J, Pozzilli P ( 2015 ) . Hot topics on diabetes in China . Diabetes/Metabolism Research and Reviews vol. 31 , ( 8 ) 779 - 780 .

Maddaloni E, D'Onofrio L, Pozzilli P ( 2015 ) . Frailty and geography: should these two factors be added to the ABCDE contemporary guide to diabetes therapy? . Diabetes/Metabolism Research and Reviews vol. 32 , ( 2 ) 169 - 175 .

Buzzetti R, Pozzilli P, Frederich R, Iqbal N, Hirshberg B ( 2015 ) . Saxagliptin improves glycaemic control and C‐peptide secretion in latent autoimmune diabetes in adults (LADA) . Diabetes/Metabolism Research and Reviews vol. 32 , ( 3 ) 289 - 296 .

Defeudis G, Gianfrilli D, Di Emidio C, Pofi R, Tuccinardi D, Palermo A, Lenzi A, Pozzilli P ( 2015 ) . Erectile dysfunction and its management in patients with diabetes mellitus . Reviews in Endocrine and Metabolic Disorders vol. 16 , ( 3 ) 213 - 231 .

Maurizi AR, Suraci C, Pitocco D, Schiaffini R, Tubili C, Morviducci L, Giordano R, Manfrini S et al. ( 2015 ) . Position Statement on the management of continuous subcutaneous insulin infusion (CSII): The Italian Lazio experience . Journal of Diabetes vol. 8 , ( 1 ) 41 - 44 .

Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T et al. ( 2015 ) . Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes . New England Journal of Medicine vol. 373 , ( 22 ) 2117 - 2128 .

Strollo R, Vinci C, Arshad MH, Perrett D, Tiberti C, Chiarelli F, Napoli N, Pozzilli P et al. ( 2015 ) . Antibodies to post-translationally modified insulin in type 1 diabetes . Diabetologia vol. 58 , ( 12 ) 2851 - 2860 .

Pozzilli P ( 2015 ) . Osteocalcin, glucose tolerance and diabetes . Annales d Endocrinologie vol. 76 , ( 4 )

Staff TPO ( 2015 ) . Correction: Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-Requirement . PLOS ONE vol. 10 , ( 8 )

Maddaloni E, Lessan N, Al Tikriti A, Buzzetti R, Pozzilli P, Barakat MT ( 2015 ) . Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-Requirement . PLOS ONE vol. 10 , ( 8 )

Nusca A, Pantano AL, Melfi R, Proscia C, Maddaloni E, Contuzzi R, Mangiacapra F, Palermo A et al. ( 2015 ) . Glycemic Variability Assessed by Continuous Glucose Monitoring and Short‐Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study . Journal of Diabetes Research vol. 2015 , ( 1 )

Lazzeri D, Pozzilli P, Persichetti P ( 2015 ) . “The Annunciation”—Girolamo Francesco Maria Mazzola called Parmigianino (1503–1540) . Journal of Endocrinological Investigation vol. 38 , ( 11 ) 1247 - 1248 .

Pozzilli P, Battelino T, Danne T, Hovorka R, Jarosz‐Chobot P, Renard E ( 2015 ) . Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics . Diabetes/Metabolism Research and Reviews vol. 32 , ( 1 ) 21 - 39 .

Ibrahim M, Abu Al Magd M, Annabi FA, Assaad-Khalil S, Ba-Essa EM, Fahdil I, Karadeniz S, Meriden T et al. ( 2015 ) . Recommendations for management of diabetes during Ramadan: update 2015 . BMJ Open Diabetes Research & Care vol. 3 , ( 1 )

Bruttomesso D, Laviola L, Lepore G, Bonfanti R, Bozzetto L, Corsi A, Di Blasi V, Girelli A et al. ( 2015 ) . Subcutaneous insulin infusion (CSII) in italy: The third national survey . Giornale Italiano di Diabetologia e Metabolismo vol. 35 , ( 2 ) 121 - 129 .

Buzzetti R, Pozzilli P, Frederich R, Iqbal N, Hirshberg B, Löffler T ( 2015 ) . Erhöhung der β-Zellfunktion und Verbesserung des HOMA-2β-Index durch Saxagliptin bei Erwachsenen mit latentem Autoimmundiabetes . Diabetologie und Stoffwechsel vol. 10 , ( S 01 )

Palermo A, D’Onofrio L, Eastell R, Schwartz AV, Pozzilli P, Napoli N ( 2015 ) . Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review . Osteoporosis International vol. 26 , ( 8 ) 2073 - 2089 .

Cugini P, Cavallini M, Pozzilli P, Palestini M, Letizia C, Di Palma L, Battisti P ( 2015 ) . T Lymphocyte Subpopulations, Plasma Cortisol and Ciclosporin in Kidney-Transplanted Subjects: A Chronobiologic Approach to the Adrenal-Immune System1 . Contributions to Nephrology vol. 83 , 264 - 269 .

Palermo A, Strollo R, Maddaloni E, Tuccinardi D, D'Onofrio L, Briganti SI, Defeudis G, De Pascalis M et al. ( 2015 ) . Irisin is associated with osteoporotic fractures independently of bone mineral density, body composition or daily physical activity . Clin Endocrinol (Oxf) vol. 82 , ( 4 ) 615 - 619 .

Lazzeri D, Pozzilli P, Zhang YX, Persichetti P ( 2015 ) . Goiter in Paintings by Rogier van der Weyden (1399–1464) . Thyroid vol. 25 , ( 5 ) 559 - 562 .

Soare A, Del Toro R, Roncella E, Khazrai YM, Angeletti S, Dugo L, Fallucca S, Fontana L et al. ( 2015 ) . The effect of macrobiotic Ma-Pi 2 diet on systemic inflammation in patients with type 2 diabetes: a post hoc analysis of the MADIAB trial . BMJ Open Diabetes Research & Care vol. 3 , ( 1 )

Elias D, Avron A, Tamir M, Eren R, Peled D, Dagan S, Raz I, Pozzilli P et al. ( 2015 ) . Retraction Note: Abstracts of the 50th Annual Meeting of the EASD, Vienna 2014. ‘Evaluation of DiaPep277® treatment in type 1 diabetes by integrated analysis’ . Diabetologia vol. 58 , ( 5 ) 1141 - 1141 .

Khazrai YM, Buzzetti R, Del Prato S, Cahn A, Raz I, Pozzilli P ( 2015 ) . The addition of E (Empowerment and Economics) to the ABCD algorithm in diabetes care . Journal of Diabetes and its Complications vol. 29 , ( 4 ) 599 - 606 .

Barchetta I, Guglielmi C, Bertoccini L, Calella D, Manfrini S, Secchi C, Pozzilli P, Cavallo MG et al. ( 2015 ) . Therapy with proton pump inhibitors in patients with type 2 diabetes is independently associated with improved glycometabolic control . Acta Diabetologica vol. 52 , ( 5 ) 873 - 880 .

Pozzilli P, Maddaloni E, Buzzetti R ( 2015 ) . Combination immunotherapies for type 1 diabetes mellitus . Nature Reviews Endocrinology vol. 11 , ( 5 ) 289 - 297 .

Bentley-Lewis R, Aguilar D, Riddle MC, Claggett B, Diaz R, Dickstein K, Gerstein HC, Johnston P et al. ( 2015 ) . Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo . American Heart Journal vol. 169 , ( 5 ) 631 - 638.e7 .

Signore A, Capriotti G, Chianelli M, Bonanno E, Galli F, Catalano C, Quintero AM, De Toma G et al. ( 2015 ) . Detection of Insulitis by Pancreatic Scintigraphy With 99mTc-Labeled IL-2 and MRI in Patients With LADA (Action LADA 10) . Diabetes Care vol. 38 , ( 4 ) 652 - 658 .

Lauria A, Barker A, Schloot N, Hosszufalusi N, Ludvigsson J, Mathieu C, Mauricio D, Nordwall M et al. ( 2015 ) . BMI is an important driver of β-cell loss in type 1 diabetes upon diagnosis in 10 to 18-year-old children . Eur J Endocrinol vol. 172 , ( 2 ) 107 - 113 .

Skyler JS ( 2015 ) . Immune Intervention for Type 1 Diabetes, 2013–2014 . Diabetes Technology & Therapeutics vol. 17 , ( S1 )

Maddaloni E, Sabatino F, Del Toro R, Crugliano S, Grande S, Lauria Pantano A, Maurizi AR, Palermo A et al. ( 2015 ) . In vivo corneal confocal microscopy as a novel non-invasive tool to investigate cardiac autonomic neuropathy in Type 1 diabetes . Diabet Med vol. 32 , ( 2 ) 262 - 266 .

Hernandez M, Mollo A, Marsal JR, Esquerda A, Capel I, Puig-Domingo M, Pozzilli P, de Leiva A et al. ( 2015 ) . Insulin secretion in patients with latent autoimmune diabetes (LADA): half way between type 1 and type 2 diabetes: action LADA 9 . BMC Endocrine Disorders vol. 15 , ( 1 )

Pozzilli P ( 2015 ) . ARE THE NEW ANTIDIABETIC DRUGS SIMPLIFYING OR COMPLICATING THE TYPE 2 DIABETES MANAGEMENT? . INTERDISCIPLINARY APPROACHES IN DIABETIC CHRONIC KIDNEY DISEASE . 25 - 27 .

Strollo R, Vinci C, Arshad MH, Perrett D, Tiberti C, Chiarelli F, Napoli N, Pozzilli P et al. ( 2015 ) . Autoantibodies to posttranslationally modified insulin in type 1 diabetes . DIABETOLOGIA . vol. 58 , S102 - S103 .

Maurizi A, Del Toro R, Menduni M, Pantano AL, Kyanvash S, Manfrini S, Pozzilli P ( 2015 ) . D-chiro-inositol improves metabolic control in overweight patients with type 1 diabetes . DIABETOLOGIA . vol. 58 , S255 - S256 .

Napoli N, Mazzanti F, Giambra E, Strollo R, Mottini G, Pozzilli P ( 2015 ) . Prevalent Gestational Diabetes Mellitus in HIV-Infected and -Uninfected Pregnant Women Living in Sub-Saharan Africa . DIABETES . vol. 64 , A381 - A381 .

Napoli N, Strollo R, Defeudis G, Leto G, Hawa MI, Leslie RDG, Pozzilli P, Buzzetti R ( 2015 ) . Serum Sclerostin and Bone Turnover in Relation to Metabolic Syndrome in Patients with Type 2 Diabetes or LADA . DIABETES . vol. 64 , A129 - A129 .

Pozzilli P ( 2015 ) . THE IMPACT OF NEW TECHNOLOGY IN TYPE 2 DIABETES . DIABETES TECHNOLOGY & THERAPEUTICS . vol. 17 , A2 - A2 .

Defeudis G, Di Emidio C, Strollo R, Rinati MV, Tuccinardi D, Palermo A, Angeletti S, Manfrini S et al. ( 2015 ) . The Efficacy of Continuous Glucose Monitoring to Improve BMI and Glycaemic Control in Prediabetes: The OBIG Trial . DIABETES . vol. 64 , A240 - A240 .

Pozzilli P, Raz I, Peled D, Elias D, Avron A, Tamir M, Eren R, Dagan S et al. ( 2014 ) . Evaluation of Long-Term Treatment Effect in a Type 1 Diabetes Intervention Trial: Differences After Stimulation With Glucagon or a Mixed Meal. Diabetes Care 2014;37:1384–1391. DOI: 10.2337/dc13-1392 . Diabetes Care vol. 38 , ( 1 ) 179 - 179 .

Raz I, Ziegler AG, Linn T, Schernthaner G, Bonnici F, Distiller LA, Giordano C, Giorgino F et al. ( 2014 ) . Treatment of Recent-Onset Type 1 Diabetic Patients With DiaPep277: Results of a Double-Blind, Placebo-Controlled, Randomized Phase 3 Trial. Diabetes Care 2014;37:1392–1400. DOI: 10.2337/dc13-1391 . Diabetes Care vol. 38 , ( 1 ) 178 - 178 .

Bruttomesso D, Laviola L, Lepore G, Bonfanti R, Bozzetto L, Corsi A, Di Blasi V, Girelli A et al. ( 2014 ) . Continuous Subcutaneous Insulin Infusion in Italy: Third National Survey . Diabetes Technology & Therapeutics vol. 17 , ( 2 ) 96 - 104 .

Palermo A, Strollo R, Papalia R, D'Onofrio L, Maddaloni E, Briganti SI, Napoli N, Vespasiani U et al. ( 2014 ) . Severe hypophosphatemic osteomalacia secondary to fanconi syndrome due to adefovir: a case report . Endocr Pract vol. 20 , ( 12 ) e246 - e249 .

Guglielmi C, Secchi C, Maddaloni E, Manfrini S, Pozzilli P ( 2014 ) . 10. Effects of Treatment with Proton Pump Inhibitors on Metabolic Control in Patients with Type 2 Diabetes (2425-PO) . Nederlands Tijdschrift voor Diabetologie vol. 12 , ( 4 ) 14 - 14 .

Napoli N, Pozzilli P ( 2014 ) . Obesity and Glucose Metabolism . Multidisciplinary Approach to Obesity , Springer Nature

Aronson R, Gottlieb PA, Christiansen JS, Donner TW, Bosi E, Bode BW, Pozzilli P, DEFEND Investigator Group ( 2014 ) . Low-dose otelixizumab anti-CD3 monoclonal antibody DEFEND-1 study: results of the randomized phase III study in recent-onset human type 1 diabetes . Diabetes Care vol. 37 , ( 10 ) 2746 - 2754 .

Zampetti S, Campagna G, Tiberti C, Songini M, Arpi ML, De Simone G, Cossu E, Cocco L et al. ( 2014 ) . High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7) . European Journal of Endocrinology vol. 171 , ( 6 ) 697 - 704 .

Weng J, Pozzilli P ( 2014 ) . Diabetes Metabolism: Research and Reviews--Chinese Diabetes Society special issue: a small but encouraging step toward the successful control of diabetes in China . Diabetes Metab Res Rev vol. 30 , ( 6 ) 445 - 446 .

Modesti PA, Omboni S, Zava D, Taddei S, Ghione S, Portaluppi F, Pozzilli P, Volpe M et al. ( 2014 ) . Efficacy of zofenopril or irbesartan both combined with hydrochlorothiazide in elderly subjects with isolated systolic hypertension untreated or uncontrolled by monotherapy . International Journal of Cardiology Cardiovascular Risk and Prevention vol. 8 ,

Maddaloni E, D'Onofrio L, Lauria A, Maurizi AR, Strollo R, Palermo A, Napoli N, Angeletti S et al. ( 2014 ) . Osteocalcin levels are inversely associated with Hba1c and BMI in adult subjects with long-standing type 1 diabetes . J Endocrinol Invest vol. 37 , ( 7 ) 661 - 666 .

Maddaloni E, Pozzilli P ( 2014 ) . SMART diabetes: the way to go (Safe and Multifactorial Approach to reduce the Risk for Therapy in diabetes) . Endocrine vol. 46 , ( 1 ) 3 - 5 .

Maddaloni E, Pozzilli P ( 2014 ) . Will we ever cure diabetes? . Diabetes Management vol. 4 , ( 3 ) 219 - 221 .

Hawa MI, Kolb H, Schloot N, Beyan H, Paschou SA, Buzzetti R, Mauricio D, De Leiva A et al. ( 2014 ) . Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype: Action LADA 7. Diabetes Care 2013;36:908–913 . Diabetes Care vol. 37 , ( 5 ) 1494 - 1494 .

Pozzilli P, Sensi M, Andreani D ( 2014 ) . Inhibition of killer cell cytotoxicity induced by carbimazole in vitro . Journal of Endocrinological Investigation vol. 5 , ( 3 ) 149 - 152 .

Di Mario U, Cavatorta FP, Perfetti R, Pugliese G, Pozzilli P, Sutherland J, Vitillo M, Andreani D ( 2014 ) . Quantitative immunological differences between newly diagnosed Graves’ disease patients and relapsed patients . Journal of Endocrinological Investigation vol. 11 , ( 2 ) 85 - 89 .

Maddaloni E, Capolupo G, Palermo A, Manfrini S, Di Matteo FM, Grasso RF, Coppola R, Pozzilli P ( 2014 ) . Continuous glucose monitoring and robot surgery of an insulinoma: a case report and review of the literature . Pancreas vol. 43 , ( 3 ) 483 - 485 .

Di Mario U, Pozzilli P, Andreani D ( 2014 ) . Immunology in the early stages of type I diabetes . Journal of Endocrinological Investigation vol. 6 , ( 5 ) 395 - 400 .

Guglielmi C, Pozzilli P ( 2014 ) . L’immunoterapia del diabete di tipo 1 . L'Endocrinologo vol. 14 , ( 3 ) 111 - 114 .

Ludvigsson J, Krisky D, Casas R, Battelino T, Castaño L, Greening J, Kordonouri O, Otonkoski T et al. ( 2014 ) . Terapia antigenica con GAD65 nel diabete mellito di tipo 1 di recente diagnosi . L'Endocrinologo vol. 13 , ( 2 ) 89 - 90 .

Pozzilli P, Maurizi AR ( 2014 ) . Quale terapia precoce per il diabete autoimmune dell’adulto? . L'Endocrinologo vol. 12 , ( 1 ) 2 - 7 .

Pozzilli P, Lauria A ( 2014 ) . Quali fattori aumentano l’incidenza del diabete di tipo 1 in Italia . L'Endocrinologo vol. 8 , ( 2 ) 80 - 84 .

Pozzilli P ( 2014 ) . Endocrinology and Art . Journal of Endocrinological Investigation vol. 22 , ( 9 ) 738 - 738 .

Pozzilli P ( 2014 ) . β-casein in cow’s milk: A major antigenic determinant for type 1 diabetes? . Journal of Endocrinological Investigation vol. 22 , ( 7 ) 562 - 567 .

Barker A, Lauria A, Schloot N, Hosszufalusi N, Ludvigsson J, Mathieu C, Mauricio D, Nordwall M et al. ( 2014 ) . Age-dependent decline of β-cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study . Diabetes Obes Metab vol. 16 , ( 3 ) 262 - 267 .

Soare A, Weiss EP, Pozzilli P ( 2014 ) . Benefits of caloric restriction for cardiometabolic health, including type 2 diabetes mellitus risk . Diabetes Metab Res Rev vol. 30 Suppl 1 , 41 - 47 .

Pozzilli P, Fallucca F ( 2014 ) . Diet and diabetes: a cornerstone for therapy . Diabetes Metab Res Rev vol. 30 Suppl 1 , 1 - 3 .

Khazrai YM, Defeudis G, Pozzilli P ( 2014 ) . Effect of diet on type 2 diabetes mellitus: a review . Diabetes Metab Res Rev vol. 30 Suppl 1 , 24 - 33 .

Khazrai YM, Maddaloni E, Altomare M, Cacciapaglia F, Pozzilli P ( 2014 ) . New technologies aiding dietary programmes for weight control: the oral glucose spray . Endocrine vol. 45 , ( 2 ) 288 - 292 .

Palermo A, Maggi D, Maurizi AR, Pozzilli P, Buzzetti R ( 2014 ) . Prevention of type 2 diabetes mellitus: is it feasible? . Diabetes Metab Res Rev vol. 30 Suppl 1 , 4 - 12 .

Suchkov S, Golubnitschaja O, von Herrath M, Pozzilli P, Paltsev M, Mkrtumyan A, Frank M, Marshall T et al. ( 2014 ) . Predictive, preventive and personalized medicine (PPPM) as a strategic avenue and global tool for advancing T1D-related care: Fundamental, Applied and Affiliated Issues . EPMA Journal vol. 5 , ( Suppl 1 )

Skyler JS ( 2014 ) . Immune Intervention for Type 1 Diabetes, 2012–2013 . Diabetes Technology & Therapeutics vol. 16 , ( S1 )

Pozzilli P, Lenzi A, Clarke BL, William F Young M ( 2014 ) . Imaging in Endocrinology . Wiley

Mitrea A, Fallucca S, Angeletti S, Soare A, Vernieri F, Ursini F, Trotta L, Mota M et al. ( 2014 ) . Adipokines: The Missing Link between Alzheimer's Disease and Type 2 Diabetes? . DIABETES . vol. 63 , A487 - A487 .

Maddaloni E, Pozzilli P ( 2014 ) . Comment on: "Early insulin treatment in type 2 diabetes: ORIGINal sin or valuable choice as ORIGINal treatment? An open debate on the ORIGIN study results" . Nutr Metab Cardiovasc Dis vol. 24 , ( 1 )

Khazrai YM, Defeudis G, Di Rosa C, Roncella E, Secchi C, Pozzilli P, Manfrini S ( 2014 ) . Conversation Maps™, an Effective Tool for Type 2 Diabetes Treatment . DIABETES . vol. 63 , A178 - A179 .

Pozzilli P, Fallucca F ( 2014 ) . Diet and diabetes: a cornerstone for therapy INTRODUCTION . DIABETES-METABOLISM RESEARCH AND REVIEWS vol. 30 , 1 - 3 .

Guglielmi C, Secchi C, Maddaloni E, Manfrini S, Pozzilli P ( 2014 ) . Effects of Treatment with Proton Pump Inhibitors on Metabolic Control in Patients with Type 2 Diabetes . DIABETES . vol. 63 , A615 - A615 .

Elias D, Avron A, Tamir M, Eren R, Peled D, Dagan S, Raz I, Pozzilli P et al. ( 2014 ) . Evaluation of DiaPep277® treatment in type 1 diabetes by integrated analysis . DIABETOLOGIA . vol. 57 , S190 - S191 .

Pozzilli P, Raz I, Peled D, Elias D, Avron A, Tamir M, Eren R, Dagan S et al. ( 2014 ) . Evaluation of long-term treatment effect in a type 1 diabetes intervention trial: differences after stimulation with glucagon or a mixed meal . Diabetes Care vol. 37 , ( 5 ) 1384 - 1391 .

Guglielmi C, Valente L, Fallucca S, Angeletti S, Lachin JM, Pozzilli P ( 2014 ) . Glucagon and Mixed-Meal Tests to Evaluate Beta-Cell Function and Incretin Axis: Relevance for Immunointervention Trials in Type 1 Diabetes . DIABETES . vol. 63 , A75 - A75 .

Guglielmi C, Valente L, Fallucca S, Angeletti S, Briganti S, De Pascalis M, Lachin JM, Pozzilli P ( 2014 ) . Glucagon and mixed-meal tests to estimate beta cell and incretin functions in normals: relevance for studies in type 1 diabetes . DIABETOLOGIA . vol. 57 , S189 - S189 .

Proscia C, Nusca A, Melfi R, Pantano AL, Maddaloni E, Contuzzi R, Campanale CM, Pozzilli P et al. ( 2014 ) . Glycemic variability assessed by continuous glucose monitoring and its correlation with renal and myocardial damage after coronary stenting . EUROPEAN HEART JOURNAL . vol. 35 , 394 - 395 .

Buzzetti R, Pozzilli P, Frederich R, Iqbal N, Hirshberg B ( 2014 ) . Increase in beta cell function and improvement in HOMA-2beta index induced by saxagliptin in patients with latent autoimmune diabetes in adults . DIABETOLOGIA . vol. 57 , S355 - S355 .

Pozzilli P, Strollo R, Bonora E ( 2014 ) . One size does not fit all glycemic targets for type 2 diabetes . JOURNAL OF DIABETES INVESTIGATION vol. 5 , ( 2 ) 134 - 141 .

Maddaloni E, Lessan N, Al Tikriti A, Pozzilli P, Barakat MT ( 2014 ) . Prevalence and Features of Adult-Onset Autoimmune Diabetes in the United Arab Emirates (UAE) . DIABETES . vol. 63 , A399 - A399 .

Pozzilli P, Buzzetti R, Frederich R, Iqbal N, Hirshberg B ( 2014 ) . Saxagliptin Increases β-Cell Function and Improves HOMA Index in Patients with Latent Autoimmune Diabetes in Adults . DIABETES . vol. 63 , A41 - A41 .

Soare A, Manon KY, Silvia A, Dugo L, Fallucca S, Fontana L, Altomare M, Gesuita R et al. ( 2014 ) . The Effect of Macrobiotic (Ma-Pi 2) Diet on Systemic Inflammation in Patients with Type 2 Diabetes . DIABETES . vol. 63 , A192 - A192 .

Napoli N, Strollo R, Paladini A, Briganti SI, Pozzilli P, Epstein S ( 2014 ) . The alliance of mesenchymal stem cells, bone, and diabetes . Int J Endocrinol vol. 2014 ,

Soare A, Khazrai YM, Del Toro R, Roncella E, Fontana L, Fallucca S, Angeletti S, Formisano V et al. ( 2014 ) . The effect of the macrobiotic Ma-Pi 2 diet vs. the recommended diet in the management of type 2 diabetes: the randomized controlled MADIAB trial . Nutr Metab (Lond) vol. 11 ,

Raz I, Ziegler AG, Linn T, Schernthaner G, Bonnici F, Distiller LA, Giordano C, Giorgino F et al. ( 2014 ) . Treatment of recent-onset type 1 diabetic patients with DiaPep277: results of a double-blind, placebo-controlled, randomized phase 3 trial . Diabetes Care vol. 37 , ( 5 ) 1392 - 1400 .

Piccirilli S, Khazrai YM, Soare A, Buzzetti R, Pozzilli P ( 2014 ) . Wrist Circumference, a Simple and Economic Marker for Obese Type 2 Diabetes Subjects . DIABETES . vol. 63 , A634 - A634 .

Pedone C, Napoli N, Pozzilli P, Lauretani F, Bandinelli S, Ferrucci L, Rossi FF, Antonelli-Incalzi R ( 2013 ) . Bone health as a function of adipokines and vitamin D pattern in elderly patients . Rejuvenation Res vol. 16 , ( 6 ) 467 - 474 .

( 2013 ) . Latent autoimmune diabetes in adults is perched between type 1 and type 2: evidence from adults in one region of Spain . Diabetes/Metabolism Research and Reviews vol. 29 , ( 8 ) 693 - 693 .

Franciscus M, Nucci A, Bradley B, Suomalainen H, Greenberg E, Laforte D, Kleemola P, Hyytinen M et al. ( 2013 ) . Recruitment and retention of participants for an international type 1 diabetes prevention trial: A coordinators’ perspective . Clinical Trials vol. 11 , ( 2 ) 150 - 158 .

Levetan C, Pozzilli P, Jovanovic L, Schatz D ( 2013 ) . Proposal for generating new beta cells in a muted immune environment for type 1 diabetes . Diabetes Metab Res Rev vol. 29 , ( 8 ) 604 - 606 .

Mitrea A, Soare A, Popa SG, Tudor MN, Mota M, Pozzilli P ( 2013 ) . Wrist Circumference: An Independent Predictor of Both Insulin Resistance and Chronic Kidney Disease in an Elderly Population . Romanian Journal of Diabetes Nutrition and Metabolic Diseases vol. 20 , ( 3 ) 323 - 329 .

Mollo A, Hernandez M, Marsal JR, Esquerda A, Rius F, Blanco-Vaca F, Verdaguer J, Pozzilli P et al. ( 2013 ) . Latent autoimmune diabetes in adults is perched between type 1 and type 2: evidence from adults in one region of Spain . Diabetes Metab Res Rev vol. 29 , ( 6 ) 446 - 451 .

Maurizi AR, Pozzilli P ( 2013 ) . Do we need continuous glucose monitoring in type 2 diabetes? . Diabetes Metab Res Rev

Mannucci E, Dicembrini I, Lauria A, Pozzilli P ( 2013 ) . Is glucose control important for prevention of cardiovascular disease in diabetes? . Diabetes Care vol. 36 Suppl 2 , ( Suppl 2 ) S259 - S263 .

Strollo R, Ponchel F, Malmström V, Rizzo P, Bombardieri M, Wenham CY, Landy R, Perret D et al. ( 2013 ) . Autoantibodies to posttranslationally modified type II collagen as potential biomarkers for rheumatoid arthritis . Arthritis Rheum vol. 65 , ( 7 ) 1702 - 1712 .

Lehtonen E, Ormisson A, Nucci A, Cuthbertson D, Sorkio S, Hyytinen M, Alahuhta K, Berseth C et al. ( 2013 ) . Use of vitamin D supplements during infancy in an international feeding trial . Public Health Nutrition vol. 17 , ( 4 ) 810 - 822 .

Bonafini B, Pozzilli P ( 2013 ) . The Three Graces: canons of beauty or disease repulsion . Int J Cardiol vol. 166 , ( 2 ) 283 - 285 .

Chon S, Lee YJ, Fraterrigo G, Pozzilli P, Choi MC, Kwon M-K, Chin SO, Rhee SY et al. ( 2013 ) . Evaluation of glycemic variability in well-controlled type 2 diabetes mellitus . Diabetes Technol Ther vol. 15 , ( 6 ) 455 - 460 .

Pham MN, Kolb H, Battelino T, Ludvigsson J, Pozzilli P, Zivehe F, Roden M, Mandrup-Poulsen T et al. ( 2013 ) . Fasting and meal-stimulated residual beta cell function is positively associated with serum concentrations of proinflammatory cytokines and negatively associated with anti-inflammatory and regulatory cytokines in patients with longer term type 1 diabetes . Diabetologia vol. 56 , ( 6 ) 1356 - 1363 .

Moran A, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Greenbaum CJ, Herold KC et al. ( 2013 ) . Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials . Lancet vol. 381 , ( 9881 ) 1905 - 1915 .

Portuesi R, Cherubini C, Gizzi A, Buzzetti R, Pozzilli P, Filippi S ( 2013 ) . A stochastic mathematical model to study the autoimmune progression towards type 1 diabetes . Diabetes Metab Res Rev vol. 29 , ( 3 ) 194 - 203 .

Strollo R, Rizzo P, Spoletini M, Landy R, Hughes C, Ponchel F, Napoli N, Palermo A et al. ( 2013 ) . HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus . Diabetologia vol. 56 , ( 3 ) 563 - 572 .

Garg SK ( 2013 ) . New Therapies for Diabetes Management . Diabetes Technology & Therapeutics . vol. 15 ,

Pham MN, Kolb H, Mandrup-Poulsen T, Battelino T, Ludvigsson J, Pozzilli P, Roden M, Schloot NC et al. ( 2013 ) . Serum adipokines as biomarkers of beta-cell function in patients with type 1 diabetes: positive association with leptin and resistin and negative association with adiponectin . Diabetes Metab Res Rev vol. 29 , ( 2 ) 166 - 170 .

Skyler JS ( 2013 ) . The Year in Immune Intervention for Type 1 Diabetes . Diabetes Technology & Therapeutics vol. 15 , ( S1 )

Portuesi R, Pozzilli P, Boehm B, Buzzetti R, Filippi S ( 2013 ) . Assessment of type 1 diabetes risk conferred by HLA-DRB1, INS-VNTR and PTPN22 genes using the Bayesian network approach . PLoS One vol. 8 , ( 11 )

Khazrai YM, De Gara L, Iorio B, Pozzilli P ( 2013 ) . Dietary Habits and Undiagnosed Diabetes in a Rural Population of Peru . DIABETES . vol. 62 , A699 - A699 .

Dagan S, Avron A, Peled D, Elias D, Tamir M, Pozzilli P, Raz I, Harari G et al. ( 2013 ) . Differences in Long-Term Changes in C-peptide Levels after Stimulation With Glucagon or a Mixed-Meal . DIABETES . vol. 62 , A64 - A64 .

Napoli N, Strollo R, Pitocco D, Bizzarri C, Maddaloni E, Maggi D, Manfrini S, Schwartz A et al. ( 2013 ) . Effect of calcitriol on bone turnover and osteocalcin in recent-onset type 1 diabetes . PLoS One vol. 8 , ( 2 )

Dang MN, Buzzetti R, Pozzilli P ( 2013 ) . Epigenetics in autoimmune diseases with focus on type 1 diabetes . Diabetes Metab Res Rev vol. 29 , ( 1 ) 8 - 18 .

Thi MNP, Burkart V, Hawa MI, Roden M, Schernthaner G, Pozzilli P, Buzzetti R, Scherbaum W et al. ( 2013 ) . Higher Serum Concentrations of TGFβ1 in Patients With Type 1 Diabetes than in Patients With Type 2 Diabetes or Latent Autoimmune Diabetes in Adults . DIABETES . vol. 62 , A447 - A447 .

Maddaloni E, Sabatino F, Del Toro R, Grande S, Palermo A, Lauria A, Maurizi A, Manfrini S et al. ( 2013 ) . In-Vivo Corneal Confocal Microscopy as a Novel Non-Invasive Tool to Study Autonomic Nerve Function in Type 1 Diabetes . DIABETES . vol. 62 , A145 - A146 .

Briganti SI, Guglielmi C, Tomao E, Avallone V, Cataldo R, Manfrini S, Pozzilli P ( 2013 ) . Obesity and Diabetes in Military and Civil Aviation Flying Personnel . DIABETES . vol. 62 , A708 - A709 .

Pozzilli P, Buzzetti R, Frederich R, Iqbal N, Hirshberg B ( 2013 ) . Saxagliptin Is Well Tolerated and Improves Glycemic Control in Adult Diabetes Patients With GAD Antibodies . DIABETES . vol. 62 , A287 - A287 .

Buzzetti R, Pozzilli P, Frederich R, Iqbal N, Hirshberg B ( 2013 ) . Saxagliptin improves glycaemic control and is well tolerated in adult diabetes patients with glutamic acid decarboxylase antibodies . DIABETOLOGIA . vol. 56 , S390 - S390 .

Thi MNP, Kolb H, Zivehe F, Battelino T, Ludvigsson J, Pozzilli P, Burkart V, Roden M et al. ( 2013 ) . Serum Concentrations of Adiponectin Associated Positively With Proinflammatory Cytokines in Patients With Type 1 Diabetes . DIABETES . vol. 62 , A64 - A64 .

Hessner M, Kaldunski M, Jia S, Wang X, Cheong S, Pickersgill L, De Koning E, Ziegler A-G et al. ( 2013 ) . Serum Signature Analysis of Participants of the Anti-Interleukin-1 in Diabetes Action (AIDA) Trial . DIABETES . vol. 62 , A63 - A64 .

Pozzilli P, Raz I, Linn T, Bonnici F, Elias D, Avron A, Tamir M, Eren R et al. ( 2013 ) . Subgroup Analysis of DIA-AID 1, an Immune Intervention Phase III Study in Newly Diagnosed Type 1 Diabetes Patients . DIABETES . vol. 62 , A64 - A64 .

Pozzilli P, Raz I, Linn T, Bonnici F, Elias D, Avron A, Tamir M, Eren R et al. ( 2013 ) . Subgroup analysis of DIA-AID 1, an immune intervention phase 3 study in newly diagnosed type 1 diabetes patients . DIABETOLOGIA . vol. 56 , S230 - S230 .

Rizzo P, Pitocco D, Scavone G, Di Stasio E, Costantini F, Strollo R, Galli M, Pozzilli P et al. ( 2013 ) . The Role of Collagen Neoepitopes Generated by Oxidative Stress in the Pathogenesis of Charcot Neuroarthropathy . DIABETES . vol. 62 , A619 - A619 .

Guglielmi C, Palermo A, Pozzilli P ( 2012 ) . Latent autoimmune diabetes in the adults (LADA) in Asia: from pathogenesis and epidemiology to therapy . Diabetes Metab Res Rev vol. 28 Suppl 2 , 40 - 46 .

Bodrova TA, Kostyushev DS, Antonova EN, Slavin S, Gnatenko DA, Bocharova MO, Legg M, Pozzilli P et al. ( 2012 ) . Introduction into PPPM as a new paradigm of public health service: an integrative view . EPMA J vol. 3 , ( 1 )

Cardwell CR, Stene LC, Ludvigsson J, Rosenbauer J, Cinek O, Svensson J, Perez-Bravo F, Memon A et al. ( 2012 ) . Breast-feeding and childhood-onset type 1 diabetes: a pooled analysis of individual participant data from 43 observational studies . Diabetes Care vol. 35 , ( 11 ) 2215 - 2225 .

Vaccaro O, Masulli M, Bonora E, Del Prato S, Giorda CB, Maggioni AP, Mocarelli P, Nicolucci A et al. ( 2012 ) . Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: Impact on cardiovascular events. A randomized controlled trial . Nutrition Metabolism and Cardiovascular Diseases vol. 22 , ( 11 ) 997 - 1006 .

Khazrai YM, Cacciapaglia F, Palermo A, Pozzilli P ( 2012 ) . The use of a glucose spray device to control progression towards hypoglycaemia . Endocrine vol. 42 , ( 2 ) 442 - 444 .

Zampetti S, Capizzi M, Spoletini M, Campagna G, Leto G, Cipolloni L, Tiberti C, Bosi E et al. ( 2012 ) . GADA Titer-Related Risk for Organ-Specific Autoimmunity in LADA Subjects Subdivided according to Gender (NIRAD Study 6) . The Journal of Clinical Endocrinology & Metabolism vol. 97 , ( 10 ) 3759 - 3765 .

Pozzilli P, Strollo R ( 2012 ) . Immunotherapy for Type 1 diabetes: getting beyond a negative first impression . Immunotherapy vol. 4 , ( 7 ) 655 - 658 .

Vesperini E, Maurizi AR, Pozzilli P, Salvinelli F ( 2012 ) . Diabetes and Auditory Risk: the Recent Data . International Journal of Clinical Reviews

Palermo A, Maddaloni E, Pozzilli P ( 2012 ) . Buccal spray insulin (Oralgen) for type 2 diabetes: what evidence? . Expert Opin Biol Ther vol. 12 , ( 6 ) 767 - 772 .

Strom A, Menart B, Simon M, Pham M, Kolb H, Roden M, Pozzilli P, Leslie R et al. ( 2012 ) . Zelluläre Interferon-γ und Interleukin-13 Immunantwort bei Typ 1, Typ 2 und Latentem Autoimmune Diabetes . Diabetologie und Stoffwechsel vol. 7 , ( S 01 )

Strom A, Menart B, Simon M-C, Pham MN, Kolb H, Roden M, Pozzilli P, Leslie RDG et al. ( 2012 ) . Cellular interferon-γ and interleukin-13 immune reactivity in type 1, type 2 and latent autoimmune diabetes: action LADA 6 . Cytokine vol. 58 , ( 2 ) 148 - 151 .

Roth J, Pozzilli P ( 2012 ) . Editors' note to Raz and Eldor's commentary "Rational therapy for diabetes: early recognition of adverse effects and avoidance of disruptive false alarms". Diabetes Metab Res Rev 2012 . Diabetes Metab Res Rev vol. 28 , ( 4 )

Pham MN, Hawa MI, Roden M, Schernthaner G, Pozzilli P, Buzzetti R, Scherbaum WA, Seissler J et al. ( 2012 ) . Increased serum concentrations of adhesion molecules but not of chemokines in patients with Type 2 diabetes compared with patients with Type 1 diabetes and latent autoimmune diabetes in adult age: action LADA 5 . Diabet Med vol. 29 , ( 4 ) 470 - 478 .

Bonafini B, Pozzilli P ( 2012 ) . Scrotal asymmetry, varicocoele and the Riace Bronzes . Int J Androl vol. 35 , ( 2 ) 181 - 182 .

Bizzarri C, Pinto RM, Pitocco D, Astorri E, Cappa M, Hawa M, Giannone G, Palermo A et al. ( 2012 ) . Diabetes-related autoantibodies in children with acute lymphoblastic leukemia . Diabetes Care vol. 35 , ( 3 )

Ludvigsson J, Krisky D, Casas R, Battelino T, Castaño L, Greening J, Kordonouri O, Otonkoski T et al. ( 2012 ) . GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus . N Engl J Med vol. 366 , ( 5 ) 433 - 442 .

Nucci AM, Becker DJ, Virtanen SM, Cuthbertson D, Softness B, Huot C, Wasikowa R, Dosch HM et al. ( 2012 ) . Growth differences between North American and European children at risk for type 1 diabetes . Pediatric Diabetes vol. 13 , ( 5 ) 425 - 431 .

Hawa MI, Kolb H, Schloot N, Beyan H, Paschou SA, Buzzetti R, Mauricio D, De Leiva A et al. ( 2012 ) . Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7 . Diabetes Care

Barker A, Lauria A, Schloot N, Hosszufalusi N, Panczel P, Ludvigsson J, Mathieu C, Mauricio D et al. ( 2012 ) . BMI is the Major Driver of Beta Cell Loss in RecentOnset Type 1 Diabetes: a Multicentre, Longitudinal Study . DIABETES . vol. 61 , A447 - A447 .

Napoli N, Strollo R, Pitocco D, Bizzarri C, Maddaloni E, Maggi D, Manfrini S, Schwartz A et al. ( 2012 ) . Calcitriol and Bone Turnover in Type 1 Diabetic Adolescents . DIABETES . vol. 61 , A331 - A331 .

Khazrai YM, Defeudis G, Cutolo S, Pasqualotto E, Pozzilli P, Manfrini S ( 2012 ) . Conversation Maps: The Path Towards Self-Management . DIABETES . vol. 61 , A179 - A179 .

Dagan S, Peled D, Elias D, Avron A, Eren R, Raz I, Pozzilli P ( 2012 ) . Evaluation of treatment effect of a type 1 diabetes intervention therapy using GST versus MMTT . DIABETOLOGIA . vol. 55 , S192 - S192 .

Napoli N, Zardi E, Strollo R, Arigliani M, Daverio A, Olearo F, Tosi D, Dicuonzo G et al. ( 2012 ) . Increased carotid thickness in subjects with recently-diagnosed diabetes from rural Cameroon . PLoS One vol. 7 , ( 8 )

Leslie RD, Hawa MI, Kolb H, Schloot N, Beyan H, Paschou SA, Buzzetti R, Mauricio D et al. ( 2012 ) . LADA is not a Distinct Form of Autoimmune Diabetes . DIABETES . vol. 61 , A24 - A25 .

VALORANI MG, Montelatici E, Germani A, Biddle A, D'Alessandro D, Strollo R, Patrizi MP, Lazzari L et al. ( 2012 ) . Pre-culturing human adipose tissue mesenchymal stem cells under hypoxia increases their adipogenic and osteogenic differentiation potential . Cell Proliferation vol. 45 , ( 3 ) 225 - 238 .

Dagan S, Ziegler AG, Pozzilli P, Linn T, Schernthaner G, Bonnici F, Elias D, Eren R et al. ( 2012 ) . Recent Data from DIA-AID 1, a Global Phase III Clinical Study in Newly Diagnosed Type 1 Diabetes Patients . DIABETES . vol. 61 , A76 - A76 .

Raz I, Linn T, Ziegler A-G, Schernthaner G, Bonnici F, Eren R, Elias D, Dagan S et al. ( 2012 ) . Recent data from DIA-AID 1, a global phase III clinical study using DiaPep277® for the treatment of newly diagnosed type 1 diabetes patients . DIABETOLOGIA . vol. 55 , S66 - S66 .

Robert JJ, Ludvigsson J, Krisky D, Casas R, Battelino T, Castano L, Greening J, Kordonouri O et al. ( 2012 ) . Treatment with GAD65 antigen in type 1 diabetes diagnosed recently . DIABETES & METABOLISM vol. 38 , A130 - A130 .

Pozzilli P ( 2011 ) . Type 1 diabetes mellitus in 2011: Heterogeneity of T1DM raises questions for therapy . Nat Rev Endocrinol vol. 8 , ( 2 ) 78 - 80 .

Buzzetti R, Cernea S, Petrone A, Capizzi M, Spoletini M, Zampetti S, Guglielmi C, Venditti C et al. ( 2011 ) . C-peptide response and HLA genotypes in subjects with recent-onset type 1 diabetes after immunotherapy with DiaPep277: an exploratory study . Diabetes vol. 60 , ( 11 ) 3067 - 3072 .

Park Y, Kim K, Pozzilli P ( 2011 ) . Preface . Diabetes Metab Res Rev vol. 27 , ( 8 )

Morviducci L, Di Flaviani A, Lauria A, Pitocco D, Pozzilli P, Suraci C, Frontoni S, CSII Study Group Of Lazio Region, Italy ( 2011 ) . Continuous subcutaneous insulin infusion (CSII) in inpatient setting: unmet needs and the proposal of a CSII unit . Diabetes Technol Ther vol. 13 , ( 10 ) 1071 - 1074 .

Di Stasio E, Maggi D, Berardesca E, Marulli GC, Bizzarri C, Lauria A, Portuesi R, Cavallo MG et al. ( 2011 ) . Blue eyes as a risk factor for type 1 diabetes . Diabetes Metab Res Rev vol. 27 , ( 6 ) 609 - 613 .

Tuccinardi D, Fioriti E, Manfrini S, D'Amico E, Pozzilli P ( 2011 ) . DiaPep277 peptide therapy in the context of other immune intervention trials in type 1 diabetes . Expert Opin Biol Ther vol. 11 , ( 9 ) 1233 - 1240 .

Napoli N, Pedone C, Pozzilli P, Lauretani F, Bandinelli S, Ferrucci L, Incalzi RA ( 2011 ) . Effect of ghrelin on bone mass density: the InChianti study . Bone vol. 49 , ( 2 ) 257 - 263 .

Barchetta I, Angelico F, Del Ben M, Baroni MG, Pozzilli P, Morini S, Cavallo MG ( 2011 ) . Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes . BMC Med vol. 9 ,

Pham MN, Hawa MI, Pfleger C, Roden M, Schernthaner G, Pozzilli P, Buzzetti R, Scherbaum WA et al. ( 2011 ) . Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4 . Diabetologia vol. 54 , ( 7 ) 1630 - 1638 .

Vadacca M, Valorani MG, von Hofe E, Kallinteris NL, Buzzetti R, Pozzilli P ( 2011 ) . Recognition of Ii-Key/MHC class II epitope hybrids derived from proinsulin and GAD peptides by T cells in type 1 diabetes . Horm Metab Res vol. 43 , ( 7 ) 483 - 488 .

Pham M, Hawa M, Roden M, Schernthaner G, Pozzilli P, Scherbaum W, Seissler J, Hunter S et al. ( 2011 ) . Erhöhte systemische Konzentrationen der Adhäsionsmoleküle sICAM-1, sVCAM-1 und sE-Selectin bei Typ 2 Diabetes verglichen mit LADA und Typ 1 Diabetes in der Action LADA Kohorte . Diabetologie und Stoffwechsel vol. 6 , ( S 01 )

Pozzilli P, Guglielmi C, Caprio S, Buzzetti R ( 2011 ) . Obesity, autoimmunity, and double diabetes in youth . Diabetes Care vol. 34 Suppl 2 , ( Suppl 2 ) S166 - S170 .

Signore A, Picarelli A, Chianelli M, Biancone L, Annovazzi A, Tiberti C, Anastasi E, Multari G et al. ( 1996 ) . 123I-Interleukin-2 Scintigraphy: A New Approach to Assess Disease Activity in Autoimmunity . Journal of Pediatric Endocrinology and Metabolism . vol. 9 , 139 - 144 .

Maurizi AR, Lauria A, Maggi D, Palermo A, Fioriti E, Manfrini S, Pozzilli P ( 2011 ) . A Novel Insulin Unit Calculator for the Management of Type 1 Diabetes . DIABETES TECHNOL THE vol. 13 , ( 4 ) 425 - 428 .

Pedone C, Napoli N, Pozzilli P, Rossi FF, Lauretani F, Bandinelli S, Ferrucci L, Antonelli-Incalzi R ( 2011 ) . Dietary pattern and bone density changes in elderly women: a longitudinal study . J Am Coll Nutr vol. 30 , ( 2 ) 149 - 154 .

Astorri E, Bombardi M, Peakman M, Pozzilli P, Pitzalis C ( 2011 ) . EVOLUTION OF ECTOPIC LYMPHOID NEOGENESIS AND IN SITU AUTOANTIBODY PRODUCTION IN AUTOIMMUNE DIABETIC NOD MICE: CELLULAR AND MOLECULAR CHARACTERIZATION OF TERTIARY LYMPHOID STRUCTURES IN PANCREATIC ISLETS . RHEUMATOLOGY . vol. 50 , 52 - 53 .

Nesbitt A, Fossati G, Whittall CE, Askari A, Middleton J, Astorri E, Bombardi M, Peakman M et al. ( 2011 ) . Cytokines and inflammatory mediators . Rheumatology vol. 50 , ( suppl_3 ) iii52 - iii55 .

Guglielmi C, Pozzilli P ( 2011 ) . Early Diagnosis of Type 1 Diabetes: Useful or a Phyrrhic Victory? . Clinical Dilemmas in Diabetes , Wiley

Haller H, Ito S, Izzo JL, Januszewicz A, Katayama S, Menne J, Mimran A, Rabelink TJ et al. ( 2011 ) . Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes . New England Journal of Medicine vol. 364 , ( 10 ) 907 - 917 .

Napoli N, Costanza F, Di Stasio E, Strollo R, Manfrini S, Cipponeri E, Picardi A, Carrano F et al. ( 2011 ) . Blood glucose monitoring in the normal population: the PREDICA study . Acta Diabetol vol. 48 , ( 1 ) 29 - 34 .

Astorri E, Bombardieri M, Gabba S, Peakman M, Pozzilli P, Pitzalis C ( 2011 ) . EVOLUTION OF ECTOPIC LYMPHOID NEOGENESIS AND IN SITU AUTOANTIBODIES PRODUCTION IN AUTOIMMUNE DIABETIC NOD MICE: CELLULAR AND MOLECULAR CHARACTERISATION OF TERTIARY LYMPHOID STRUCTURES IN PANCREATIC ISLETS . ANNALS OF THE RHEUMATIC DISEASES . vol. 70 ,

Pedone C, Napoli N, Pozzilli P, Lauretani F, Bandinelli S, Ferrucci L, Antonelli-Incalzi R ( 2011 ) . Quality of diet and potential renal acid load as risk factors for reduced bone density in elderly women . Bone vol. 48 , ( 2 )

Portuesi R, Cherubini C, Gizzi A, Valorani G, Buzzetti R, Filippi S, Pozzilli P ( 2011 ) . A Mathematical Model To Study the Autoimmune Progression towards Type 1 Diabetes . DIABETES . vol. 60 , A668 - A668 .

Pham MN, Kolb H, Mandrup-Poulsen T, Battelino T, Ludvigsson J, Pozzilli P, Roden M, Schloot NC ( 2011 ) . Adiponectin levels negatively associate with beta cell function in type 1 diabetes, in contrast to leptin and resistin . DIABETOLOGIA . vol. 54 , S304 - S304 .

Bonafini BA, Pozzilli P ( 2011 ) . Body weight and beauty: the changing face of the ideal female body weight . Obes Rev vol. 12 , ( 1 ) 62 - 65 .

Palermo A, Napoli N, Manfrini S, Lauria A, Strollo R, Pozzilli P ( 2011 ) . Buccal spray insulin in subjects with impaired glucose tolerance: the prevoral study . Diabetes Obes Metab vol. 13 , ( 1 ) 42 - 46 .

Palermo A, Napoli N, Maddaloni E, Lauria A, Manfrini S, Maurizi A, Altomare M, Leotta S et al. ( 2011 ) . Buccal spray insulin: a new tool to treat subjects with impaired glucose tolerance . DIABETOLOGIA . vol. 54 , S52 - S52 .

Pozzilli P, Guglielmi C, Maggi D, Carlone A, Buzzetti R, Manfrini S ( 2011 ) . Clinical update on the use of immuno modulators (antiCD3, GAD, Diapep277, anti-IL1) in type 1 diabetes . Curr Pharm Des vol. 17 , ( 29 ) 3224 - 3228 .

Maurizi AR, Napoli N, Strollo R, Lauria A, Manfrini S, Schwatz A, Pozzilli P ( 2011 ) . Osteocalcin and Residual β-Cell Function in Type 1 Diabetes . DIABETES . vol. 60 , A485 - A485 .

Minh-Nguyet P, Hawa M, Roden M, Schernthaner G, Pozzilli P, Buzzetti R, Scherbaum W, Seissler J et al. ( 2011 ) . Similar Circulating Concentrations of Adhesion Molecules between Type 1 Diabetes and LADA Patients: Results from the Action LADA Study . DIABETES . vol. 60 , A144 - A144 .

Pozzilli P, Schloot NC, Hosszufalusi N, Lauria A, Ludvigsson J, Mathieu C, Mauricio D, Rubinat E et al. ( 2011 ) . Time dependent C-peptide decline in 4411 patients with recent onset type 1 diabetes followed for up to 10 years: a meta-analysis from 8 European centres . DIABETOLOGIA . vol. 54 , S74 - S74 .

Palermo A, Napoli N, Maddaloni E, Lauria A, Manfrini S, Altomare M, Leotta S, Pozzilli P ( 2011 ) . Treatment of Impaired Glucose Tolerance with Buccal Spray Insulin: A 6 Months Randomised Controlled Trial . DIABETES . vol. 60 , A592 - A593 .

POZZILLI P, STROLLO, R, NAPOLI, N ( 2010 ) . Iatrogenic immunoendocrinopathy . Immunoendocrinology: Scientific and Clinical Aspects , Editors: Eisenbarth, GS , Humana Pr Inc

Napoli N, Pedone C, Pozzilli P, Lauretani F, Ferrucci L, Incalzi RA ( 2010 ) . Adiponectin and bone mass density: The InCHIANTI study . Bone vol. 47 , ( 6 ) 1001 - 1005 .

Astorri E, Guglielmi C, Bombardieri M, Alessandri C, Buzzetti R, Maggi D, Valesini G, Pitzalis C et al. ( 2010 ) . Circulating Reg1α proteins and autoantibodies to Reg1α proteins as biomarkers of β-cell regeneration and damage in type 1 diabetes . Horm Metab Res vol. 42 , ( 13 ) 955 - 960 .

Astorri E, Bombardieri M, Gabba S, Peakman M, Pozzilli P, Pitzalis C ( 2010 ) . Evolution of ectopic lymphoid neogenesis and in-situ autoantibodies production in autoimmune diabetic NOD mice: cellular and molecular characterization of tertiary lymphoid structures in pancreatic islet . IMMUNOLOGY . vol. 131 , 63 - 63 .

Pozzilli P, Strollo R, Napoli N ( 2010 ) . Drug-Induced Endocrine Autoimmunity . Immunoendocrinology: Scientific and Clinical Aspects , Springer Nature

Bizzarri C, Patera PI, Arnaldi C, Petrucci S, Bitti MLM, Scrocca R, Manfrini S, Portuesi R et al. ( 2010 ) . Incidence of type 1 diabetes has doubled in Rome and the Lazio region in the 0- to 14-year age-group: a 6-year prospective study (2004-2009) . Diabetes Care vol. 33 , ( 11 )

Astorri E, Bombardieri M, Gabba S, Peakman M, Pozzilli P, Pitzalis C ( 2010 ) . Evolution of ectopic lymphoid neogenesis and in situ autoantibody production in autoimmune nonobese diabetic mice: cellular and molecular characterization of tertiary lymphoid structures in pancreatic islets . J Immunol vol. 185 , ( 6 ) 3359 - 3368 .

Maurizi A, Palermo A, Anguissola GB, Benevento D, Lauria A, Cipponeri H, Tuccinardi D, Manfrini S et al. ( 2010 ) . A pocket instrument for calculating insulin need in the management of type 1 diabetes . DIABETOLOGIA . vol. 53 ,

Bruno G, Maule M, Merletti F, Novelli G, Falorni A, Iannilli A, Iughetti L, Altobelli E et al. ( 2010 ) . Age-period-cohort analysis of 1990-2003 incidence time trends of childhood diabetes in Italy: the RIDI study . Diabetes vol. 59 , ( 9 ) 2281 - 2287 .

Pozzilli P, Ghirlanda G, Brennan AM, Belanger B, Mckee CM ( 2010 ) . Fasting and stimulated C-peptide at aseline in DEFEND-1, a phase 3 study of otelixizumab in new onset type 1 diabetes . DIABETOLOGIA . vol. 53 , S189 - S190 .

Portuesi R, Bohm BO, Julier C, Pozzilli P ( 2010 ) . HLA and insulin genes: Bayesian networks confirm interaction between the two most important susceptibility genes in type 1 diabetes in a French caucasian population . DIABETOLOGIA . vol. 53 , S77 - S78 .

Bizzarri C, Pitocco D, Napoli N, Di Stasio E, Maggi D, Manfrini S, Suraci C, Cavallo MG et al. ( 2010 ) . No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial . Diabetes Care vol. 33 , ( 9 ) 1962 - 1963 .

Napoli N, Bizzarri C, Pitocco D, Suraci C, Altomare M, Sacchetti E, Valente L, Pozzilli P ( 2010 ) . Osteocalcin and its effect on metabolic control in type 1 diabetes . DIABETOLOGIA . vol. 53 ,

Pham MN, Hawa MI, Pfleger C, Roden M, Schernthaner G, Pozzilli P, Buzzetti R, Seissler J et al. ( 2010 ) . Proinflammatory and regulatory cytokines are similar in type 1 diabetes (T1D) and LADA and lower compared to type 2 diabetes (T2D) patients: results from Action LADA Study . DIABETOLOGIA . vol. 53 , S184 - S185 .

Occhicone F, Quattrocchi CC, Napoli N, Dell'Aia P, D'Agostino F, Pozzilli P, Beomonte Zobel B ( 2010 ) . Incidence of new fractures in women with osteoporosis-induced vertebral fractures detected on routine lateral chest radiographs . Radiol Med vol. 115 , ( 5 ) 815 - 825 .

Hilner JE, Perdue LH, Sides EG, Pierce JJ, Wägner AM, Aldrich A, Loth A, Albret L et al. ( 2010 ) . Designing and implementing sample and data collection for an international genetics study: the Type 1 Diabetes Genetics Consortium (T1DGC) . Clinical Trials vol. 7 , ( 1_suppl ) s5 - s32 .

Valorani MG, Germani A, Otto WR, Harper L, Biddle A, Khoo CP, Lin WR, Hawa MI et al. ( 2010 ) . Hypoxia increases Sca-1/CD44 co-expression in murine mesenchymal stem cells and enhances their adipogenic differentiation potential . Cell Tissue Res vol. 341 , ( 1 ) 111 - 120 .

Bizzarri C, Pitocco D, Napoli N, Maggi D, Suraci C, Di Stasio E, Anguissola GB, Pozzilli P et al. ( 2010 ) . A Double-Blind Trial with Calcitriol in Recent Onset Type 1 Diabetes (IMDIAB XIII) . DIABETES . vol. 59 , A88 - A88 .

Maurizi AR, Palermo A, Anguissola GB, Benevento D, Pantano AL, Cipponeri E, Tuccinardi D, Manfrini S et al. ( 2010 ) . A Novel Insulin Unit Calculator for the Management of Type 1 Diabetes . DIABETES . vol. 59 , A539 - A539 .

Zampetti S, Spoletini M, Petrone A, Capizzi M, Arpi ML, Tiberti C, Di Pietro S, Bosi E et al. ( 2010 ) . Association of TCF7L2 gene variants with low GAD autoantibody titre in LADA subjects (NIRAD Study 5) . Diabet Med vol. 27 , ( 6 ) 701 - 704 .

Benevento D, Bizzarri C, Pitocco D, Crinò A, Moretti C, Spera S, Tubili C, Costanza F et al. ( 2010 ) . Computer use, free time activities and metabolic control in patients with type 1 diabetes . Diabetes Res Clin Pract vol. 88 , ( 3 ) e32 - e34 .

Khazrai YM, Cacciapaglia F, Sellaci T, Benevento D, Fioriti E, Manfrini S, Pozzilli P ( 2010 ) . Dietary and Lifestyle Differences between an Urban and a Rural Population in Central Italy . DIABETES . vol. 59 , A679 - A679 .

Maggi D, Camera E, Abril E, Picardo M, Maurizi AR, Manfrini S, Pozzilli P ( 2010 ) . Effects of a Loofa Scrub Soap Prepared from Dead Sea for Care of Diabetic Foot . DIABETES . vol. 59 , A628 - A629 .

Khazrai YM, Cacciapaglia F, Manfrini S, Bodoni G, Gillanti G, Lorubbio A, Leto G, Buzzetti R et al. ( 2010 ) . Empowering People with Diabetes Is a Key for Optimal Disease Management . DIABETES . vol. 59 , A602 - A602 .

Spoletini M, Maggi D, Zampetti S, Astorri E, Buzzetti R, Pozzilli P, Imdiab Grp ( 2010 ) . OCA2 Gene Polymorphisms Are Associated with Specific Eye Colour and Skin Phenotype in Type 1 Diabetes . DIABETES . vol. 59 , A330 - A331 .

Napoli N, Zardi E, Strollo R, Arigliani M, Guglielmi C, Tosi D, Daverio A, Scarpa F et al. ( 2010 ) . The Effect of a Dietary Education Program in a Diabetic Population from Sub-Saharian Africa . DIABETES . vol. 59 , A275 - A275 .

Napoli N, Strollo R, Pozzilli P ( 2010 ) . CALCITIOL ADMINISTRATION IN TYPE 1 DIABETIC ADOLESCENTS: DOES IT IMPROVE OR IMPAIR BONE HEALTH? . OSTEOPOROSIS INTERNATIONAL . vol. 21 , 309 - 309 .

Pozzilli P, Leslie RD, Chan J, De Fronzo R, Monnier L, Raz I, Del Prato S ( 2010 ) . The A1C and ABCD of glycaemia management in type 2 diabetes: a physician's personalized approach . Diabetes Metab Res Rev vol. 26 , ( 4 ) 239 - 244 .

Cardwell CR, Stene LC, Joner G, Davis EA, Cinek O, Rosenbauer J, Ludvigsson J, Castell C et al. ( 2010 ) . Birthweight and the risk of childhood-onset type 1 diabetes: a meta-analysis of observational studies using individual patient data . Diabetologia vol. 53 , ( 4 ) 641 - 651 .

Pedone C, Napoli N, Pozzilli P, Lauretani F, Bandinelli S, Ferrucci L, Antonelli-Incalzi R ( 2010 ) . Quality of diet and potential renal acid load as risk factors for reduced bone density in elderly women . Bone vol. 46 , ( 4 ) 1063 - 1067 .

Napoli N, Strollo R, Tosi D, Daverio A, Arigliani M, Mottini G, Pozzilli P ( 2010 ) . The effect of dietary education on metabolic control and vascular impairment in a diabetic population from sub-saharian Africa . ENDOCR J vol. 57 , S358 - S359 .

Pallone F, Montano S, Fais S, Boirivant M, Signore A, Pozzilli P ( 2010 ) . Studies of Peripheral Blood Lymphocytes in Crohn's Disease: Circulating Activated T Cells . Scandinavian Journal of Gastroenterology vol. 18 , ( 8 ) 1003 - 1008 .

Cardwell CR, Stene LC, Joner G, Bulsara MK, Cinek O, Rosenbauer J, Ludvigsson J, Jané M et al. ( 2010 ) . Maternal age at birth and childhood type 1 diabetes: a pooled analysis of 30 observational studies . Diabetes vol. 59 , ( 2 ) 486 - 494 .

Pozzilli P, Raskin P, Parkin CG ( 2010 ) . Review of clinical trials: update on oral insulin spray formulation . Diabetes Obes Metab vol. 12 , ( 2 ) 91 - 96 .

Khazrai Y, Manfrini S, Pozzilli P ( 2010 ) . Diet and diabetes . Functional Foods, Cardiovascular Disease and Diabetes , Taylor & Francis

Pozzilli P ( 2010 ) . NEW CURATIVE TREATMENT FOR TYPE 1 DIABETES . CHILD CARE HLTH DEV vol. 36 , 14 - 14 .

Pozzilli P, Guglielmi C ( 2010 ) . Prevention of type 1 diabetes mellitus . Principles of Diabetes Mellitus ,

Napoli N, Mottini G, Arigliani M, Creta A, Giua R, Incammisa A, Carotti S, Sihom F et al. ( 2010 ) . Unexpectedly high rates of obesity and dysglycemia among villagers in Cameroon . Diabetes Metab Res Rev vol. 26 , ( 1 ) 10 - 12 .

Pozzilli P, Strollo R, Barchetta I ( 2009 ) . Natural history and immunopathogenesis of type 1 diabetes . Endocrinol Nutr vol. 56 Suppl 4 , 50 - 52 .

Pozzilli P, Guglielmi C ( 2009 ) . Prevention of Type 1 Diabetes Mellitus . Principles of Diabetes Mellitus , Springer Nature

Cernea S, Buzzetti R, Pozzilli P ( 2009 ) . Beta-cell protection and therapy for latent autoimmune diabetes in adults . Diabetes Care . vol. 32 Suppl 2 , S246 - S252 .

Cernea S, Raz I, Herold KC, Hirshberg B, Roep BO, Schatz DA, Fleming GA, Pozzilli P et al. ( 2009 ) . Challenges in developing endpoints for type 1 diabetes intervention studies . Diabetes Metab Res Rev vol. 25 , ( 8 ) 694 - 704 .

Barchetta I, Cavallo MG, Angelico F, Del Ben M, Fraioli A, Morini S, Pozzilli P ( 2009 ) . HYPOVITAMINOSIS D IS ASSOCIATED WITH MILD NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND METABOLIC SYNDROME'S COMPONENTS IN DYS-METABOLIC ADULT PATIENTS . HEPATOLOGY . vol. 50 , 797A - 797A .

Buzzetti R, Cernea S, Petrone A, Spoletini M, Zampetti S, Guglielmi C, Venditti C, Pozzilli P ( 2009 ) . C-Peptide response and HLA genotypes in subjects with recent onset type 1 diabetes following immunotherapy with diapep277 . DIABETOLOGIA . vol. 52 , S192 - S193 .

Napoli N, Pitocco D, Di Stasio E, Bizzarri C, Maggi D, Strollo R, Barchetta I, Suraci C et al. ( 2009 ) . Calcitriol administration in the youth reduces bone turnover and may prevent bone loss in type 1 diabetes . DIABETOLOGIA . vol. 52 , S347 - S347 .

Palermo A, Napoli N, Costanza F, Beretta G, Manfrini S, Pozzilli P ( 2009 ) . Management of impaired glucose tolerance using buccal spray insulin . DIABETOLOGIA . vol. 52 , S373 - S373 .

Fallucca F, Pozzilli P ( 2009 ) . Physical exercise, public health and quality of life in diabetes . Diabetes Metab Res Rev vol. 25 Suppl 1 , S1 - S3 .

Pronina E, Guglielmi C, Petraikina H, Antsiferov M, Duchareva O, Pozzilli P ( 2009 ) . Rapid GlucoseSpray: an innovative tool to control hypoglycaemia and improve HbA(1c) in children with type 1 diabetes . DIABETOLOGIA . vol. 52 , S346 - S346 .

Pozzilli P, Spoletini M, Zampetti S, Capizzi M, Kyanvash S, Venditti C, Buzzetti R, IMDIAB Grp ( 2009 ) . Similar frequencies of HLA risk genotypes in type 1 diabetes over the past six decades in a southern European Caucasian population . DIABETOLOGIA . vol. 52 , S120 - S120 .

Pozzilli P ( 2009 ) . Immunotherapy in Type 1 Diabetes . Diabetic Medicine vol. 5 , ( 8 ) 734 - 738 .

Pozzilli P, Leslie RDG ( 2009 ) . Infections and Diabetes: Mechanisms and Prospects for Prevention . Diabetic Medicine vol. 11 , ( 10 ) 935 - 941 .

Pozzilli P, Visalli N, Ghirlanda G, Manna R, Andreani D ( 2009 ) . Nicotinamide Increases C‐peptide Secretion in Patients with Recent Onset Type 1 Diabetes . Diabetic Medicine vol. 6 , ( 7 ) 568 - 572 .

Pozzilli P, Visalli N, Boccuni ML, Baroni MG, Buzzetti R, Fioriti E, Signore A, Cavallo MG et al. ( 2009 ) . Randomized Trial Comparing Nicotinamide and Nicotinamide Plus Cyclosporin in Recent Onset Insulin‐dependent Diabetes (IMDIAB 1) . Diabetic Medicine vol. 11 , ( 1 ) 98 - 104 .

Pozzilli P, Andreani D ( 2009 ) . Type 1 Diabetes at Presentation: the Scene Changes . Diabetic Medicine vol. 7 , ( 9 ) 762 - 763 .

Signore A, Beverley PCL, Parman A, Negri M, Pozzilli P ( 2009 ) . Labelling of Interleukin-2 (IL-2) with 123-Iodine with Retention of Its Capacity to Bind to Activated Lymphocytes . Experimental and Clinical Endocrinology & Diabetes vol. 89 , ( 03 ) 301 - 306 .

Muir A, Schatz DA, Pozzilli P, Maclaren NK ( 2009 ) . Intervention Therapies for Insulin-Dependent Diabetes . Autoimmunity vol. 16 , ( 4 ) 301 - 310 .

Beales PE, Liddf R, Endl J, Kientsch-Engel R, Pozzilli P ( 2009 ) . Intradermal Administration of GAD & Evaluation of Diabetes Incidence in Mice: Possible Relevance for Skin Tests in Humans . Autoimmunity vol. 32 , ( 2 ) 109 - 113 .

Cugini P, Battisti P, Di Palma L, Cavallini M, Pozzilli P, Scibilia G, Letizia C, Cassisi A et al. ( 2009 ) . Secondary Aldosteronism Documented by Plasma Renin and Aldosterone Circadian Rhythm in Subjects with Kidney or Heart Transplantation . Renal Failure vol. 14 , ( 1 ) 69 - 76 .

Beales PE, Delovitch TL, Signore A, Pozzilli P ( 2009 ) . Standardizing Experiments with NOD Mice . Autoimmunity vol. 24 , ( 2 ) 127 - 129 .

Monetini L, Cavallo MG, Barone F, Valente L, Russo M, Walker B, Thorpe R, Pozzilli P ( 2009 ) . T Cell Reactivity to Human Insulinoma Cell Line (CM) Antigens in Patients with Type 1 Diabetes . Autoimmunity vol. 29 , ( 3 ) 171 - 177 .

Signore A, Fiore V, Chianelli M, Ronga G, Pozzilli P ( 2009 ) . Effect of metformin on liver insulin metabolism and regional blood flow . Diabetes/Metabolism Research and Reviews vol. 11 , ( S1 ) s13 - s21 .

Leslie RDG, Carotenuto P, Pozzilli P ( 1993 ) . New developments in non‐specific and semi‐specific immunosuppression in type I diabetes . Diabetes/Metabolism Research and Reviews . vol. 9 , 257 - 267 .

Andreani D, Di Mario U, Pozzilli P ( 2009 ) . Prediction, prevention, and early intervention in insulin‐dependent diabetes . Diabetes/Metabolism Research and Reviews vol. 7 , ( 1 ) 61 - 77 .

Colle E, Lounamaa R, Tuomilehto J, De Beaufort, Balzano E, Bruno G, Cacciari E, Cerutti F et al. ( 2009 ) . The epidemiology and immunogenetics of IDDM in Italian‐heritage populations . Diabetes/Metabolism Research and Reviews vol. 6 , ( 2 ) 63 - 69 .

Pozzilli P, Andreani D ( 2009 ) . The potential role of nicotinamide in the secondary prevention of IDDM . Diabetes/Metabolism Research and Reviews vol. 9 , ( 3 ) 219 - 230 .

Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HA, Julier C, Morahan G et al. ( 2009 ) . Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes . Nature Genetics vol. 41 , ( 6 ) 703 - 707 .

Napoli N, Pozzilli P, Rini GB, Armamento-Villareal R ( 2009 ) . HIGH PREVALENCE OF LOW VITAMIN D AND MUSCULOSKELETAL COMPLAINTS IN WOMEN WITH BREAST CANCER: THE IMPLICATIONS FOR AROMATASE INHIBITOR THERAPY . Maturitas vol. 63 ,

Napoli N, Rini GB, Pozzilli P, Armamento-Villareal R ( 2009 ) . THE A ALLELE AT VALINE80 OF THE CYP19 GENE IS A RISK FACTOR FOR AROMATASE INHIBITORS ASSOCIATED BONE LOSS . Maturitas vol. 63 ,

Beyan H, Buckley LR, Bustin SA, Yousaf N, Pozzilli P, Leslie RD ( 2009 ) . Altered monocyte cyclo-oxygenase response in non-obese diabetic mice . Clin Exp Immunol vol. 155 , ( 2 ) 304 - 310 .

Di Gialleonardo V, de Vries EFJ, Chianelli M, Wolffenbuttel BHR, De Vos P, Pozzilli P, Dierckx RA, Signore A ( 2009 ) . <SUP>18</SUP>F-Interleukin-2, a novel radioactive probe for insulitis imaging by PET . EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING . vol. 36 , S211 - S211 .

Khoo CP, Valorani MG, Brittan M, Alison MR, Warnes G, Johansson U, Hawa M, Pozzilli P ( 2009 ) . Characterization of endothelial progenitor cells in the NOD mouse as a source for cell therapies . Diabetes Metab Res Rev vol. 25 , ( 1 ) 89 - 93 .

Pozzilli P, Guglielmi C ( 2009 ) . Double diabetes: a mixture of type 1 and type 2 diabetes in youth . Endocr Dev vol. 14 , 151 - 166 .

Hawa MI, Thivolet C, Mauricio D, Alemanno I, Cipponeri E, Collier D, Hunter S, Buzzetti R et al. ( 2009 ) . Metabolic syndrome and autoimmune diabetes: action LADA 3 . Diabetes Care vol. 32 , ( 1 ) 160 - 164 .

Pozzilli P, Tamburrano G, Mercalli M, Javicoli M ( 2008 ) . Raised Alpha-2-Macroglobulin Levels in Acromegaly . Hormone and Metabolic Research vol. 10 , ( 04 ) 359 - 359 .

Sensi M, Tanzi P, Bruno MR, Pozzilli P, Mancuso M, Gambardella S, Di Mario U ( 2008 ) . Nonenzymic Glycation of Isolated Human Glomerular Basement Membrane Changes Its Physicochemical Characteristics and Binding Properties . Nephron vol. 52 , ( 3 ) 222 - 226 .

Khoo CP, Pozzilli P, Alison MR ( 2008 ) . Endothelial progenitor cells and their potential therapeutic applications . Regen Med vol. 3 , ( 6 ) 863 - 876 .

Picardi A, Cipponeri E, Bizzarri C, Fallucca S, Guglielmi C, Pozzilli P ( 2008 ) . Menarche in type 1 diabetes is still delayed despite good metabolic control . Fertil Steril vol. 90 , ( 5 ) 1875 - 1877 .

Cernea S, Pozzilli P ( 2008 ) . New potential treatments for protection of pancreatic B-cell function in Type 1 diabetes . Diabet Med vol. 25 , ( 11 ) 1259 - 1267 .

Leslie RDG, Kolb H, Schloot NC, Buzzetti R, Mauricio D, De Leiva A, Yderstraede K, Sarti C et al. ( 2008 ) . Diabetes classification: grey zones, sound and smoke: Action LADA 1 . Diabetes Metab Res Rev vol. 24 , ( 7 ) 511 - 519 .

( 2008 ) . Errata . Diabetes Care vol. 31 , ( 10 ) 2077 - 2077 .

Greenbaum CJ, Mandrup-Poulsen T, McGee PF, Battelino T, Haastert B, Ludvigsson J, Pozzilli P, Lachin JM et al. ( 2008 ) . Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes . Diabetes Care vol. 31 , ( 10 ) 1966 - 1971 .

Brophy S, Yderstraede K, Mauricio D, Hunter S, Hawa M, Pozzilli P, Schernthaner G, Schloot N et al. ( 2008 ) . on behalf of the Action LADA Group: Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults. (vol 31, pg 439, 2008) . DIABETES CARE vol. 31 , ( 10 ) 2077 - 2077 .

Guglielmi C, Astorri E, Portuesi R, Bombardieri M, Valorani M, Pozzilli P ( 2008 ) . A diet rich in protein and poor in starch with reduced food intake prevents diabetes in the NOD moose: the significance of Reg gene expression in the pancreas . DIABETOLOGIA vol. 51 , S229 - S229 .

Astorri E, Bombardieri M, Guglielmi C, Pitzalis C, Pozzilli P ( 2008 ) . Beta cell regeneration in type 1 diabetes: the role of Reg genes in NOD mice . DIABETOLOGIA vol. 51 , S186 - S186 .

Bizzarri C, Benevento D, Pitocco D, Crino A, Spera S, Tubili C, Costanza F, Maurizi A et al. ( 2008 ) . Free time activities and blood glucose control in patients with type 1 diabetes . DIABETOLOGIA vol. 51 , S419 - S419 .

Pronina E, Petraikina H, Antsiferov M, Duchareva O, Guglielmi C, Khazrai M, Pozzilli P ( 2008 ) . Glucose RapidSpray (TM) for a new management of hypoglycaemia in children up to 5 years of age with type 1 diabetes . DIABETOLOGIA . vol. 51 , S383 - S383 .

Khoo CP, Hill N, Valorani MG, Signore A, Pozzilli P ( 2008 ) . Intracellular inhibition of JNK kinase reduces lymphocyte homing into endocrine pancreas of non obese diabetic (NOD) mouse . DIABETOLOGIA vol. 51 , S228 - S229 .

Schloot NC, Hawa MI, Scherbaum WA, Pozzilli P, Leslie R, Seissler J, Action LADA Consortium ( 2008 ) . Organ specific autoantibodies in patients with type 1 diabetes, LADA and type 2 diabetes . DIABETOLOGIA vol. 51 , S235 - S235 .

Petrone A, Park Y, Genovese S, Woo JT, Giordano C, Lee KW, Pontiroli AE, Paik SH et al. ( 2008 ) . Similarities and differences between Caucasian and Asian LADA . DIABETOLOGIA vol. 51 , S155 - S156 .

Cernea S, Moretti C, Tubili C, Suraci C, Pitocco D, Barchetta I, Manfrini S, Napoli N et al. ( 2008 ) . The natural history of residual beta cell function in patients with type 1 diabetes under continuous subcutaneous insulin infusion therapy . DIABETOLOGIA vol. 51 , S397 - S397 .

Hawa MI, Cipponeri E, Collier D, Loh Y, Pozzilli P, Brophy S, Hunter S, Thivolet C et al. ( 2008 ) . The prevalence of metabolic syndrome is much less in LADA and type 1 diabetes than type 2 diabetes: ACTION LADA 3 . DIABETOLOGIA vol. 51 , S155 - S155 .

Pronina EA, Petraikina EE, Antsiferov MB, Duchareva OV, Petrone A, Buzzetti R, Pozzilli P ( 2008 ) . A 10-year (1996-2005) prospective study of the incidence of Type 1 diabetes in Moscow in the age group 0-14 years . Diabet Med vol. 25 , ( 8 ) 956 - 959 .

Cavallo MG, Pozzilli P, Misiti S, Baroni MG ( 2008 ) . Insulinoma CM cell line as in vitro model for beta-cell . J Cell Physiol vol. 216 , ( 2 )

CAVALLO MG, POZZILLI P, THORPE R ( 2008 ) . Cytokines and autoimmunity . Clinical & Experimental Immunology vol. 96 , ( 1 ) 1 - 7 .

Cavallo MG, Pozzilli JP, Bird C, Wadhwa M, Meager A, Visalli N, Gearing AJH, Andreani D et al. ( 2008 ) . Cytokines in sera from insulin-dependent diabetic patients at diagnosis . Clinical & Experimental Immunology vol. 86 , ( 2 ) 256 - 259 .

Baroni MG, Alcolado JC, Pozzilli P, Cavallo MG, Li S, Galton DJ ( 2008 ) . Polymorphisms at the GLUT2 (β‐cell/liver) glucose transporter gene and non‐insulin‐dependent diabetes mellitus (NIDDM): analysis in affected pedigree members . Clinical Genetics vol. 41 , ( 5 ) 229 - 234 .

Vadacca M, Valorani MG, Humphreys R, Kallinteris N, Valente L, Pozzilli P ( 2008 ) . Detection of T cell response to insulin and GAD in Type 1 diabetes using the Ii-Key-hybrid technique . DIABETES . vol. 57 , A18 - A18 .

Guglielmi C, Astorri E, Bizzarri C, Suraci C, Pitocco D, Morviducci L, Buzzetti R, Pozzilli P et al. ( 2008 ) . High prevalence of double diabetes in a Caucasian population . DIABETES . vol. 57 , A273 - A274 .

Picardi A, Costanza F, Di Stasio E, Napoli N, Carrano F, Dell'Anna V, Macin W, Pozzilli P ( 2008 ) . The PREDICA study (PREdiction of diabetes from CApillary Blood Glucose) in the general population . DIABETES . vol. 57 , A674 - A675 .

Petrone A, Spoletini M, Zampetti S, Capizzi M, Zavarella S, Osborn J, Pozzilli P, Buzzetti R et al. ( 2008 ) . The PTPN22 1858T gene variant in type 1 diabetes is associated with reduced residual beta-cell function and worse metabolic control . Diabetes Care vol. 31 , ( 6 ) 1214 - 1218 .

Khazrai M, Cacciapaglia F, Picardi A, Anguissola GB, Guglielmi C, Manfrini S, Pozzilli P ( 2008 ) . Treatment of symptoms of neuroglycopenia with Glucose Rapid-Spray (TM) to avoid rebound hyperglycaemia . DIABETES . vol. 57 , A564 - A564 .

Cardwell CR, Stene LC, Joner G, Cinek O, Svensson J, Goldacre MJ, Parslow RC, Pozzilli P et al. ( 2008 ) . Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies . Diabetologia vol. 51 , ( 5 ) 726 - 735 .

Pozzilli P, Carotenuto P, Delltala G ( 2008 ) . Lymphocytic traffic and homing into target tissue and the generation of endocrine autoimmunity . Clinical Endocrinology vol. 41 , ( 5 ) 545 - 554 .

POZZILLI P, POZZILLI C, PANTANO P, NEGRI M, ANDREANI D, CUDWORTH AG ( 2008 ) . TRACKING OF INDIUM‐111‐OXINE LABELLED LYMPHOCYTES IN AUTOIMMUNE THYROID DISEASE . Clinical Endocrinology vol. 19 , ( 1 ) 111 - 116 .

Pozzilli P, Di Mario U, Javicoli M, Chinca M, Orsini M ( 2008 ) . Alpha 2 Macroglobulin: Its Variability in Diabetes . Hormone and Metabolic Research vol. 12 , ( 08 ) 409 - 410 .

Di Mario U, Vitillo M, Perfetti R, Mancuso M, Morellini M, Cappellacci S, Pozzilli P, Andreani D ( 2008 ) . Humoral and Cellular Immunological Factors as Possible Markers of Clinical Relapse in HLA-Typed Graves' Patients Followed with Time . Hormone and Metabolic Research vol. 21 , ( 05 ) 267 - 271 .

Krug J, Lampeter E, Williams AJK, Procaccini E, Cartledge C, Signore A, Beales P, Pozzilli P ( 2008 ) . Immunotherapy with Ciamexon in the Non Obese Diabetic (NOD) Mouse . Hormone and Metabolic Research vol. 24 , ( 01 ) 1 - 4 .

Pozzilli P, Andreani D ( 2008 ) . Increased ‘Killer’ Cells in Graves' Disease . Hormone and Metabolic Research vol. 14 , ( 01 ) 56 - 56 .

Beales P, Williams AJK, Albertini M, Pozzilli P ( 2008 ) . Vitamin E Delays Diabetes Onset in the Non-Obese Diabetic Mouse . Hormone and Metabolic Research vol. 26 , ( 10 ) 450 - 452 .

Petrone A, Suraci C, Capizzi M, Giaccari A, Bosi E, Tiberti C, Cossu E, Pozzilli P et al. ( 2008 ) . The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3 . Diabetes Care vol. 31 , ( 3 ) 534 - 538 .

Brophy S, Yderstraede K, Mauricio D, Hunter S, Hawa M, Pozzilli P, Schernthaner G, Schloot N et al. ( 2008 ) . Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults . Diabetes Care vol. 31 , ( 3 ) 439 - 441 .

Chianelli M, Parisella MG, Visalli N, Mather SJ, D'Alessandria C, Pozzilli P, Signore A, IMDIAB study group ( 2008 ) . Pancreatic scintigraphy with 99mTc-interleukin-2 at diagnosis of type 1 diabetes and after 1 year of nicotinamide therapy . Diabetes Metab Res Rev vol. 24 , ( 2 ) 115 - 122 .

Pitocco D, DiStasio E, Crinò A, Manfrini S, Guglielmi C, Visalli N, Suraci C, Matteoli MC et al. ( 2008 ) . Age at diagnosis of type 1 diabetes and the effect of immunomodulatory therapies on residual beta cell function . Horm Metab Res vol. 40 , ( 1 ) 66 - 68 .

Cacciapaglia F, Arcarese L, Rigon A, Vadacca M, Valorani MG, Pozzilli P, Afeltra A ( 2008 ) . Antinuclear antibodies prevalence in Filipinos migrated to Italy . Eur Rev Med Pharmacol Sci vol. 12 , ( 4 ) 267 - 270 .

Pronina E, Petraikina H, Antsiferov M, Duchareva O, Guglielmi C, Merola MY, Pozzilli P ( 2008 ) . Treatment of Hypoglycaemia in Very Young Children (< 5 Years of Age) with Type 1 Diabetes Using the Glucose RapidSpray™ . Canadian Journal of Diabetes vol. 32 , ( 4 )

Noble JA, Martin A, Valdes AM, Lane JA, Galgani A, Petrone A, Lorini R, Pozzilli P et al. ( 2008 ) . Type 1 diabetes risk for human leukocyte antigen (HLA)-DR3 haplotypes depends on genotypic context: association of DPB1 and HLA class I loci among DR3- and DR4-matched Italian patients and controls . Hum Immunol vol. 69 , ( 4-5 ) 291 - 300 .

Gentilucci UV, Picardi A, Manfrini S, Khazrai YM, Fioriti E, Altomare M, Guglielmi C, Di Stasio E et al. ( 2008 ) . Westernization of the Filipino population resident in Rome: obesity, diabetes and hypertension . Diabetes Metab Res Rev vol. 24 , ( 5 ) 364 - 370 .

Merriman T, Twells R, Merriman M, Eaves I, Cox R, Cucca F, McKinney P, Shield J et al. ( 2007 ) . Evidence by allelic association-dependent methods for a type 1 diabetes polygene (IDDM6) on chromosome 18q21 (vol 6, pg 1003, 1997) . HUM MOL GENET vol. 16 , ( 24 ) 3197 - 3197 .

Pozzilli P, Guglielmi C, Pronina E, Petraikina E ( 2007 ) . Double or hybrid diabetes associated with an increase in type 1 and type 2 diabetes in children and youths . Pediatr Diabetes vol. 8 Suppl 9 , 88 - 95 .

Spoletini M, Petrone A, Zampetti S, Capizzi M, Zavarella S, Osborn J, Foffi C, Tuccinardi D et al. ( 2007 ) . Low-risk HLA genotype in Type 1 diabetes is associated with less destruction of pancreatic B-cells 12 months after diagnosis . Diabet Med vol. 24 , ( 12 ) 1487 - 1490 .

Guglielmi C, Battistoni F, Valente L, Astorri E, Valorani MG, Pitocco D, Pozzilli P, IMDIAB Grp ( 2007 ) . Circulating Reg1-alpha plasma levels as potential marker of beta cell regeneration in type 1 diabetes . ACTA DIABETOL vol. 44 , S18 - S19 .

Vadacca M, Valorani G, Humphreys R, Kallinteris N, Valente L, D'Agostino G, Pozzilli P, IMDIAB Grp ( 2007 ) . Ii-key/MHC class II epitope hybrid technology to detect T cell response to insulin and GAD in type 1 diabetes . DIABETOLOGIA . vol. 50 , S30 - S30 .

Khoo CP, Valorani MG, Brittan M, Alison MR, Guglielmi C, Warnes G, Johansson U, Hawa MI et al. ( 2007 ) . Isolation, characterisation and prospects of endothelial progenitor cells to aid pancreatic beta cell regeneration . DIABETOLOGIA . vol. 50 , S221 - S222 .

Brunetti P, Muggeo M, Cattin L, Arcangeli A, Pozzilli P, Provenzano V, Francesconi A, Calatola P et al. ( 2007 ) . Italian experience trial for the implementation of insulin glargine in basal-bolus regimen in patients with type 1 diabetes . DIABETOLOGIA . vol. 50 , S394 - S394 .

Spoletini M, Petrone A, Capizzi M, Zavarella S, Zampetti S, Leto G, Alemanno I, Pozzilli P et al. ( 2007 ) . Low risk HLA genotype is associated with less destruction of beta cells persisting 12 months after diagnosis . DIABETOLOGIA . vol. 50 , S133 - S133 .

Petrone A, Spoletini M, Capizzi M, Zampetti S, Zavarella S, Venditti C, Foffi C, Alemanno I et al. ( 2007 ) . The PTPN22 1858T gene variant is associated with reduced residual insulin secretion and worst metabolic control in type 1 diabetes . DIABETOLOGIA . vol. 50 , S113 - S113 .

Locatelli M, Buzzetti R, Galgani A, Montemari AL, Khazrai M, Petrone A, Visalli N, Meschi F et al. ( 2007 ) . Length of gestation and gender are associated with HLA genotypes at risk for Type 1 diabetes (Italian DIABFIN 3) . Diabet Med vol. 24 , ( 8 ) 916 - 919 .

Maggi D, Berardesca E, Marulli G, Manfrini S, Bizzarri C, Lauria A, Pitocco D, Pozzilli P ( 2007 ) . Blue eyes and fair skin are risk factors for type 1 diabetes in the Mediterranean region . DIABETES . vol. 56 , A267 - A267 .

Khazrai YM, Manfrini S, Cacciapaglia F, Spallina F, Picardi A, Spera S, Benevento D, Pozzilli P ( 2007 ) . Effectiveness of group medical nutrition therapy in lowering HbA(1c) in type 2 diabetes . DIABETES . vol. 56 , A41 - A41 .

Picardi A, Merola YM, Altomare M, Visalli N, Cipponeri E, Pozzilli P ( 2007 ) . Glucose rapidspray, a new tool to control progression towards hypoglycaemia . DIABETES . vol. 56 , A128 - A128 .

Napoli N, Arigliani M, Creta A, Giua R, Incam-Misa A, Mottini G, Carotti C, Sihom F et al. ( 2007 ) . High prevalence of diabetes, impaired glucose tolerance and increased body weight in a rural population of sub-Saharian Africa despite lack of known risk factors . DIABETES . vol. 56 , A632 - A632 .

Brunetti P, Muggeo M, Cattin L, Arcangeli A, Pozzilli P, Provenzano V, Francesconi A, Calatola P et al. ( 2007 ) . Italian experience trial for the implementation of LANTUS in basal-bolus regimen in patients with type 1 diabetes . DIABETES . vol. 56 , A558 - A558 .

Guglielmi C, Battistoni F, Valente L, Astorri E, Valorani MG, Pozzilli P, Imdiab G ( 2007 ) . Raised levels of reg1-alpha in sera of subjects with type I diabetes: Evidence for beta cell regeneration . DIABETES . vol. 56 , A323 - A323 .

Khazrai YM, Altomare M, Visalli N, Cipolloni L, Maurizi AM, Pozzilli P ( 2007 ) . Reduction of body weight through diet and the use of glucose rapidspray . DIABETES . vol. 56 , A463 - A463 .

Hans K. Akerblom, Mikael Knip, Dorothy Becker, Hans-Michael Dosch, John Dupre, Jorma Ilonen, Jeffrey P. Krischer, The TRIGR Study Group ( 2007 ) . The TRIGR Trial: Testing the Potential Link between Weaning Diet and Type 1 Diabetes . Immunology Endocrine & Metabolic Agents - Medicinal Chemistry vol. 7 , ( 3 ) 251 - 263 .

Pozzilli P ( 2007 ) . Immuno-intervention and preservation of beta-cell function in type 1 diabetes . Diabetes Metab Res Rev vol. 23 , ( 4 ) 255 - 256 .

Wild T, Scherbaum W, Gleichmann H, Landt M, Santiago J, Endl J, Landgraf R, Cavallo M et al. ( 2007 ) . Comparison of a New Anti-Glutamic Acid Decarboxylase (GAD) Enzyme-Linked Immunosorbent Assa (ELISA) with Radioimmunoassay Methods: A Multicenter Study . Hormone and Metabolic Research vol. 29 , ( 08 ) 403 - 406 .

Beales P, Giorgini A, Annovazzi A, Signore A, Parlapiiano C, Pozzilli P ( 2007 ) . Metformin Does Not Alter Diabetes Incidence in the NOD Mouse . Hormone and Metabolic Research vol. 29 , ( 06 ) 261 - 263 .

Liddi R, Beales P, Rosignoli G, Pozzilli P ( 2007 ) . Incomplete Freund's Adjuvant Reduces Diabetes in the Non-Obese Diabetic Mouse . Hormone and Metabolic Research vol. 32 , ( 06 ) 201 - 206 .

Giorgini A, Beales P, Mire-Sluis A, Scott D, Liddi R, Pozzilli P ( 2007 ) . Troglitazone Exhibits Immunomodulatory Activity on the Cytokine Production of Activated Human Lymphocytes . Hormone and Metabolic Research vol. 31 , ( 01 ) 1 - 4 .

Pozzilli P, Buzzetti R ( 2007 ) . A new expression of diabetes: double diabetes . Trends Endocrinol Metab vol. 18 , ( 2 ) 52 - 57 .

Picardi A, Valorani MG, Vespasiani Gentilucci U, Manfrini S, Ciofini O, Cappa M, Guglielmi C, Pozzilli P et al. ( 2007 ) . Raised C-reactive protein levels in patients with recent onset type 1 diabetes . Diabetes Metab Res Rev vol. 23 , ( 3 ) 211 - 214 .

Pitocco D, Pozzilli P ( 2007 ) . Authors' response [4] . Diabetic Medicine vol. 24 , ( 2 ) 219 - 220 .

Pitocco D, Pozzilli P, IMDIAB Grp ( 2007 ) . The effects of calcitriol and nicotinamide on residual pancreatic beta-cell funtion in patients with recent-onset Type 1 diabetes (IMDIAB XI) - Response . DIABETIC MED vol. 24 , ( 2 ) 219 - 220 .

Pitocco D, Pozzilli P, Group OBOTI ( 2007 ) . Authors’ response . Diabetic Medicine vol. 24 , ( 2 ) 220 - 220 .

Papavramidou N, Christopoulou-Aletra H, Pozzilli P ( 2007 ) . Endocrinology and art . J ENDOCRINOL INVEST vol. 30 , ( 1 ) 83 - 83 .

Christopoulou-Aletra H, Papavramidou N, Pozzilli P ( 2007 ) . Goitrous beauty in Artemisia Gentileschi's Judith and her Maidservant . Thyroid vol. 17 , ( 1 ) 37 - 38 .

Gentilucci UV, Picardi A, Pozzilli P ( 2006 ) . Glucose abnormalities in patients with hepatitis C virus infection: epidemiology and pathogenesis: response to Lecube et al . Diabetes Care vol. 29 , ( 11 ) 2558 - 2559 .

Pozzilli P, Guglielmi C ( 2006 ) . Immunomodulation for the prevention of SPIDDM and LADA . Ann N Y Acad Sci . vol. 1079 , 90 - 98 .

Picardi A, Visalli N, Lauria A, Suraci C, Buzzetti R, Merola MK, Manfrini S, Guglielmi C et al. ( 2006 ) . Metabolic factors affecting residual beta cell function assessed by C-peptide secretion in patients with newly diagnosed type 1 diabetes . Horm Metab Res vol. 38 , ( 10 ) 668 - 672 .

Manfrini S, Bruni R, Terminio N, Khazrai M, Sandri G, Benevento D, Spera S, Ganz M et al. ( 2006 ) . Alexithymia in type 1 diabetes and coeliac disease . DIABETOLOGIA . vol. 49 , 531 - 532 .

Vadacca M, Valorani G, Humphreys RE, Kallinteris N, Valente L, Pozzilli P, Group I ( 2006 ) . Ii-key/MHC class II epitope hybrid technology and ELISPOT as say in type 1 diabetes . DIABETOLOGIA . vol. 49 , 165 - 166 .

Spoletini M, Petrone A, Zampetti S, Alemanno I, Capizzi M, Zavarella S, Bizzarri C, Pozzilli P et al. ( 2006 ) . Preservation of beta cell secretion in T1DM subjects with low risk HLA genotype . DIABETOLOGIA . vol. 49 , 444 - 445 .

Mandrup-Poulsen TR, Battelino T, Haastert B, Ludvigsson J, Pozzilli P, Lalic NM, Martinez-Larrad MT, Mauricio D et al. ( 2006 ) . The European C-Peptide Trial CPT: comparison of liquid mixed meal and glucagon stimulation assays for the analysis of residual beta cell function in type 1 diabetes . DIABETOLOGIA . vol. 49 , 375 - 376 .

Petrone A, Capizzi M, Giaccari A, Bosi E, Cucinotta D, Cossu E, Suraci C, Falorni A et al. ( 2006 ) . The Protein Tyrosine Phosphatase Non receptor (PTPN22) is associated with high GAD antibody titre in adult-onset autoimmune diabetes (The NIRAD Study) . DIABETOLOGIA . vol. 49 , 183 - 184 .

Prisco F, Picardi A, Iafusco D, Lorini R, Minicucci L, Martinucci ME, Toni S, Cerutti F et al. ( 2006 ) . Blood ketone bodies in patients with recent-onset type 1 diabetes (a multicenter study) . Pediatr Diabetes vol. 7 , ( 4 ) 223 - 228 .

Bessaoud K, Boudraa G, de Ropolo MM, de Sereday M, Marti ML, Moser M, Lapertosa S, Damiano M et al. ( 2006 ) . Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999 . DIABETIC MED vol. 23 , ( 8 ) 857 - 866 .

Christopoulou-Aletra H, Papavramidou N, Pozzilli P ( 2006 ) . Obesity in the Neolithic era: a Greek female figurine . Obes Surg vol. 16 , ( 8 ) 1112 - 1114 .

Pitocco D, Crinò A, Di Stasio E, Manfrini S, Guglielmi C, Spera S, Anguissola GB, Visalli N et al. ( 2006 ) . The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI) . Diabet Med vol. 23 , ( 8 ) 920 - 923 .

Pozzilli P, Astorri E, Bizzari C, Cappa M, De Rossi G, Leslie RDG, Hawa M, Spoletini ML et al. ( 2006 ) . GAD, IA2 and insulin autoantibodies in children diagnosed with acute lymphoblastic leukaemia: Relevance for type 1 diabetes . DIABETES . vol. 55 , A412 - A412 .

Vadacca M, Valeri C, Gigante A, Guglielmi C, Pozzilli P, Action LADA Grp ( 2006 ) . Gender differences and the metabolic syndrome in patients with type 2 diabetes with or without auioantibodies to glutamic acid decarboxilase (GAD) . DIABETES . vol. 55 , A283 - A283 .

Vadacca M, Humphreys RE, Kallinteris NL, Valente L, Valorani G, Pozzilli P, IMDIAB Grp ( 2006 ) . Ii-key/insulin MHC class-II antigenic epitope peptides in type 1 diabetes . DIABETES . vol. 55 , A88 - A88 .

Yeganeh MK, Cacciapaglia F, Beretta G, Altomare M, Cherubini V, Suraci C, Pozzilli P, Trigr Study Grp ( 2006 ) . Pregnancy and offspring outcomes in families with one parent affected by type 1 diabetes . DIABETES . vol. 55 , A607 - A607 .

Pozzilli P, Palermo A, Manfrini S, Fioriti E, Visalli N, Suraci C, Picardi A, IMDIAB Grp ( 2006 ) . Prevalence of the metabolic syndrome in type 1 diabetes . DIABETES . vol. 55 , A233 - A233 .

Leslie RDG, Williams R, Pozzilli P ( 2006 ) . Clinical review: Type 1 diabetes and latent autoimmune diabetes in adults: one end of the rainbow . J Clin Endocrinol Metab vol. 91 , ( 5 ) 1654 - 1659 .

Ou D, Wang X, Metzger DL, Ao Z, Pozzilli P, James RFL, Chen L, Warnock GL ( 2006 ) . Suppression of Human T-Cell Responses to β-Cells by Activation of B7-H4 Pathway . Cell Transplant vol. 15 , ( 5 ) 399 - 410 .

Genovese S, Bazzigaluppi E, Gonçalves D, Ciucci A, Cavallo MG, Purrello F, Anello M, Rotella CM et al. ( 2006 ) . Clinical phenotype and beta-cell autoimmunity in Italian patients with adult-onset diabetes . Eur J Endocrinol vol. 154 , ( 3 ) 441 - 447 .

Hawa MI, Picardi A, Costanza F, D'Avola D, Beretta Anguissola G, Guglielmi C, Mottini G, Fezeu L et al. ( 2006 ) . Frequency of diabetes and thyroid autoantibodies in patients with autoimmune endocrine disease from Cameroon . Clin Immunol vol. 118 , ( 2-3 ) 229 - 232 .

Pozzilli P, Valeri C, Gigante A, Group TI ( 2006 ) . Gender related differences in patients with type 2 diabetes with or without autoantibodies to glutamic acid decarboxilase (GAD) . Gender Medicine vol. 3 ,

Pozzilli P ( 2006 ) . Prevention of diabetes in children . HORM RES vol. 65 , 9 - 9 .

Ou D, Wang X, Metzger DL, Ao Z, Pozzilli P, James RFL, Chen L, Warnock GL ( 2006 ) . Suppression of human T-cell responses to beta-cells by activation of B7-H4 pathway . Cell Transplant vol. 15 , ( 5 ) 399 - 410 .

Pozzilli P, Pagani S, Buzzetti R, Cruciani L, Beales PE, Cucinotta D, Benzi L, Porta M et al. ( 2005 ) . Prevalence of serological markers for hepatitis‐B in patients with insulin‐dependent diabetes . Practical Diabetes vol. 8 , ( 1 ) 5 - 6 .

Pozzilli P, Leslie R ( 2005 ) . Aspirin and diabetes . Practical Diabetes vol. 16 , ( 8 ) 259 - 261 .

Pozzilli P ( 2005 ) . Cow's milk and Type 1 diabetes: New evidence about β casein . Practical Diabetes vol. 15 , ( 2 ) 49 - 50 .

Connor H ( 2005 ) . Glycaemic outcome in patients with type 2 diabetes referred to a hospital clinic because of poor control . Practical Diabetes vol. 16 , ( 8 ) 247 - 249 .

Pozzilli P, Manfrini S, Crinò A, Picardi A, Leomanni C, Cherubini V, Valente L, Khazrai M et al. ( 2005 ) . Low levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diabetes . Horm Metab Res vol. 37 , ( 11 ) 680 - 683 .

Crinó A, Schiaffini R, Ciampalini P, Suraci MC, Manfrini S, Visalli N, Matteoli MC, Patera P et al. ( 2005 ) . A two year observational study of nicotinamide and intensive insulin therapy in patients with recent onset type 1 diabetes mellitus . J Pediatr Endocrinol Metab vol. 18 , ( 8 ) 749 - 754 .

Pozzilli P, Manfrini S, Costanza F, Coppolino G, Cavallo MG, Fioriti E, Modi P ( 2005 ) . Biokinetics of buccal spray insulin in patients with type 1 diabetes . Metabolism vol. 54 , ( 7 ) 930 - 934 .

Ou D, Wang X, Metzger DL, Robbins M, Huang J, Jobin C, Chantler JK, James RFL et al. ( 2005 ) . Regulation of TNF-related apoptosis-inducing ligand-mediated death-signal pathway in human beta cells by Fas-associated death domain and nuclear factor kappaB . Hum Immunol vol. 66 , ( 7 ) 799 - 809 .

Pozzilli P ( 2005 ) . Genetic Screening and Prevention of Type 2 Diabetes . Prevention of Type 2 Diabetes , Wiley

Pozzilli P, Manfrini S, Buzzetti R, Lampeter E, Leeuw ID, Iafusco D, Prisco M, Ionescu-Tirgoviste C et al. ( 2005 ) . Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study . Diabetes Res Clin Pract vol. 68 , ( 3 ) 258 - 264 .

Ou D, Wang X, Metzger DL, James RFL, Pozzilli P, Plesner A, Korneluk RG, Verchere CB et al. ( 2005 ) . Synergistic inhibition of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human pancreatic beta cells by Bcl-2 and X-linked inhibitor of apoptosis . Hum Immunol vol. 66 , ( 3 ) 274 - 284 .

Pozzilli P, Khazrai YM ( 2005 ) . "La Monstrua Vestida", a case of Prader-Willi syndrome . J Endocrinol Invest vol. 28 , ( 2 )

Vadacca M, Valorani MG, Valente L, Humpreys RE, Pozzilli P ( 2005 ) . A novel approach to study T cell response to Ii-KEY/MHC class II epitope hybrid peptides in type 1 diabetes . DIABETOLOGIA . vol. 48 , A99 - A99 .

Manfrini S, Bruni R, Terminio N, Poterzio F, Ricci S, Sforza S, Pantano AL, Costanza E et al. ( 2005 ) . Alexithymia in subjects with type 1 diabetes . DIABETOLOGIA . vol. 48 , A323 - A324 .

Ou D, Wang X, Metzger DL, Ao Z, Pozzilli P, Chen L, Warnock GL ( 2005 ) . B7-H4.Ig inhibits human beta-cell destruction mediated by beta cell-specific cytotoxic T cells derived from patients with type 1 diabetes . DIABETES . vol. 54 , A311 - A311 .

POZZILLI P, Warnock G, Ou D, Chen L, Ao Z, Metzger DL, Wang X, James RFL ( 2005 ) . Induction of human T-cell tolerance to B cells by activation of B7-H4 pathway . Human Immunology

Spoletini M, Petrone A, Galgani A, Bassotti G, Guglielmi C, Picardi A, Manfrini S, Imdiab G et al. ( 2005 ) . Insulin secretion at diagnosis of type 1 diabetes is associated with both age of onset and HLA class II . DIABETOLOGIA . vol. 48 , A115 - A116 .

Locatelli M, Buzzetti R, Galgani A, Montemari A, Lorini R, Meschi F, Bottazzo G, Pozzilli P ( 2005 ) . Investigation of risk factors associated with different HLA genotypes of susceptibility to type 1 diabetes . DIABETES . vol. 54 , A276 - A277 .

Valiante S, Barchetta I, Calabria M, Leomanni C, Manfrini S, Hawa M, Leslie D, Pozzilli P et al. ( 2005 ) . Prevalence of GAD antibodies in diabetic patients with or without the metabolic syndrome . DIABETES . vol. 54 , A310 - A310 .

Picardi A, Valorani MG, Cio-Fini O, Manfrini S, D'Avola D, Valente L, Cappa M, Pozzilli P et al. ( 2005 ) . Raised C-reactive protein in recent onset type 1 diabetes . DIABETES . vol. 54 , A176 - A176 .

Petrone A, Galgani A, Spoletini M, Alemanno I, Di Cola S, Bassotti G, Picardi A, Manfrini S et al. ( 2005 ) . Residual insulin secretion at diagnosis of type 1 diabetes is independently associated with both, age of onset and HLA genotype . Diabetes Metab Res Rev vol. 21 , ( 3 ) 271 - 275 .

Lorini R, Minicucci L, Napoli F, Padovani P, Bazzigaluppi E, Tortoioli C, Cherubini V, Bottazzo G et al. ( 2005 ) . Screening for type 1 diabetes genetic risk in newborns of continental Italy. Primary prevention (Prevefin Italy)--preliminary data . Acta Biomed vol. 76 Suppl 3 , 31 - 35 .

Carle F, Gesuita R, Bruno G, Coppa GV, Falorni A, Lorini R, Martinucci ME, Pozzilli P et al. ( 2004 ) . Diabetes incidence in 0- to 14-year age-group in Italy: a 10-year prospective study . Diabetes Care vol. 27 , ( 12 ) 2790 - 2796 .

Monetini L, Cavallo MG, Sarugeri E, Sentinelli F, Stefanini L, Bosi E, Thorpe R, Pozzilli P et al. ( 2004 ) . Cytokine profile and insulin antibody IgG subclasses in patients with recent onset type 1 diabetes treated with oral insulin . Diabetologia vol. 47 , ( 10 ) 1795 - 1802 .

Guo D, Li M, Zhang Y, Yang P, Eckenrode S, Hopkins D, Zheng W, Purohit S et al. ( 2004 ) . A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes (vol 36, pg 837, 2004) . NAT GENET vol. 36 , ( 9 ) 1024 - 1024 .

Hawa MI, Valorani MG, Buckley LR, Beales PE, Afeltra A, Cacciapaglia F, Leslie RD, Pozzilli P ( 2004 ) . Lack of effect of vitamin D administration during pregnancy and early life on diabetes incidence in the non-obese diabetic mouse . Horm Metab Res vol. 36 , ( 9 ) 620 - 624 .

Guo D, Li M, Zhang Y, Yang P, Eckenrode S, Hopkins D, Zheng W, Purohit S et al. ( 2004 ) . A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes . Nat Genet vol. 36 , ( 8 ) 837 - 841 .

Beyan H, Valorani GM, Imdiab G, Pozzilli P, Leslie RDG ( 2004 ) . Abnormalities in plasma 1,25-dihydroxyvitamin D3, and cellular 1-alpha hydroxylase and Cyclooxygenase-2 mRNA levels in recent-onset type 1 diabetes . DIABETOLOGIA . vol. 47 , A188 - A188 .

Ola TO, Hawa MI, Beck-Nielsen H, Buzzetti R, Scherbaum W, Kolb H, Tuomilehto J, Thivolet C et al. ( 2004 ) . Action LADA a multinational European project in latent autoimmune diabetes in adults . DIABETOLOGIA . vol. 47 , A113 - A113 .

Pozzilli P, Pitocco D, Visalli N, Spera S, Corbi S, Suraci C, Crino A, Patera P et al. ( 2004 ) . C-peptide and HbA1c levels at diagnosis indicate a different pathogenic process depending on the age at onset of Type 1 diabetes . DIABETOLOGIA . vol. 47 , A299 - A299 .

Pitocco D, Visalli N, Crino A, Costantino F, Manfrini S, Spera S, Suraci C, Patera P et al. ( 2004 ) . Calcitriol versus nicotinamide in patients with recent onset Type 1 diabetes: IMDIAB XI randomised trial . DIABETOLOGIA . vol. 47 , A185 - A186 .

Anguissola GB, Totonelli A, D'Avola D, Longhitano S, Costanza F, Fioriti E, Agro F, Pozzilli P ( 2004 ) . Continuous glucose monitoring for the evaluation of peri-operative stress in patients with Type 2 diabetes, impaired glucose tollerance and normal subjects . DIABETOLOGIA . vol. 47 , A309 - A309 .

Khazrai YM, Manfrini S, Pozzilli P ( 2004 ) . Diet and diabetes: Prevention and control . Functional Foods, Cardiovascular Disease and Diabetes ,

Guglielmi C, Galgani A, Anguissola GB, D'Avola D, Pozzilli P ( 2004 ) . Different HLA pattern in patients affected by LADA in Congo, central Africa . DIABETOLOGIA . vol. 47 , A130 - A130 .

Leslie RDG, Taylor R, Pozzilli P ( 2004 ) . The Role of Insulin Resistance in the Natural History of Type 1 Diabetes . Diabetic Medicine vol. 14 , ( 4 ) 327 - 331 .

Palmer JP, Fleming GA, Greenbaum CJ, Herold KC, Jansa LD, Kolb H, Lachin JM, Polonsky KS et al. ( 2004 ) . C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop (vol 53, pg 250, 2004) . DIABETES vol. 53 , ( 7 ) 1934 - 1934 .

( 2004 ) . Erratum . Diabetes vol. 53 , ( 7 ) 1934 - 1934 .

Pozzilli P, Visalli N, Picardi A, Manfrini S, Crino A, Suraci C, Pitocco D, Ghirlanda G et al. ( 2004 ) . C-peptide and HbA1c levels at diagnosis indicate a different pathogenic process depending on the age of onset of type 1 diabetes . DIABETES . vol. 53 , A603 - A603 .

Ou DW, Wang XJ, Metzger DL, James RFL, Pozzilli P, Plesner A, Korneluk RG, Verchere CB et al. ( 2004 ) . Cytoprotection of pancreatic beta cells by co-overexpression of Bcl-2 and XIAP genes blocking TRAIL-mediated death-signal transduction pathways . DIABETES . vol. 53 , A444 - A444 .

Gugielmi C, Galgani A, Beretta G, Davola D, Tshilolo L, Mottini G, Caro A, Spoletini M et al. ( 2004 ) . Different HLA pattern in patients affected by LADA in Congo, central Africa . DIABETES . vol. 53 , A536 - A536 .

Noble JA, Valdes AM, McGrue Q, Martin A, Galgani A, Di Cola S, Petrone A, Erlich HA et al. ( 2004 ) . Genetics of type 1 diabetes in Italy: Variation among populations . DIABETES . vol. 53 , A536 - A536 .

Lorini R, Minicucci L, Napoli F, Padovani P, Bazzigaluppi E, Cherubini V, Bottazzo G, Pozzilli P et al. ( 2004 ) . HLA screening for type 1 diabetes at birth in the general population in Italy and implementation of a primary prevention trial with vitamin D and cow's milk hydrolysate. (The PREVEFIN trial) . DIABETES . vol. 53 , A299 - A299 .

Beyan H, Valorani MG, Valente L, Pozzilli P, Leslie RDG ( 2004 ) . Plasma 1,25-dihydroxyvitamin D3,one-alpha hydroxylase and vitamin D receptor mRNA in patients with recent-onset type I diabetes . DIABETES . vol. 53 , A296 - A296 .

Nisticò L, Cascino I, Buzzetti R, Pozzilli P ( 2004 ) . CTLA4 in Type 1 Diabetes Mellitus . CTLA-4 in Autoimmune Disease , Taylor & Francis

Crinò A, Schiaffini R, Manfrini S, Mesturino C, Visalli N, Beretta Anguissola G, Suraci C, Pitocco D et al. ( 2004 ) . A randomized trial of nicotinamide and vitamin E in children with recent onset type 1 diabetes (IMDIAB IX) . Eur J Endocrinol vol. 150 , ( 5 ) 719 - 724 .

Pozzilli P ( 2004 ) . Umberto Di Mario, 1948-2004, professor of Endocrinology at the University of Rome, La Sapienza, Co-editor of 'Diabetes and metabolism research and reviews', president of the Italian Society of Diabetes . DIABETES-METAB RES vol. 20 , ( 3 ) 177 - 177 .

Gentilucci UV, Picardi A, Manfiini S, D'Avola D, Costantino S, Pozzilli P ( 2004 ) . Granulomatous thyroiditis: an unexpected finding leading to the diagnosis of sarcoidosis . Acta Biomed vol. 75 , ( 1 ) 69 - 73 .

Gale EAM, Bingley PJ, Knip M, Emmett CL, Swankie H, Fewell S, Kearsey P, Schober E et al. ( 2004 ) . European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes . LANCET vol. 363 , ( 9413 ) 925 - 931 .

Khazrai YM, Manfrini S, Pozzilli P ( 2004 ) . 7 Diet and diabetes: prevention and control . Functional Foods, Cardiovascular Disease and Diabetes , Elsevier

Palmer JP, Fleming GA, Greenbaum CJ, Herold KC, Jansa LD, Kolb H, Lachin JM, Polonsky KS et al. ( 2004 ) . C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001 . Diabetes vol. 53 , ( 1 ) 250 - 264 .

Guo D, Li M, Zhang Y, Yang P, Eckenrode S, Hopkins D, Zheng W, Purohit S et al. ( 2004 ) . Erratum: A functional variant of SUMO4, a new IκBα modifier, is associated with type 1 diabetes (Nature Genetics (2004) 36 (837-841)) . Nature Genetics vol. 36 , ( 9 )

Buzzetti R, Galgani A, Petrone A, Del Buono ML, Erlich HA, Bugawan TL, Lorini R, Meschi F et al. ( 2004 ) . Genetic prediction of type 1 diabetes in a population with low frequency of HLA risk genotypes and low incidence of the disease (the DIABFIN study) . Diabetes Metab Res Rev vol. 20 , ( 2 ) 137 - 143 .

Valeri C, Pozzilli P, Leslie D ( 2004 ) . Glucose control in diabetes . Diabetes Metab Res Rev vol. 20 Suppl 2 , S1 - S8 .

Pozzilli P, Leomanni C, Merola KYM ( 2004 ) . Immunointervention in Type 1 diabetes . PROCEEDINGS OF THE 12TH INTERNATIONAL CONGRESS OF ENDOCRINOLOGY . 327 - 334 .

Valorani MG, Hawa MI, Buckley LR, Afeltra A, Cacciapaglia F, Pozzilli P ( 2004 ) . The natural history of insulin content in the pancreas of female and male non-obese diabetic mouse: implications for trials of diabetes prevention in humans . Diabetes Metab Res Rev vol. 20 , ( 5 ) 394 - 398 .

Pozzilli P, Leslie RDG ( 2003 ) . Infections, Immunity, and Diabetes . International Textbook of Diabetes Mellitus , Wiley

Noble JA, Valdes AM, McGrue Q, Galgani A, Petrone A, Di Cola S, Erlich HA, Pozzilli P et al. ( 2003 ) . A study of DR-DQ matched T1D cases and controls in a continental Italian population reveals susceptibility effects of DPB1 and HLA-A alleles . AMERICAN JOURNAL OF HUMAN GENETICS . vol. 73 , 523 - 523 .

Pozzilli P, Manfrini S, Picardi A ( 2003 ) . Cow's milk and trials for prevention of Type 1 diabetes . Diabet Med vol. 20 , ( 11 ) 871 - 872 .

Pozzilli P, Leslie D ( 2003 ) . Endocrinology and Art. Louise ou la Servante Bretonne . J Endocrinol Invest vol. 26 , ( 10 )

Pozzilli P ( 2003 ) . Blessed with exophthalmos in Michelangelo's Last judgment . QJM vol. 96 , ( 9 ) 688 - 690 .

Mottini G, D'Avola D, Dimbelolo JC, Lumu R, Gallizioli E, Nisita J, Manfrini S, De Clerck M et al. ( 2003 ) . A hospital survey of the clinical features of diabetes in Congo . Diabetes Nutr Metab vol. 16 , ( 4 ) 236 - 242 .

Buckley LR, Hawa MI, Beyan H, Valorani MG, Pozzilli P, Leslie RDG ( 2003 ) . Altered monocyte cyclooygenase expression in non-obese diabetic mice . DIABETOLOGIA . vol. 46 , A180 - A180 .

Visalli N, Sebastiani L, Adorisio E, Conte A, De Cicco AL, D'Elia R, Manfrini S, Pozzilli P et al. ( 2003 ) . Environmental risk factors for type 1 diabetes in Rome and province . Arch Dis Child vol. 88 , ( 8 ) 695 - 698 .

Valdes A, Buzzetti R, Galgani A, Visalli N, Montemari AL, Bosi E, Meschi F, Lorini R et al. ( 2003 ) . Investigation of risk factors associated with different HLA genotypes of susceptibility to Type 1 diabetes (The DIABFIN Project) . DIABETOLOGIA . vol. 46 , A113 - A113 .

Bugawan TL, Mirel DB, Valdes AM, Panelo A, Pozzilli P, Erlich HA ( 2003 ) . Association and interaction of the IL4R, IL4, and IL13 loci with type 1 diabetes among Filipinos . Am J Hum Genet vol. 72 , ( 6 ) 1505 - 1514 .

Pozzilli P, Marchini F ( 2003 ) . Puppet with a voluminous goiter . J Endocrinol Invest vol. 26 , ( 6 )

Ou DW, Wang XJ, Metzger D, Jobin C, Chantler J, James R, Pozzilli P, Tingle A ( 2003 ) . Regulation of TRAIL-mediated human beta-cells destruction by FADD and NF-kappa B . DIABETES . vol. 52 , A423 - A423 .

Battelino T, Ursic-Bratina N, Dolzan V, Stopar-Obreza M, Pozzilli P, Krzisnik C, Vidan-Jeras B ( 2003 ) . The HLA-DRB, -DQB polymorphism and anti-insulin antibody response in Slovenian patients with type 1 diabetes . Eur J Immunogenet vol. 30 , ( 3 ) 223 - 227 .

Visalli N, Crino A, Spera S, Costanza F, Fioriti E, Corbi S, Beretta G, Pozzilli P et al. ( 2003 ) . The natural history of C-peptide secretion in the first year of type 1 diabetes . DIABETES . vol. 52 , A277 - A277 .

Prisco F, Iafusco D, Lorini R, Minicucci L, Martinucci M, Toni S, Cerrutti F, Rabbone I et al. ( 2003 ) . Usefulness of blood ketone bodies for monitoring insulin therapy in patients with recent onset type 1 diabetes (a multicenter study) . DIABETES . vol. 52 , A131 - A131 .

Pozzilli P, Crino A, Costantino F, Manfrini S, Spera S, Suraci C, Pitocco D, Patera P et al. ( 2003 ) . Vitamin D supplementation in patients with recent onset type I diabetes: IMDIAB XI trial . DIABETES . vol. 52 , A44 - A44 .

Picardi A, Gentilucci UV, Zardi EM, Caccavo D, Petitti T, Manfrini S, Pozzilli P, Afeltra A ( 2003 ) . TNF-alpha and growth hormone resistance in patients with chronic liver disease . J Interferon Cytokine Res vol. 23 , ( 5 ) 229 - 235 .

Picardi A, Gentilucci UV, Zardi EM, Manfrini S, Afeltra A, Pozzilli P ( 2003 ) . GH-resistance in different stages of chronic liver disease . JOURNAL OF HEPATOLOGY . vol. 38 , 67 - 68 .

Picardi A, Gentilucci UV, Zardi EM, Intelligente F, Manfrini S, Afeltra A, Pozzilli P ( 2003 ) . Growth hormone-stimulated insulin-like factor-1 and acid labile subunit in chronic liver disease . JOURNAL OF HEPATOLOGY . vol. 38 , 68 - 68 .

Pozzilli P, Adorini L ( 2003 ) . Prevention of type 1 diabetes: where do we start? . J Endocrinol Invest vol. 26 , ( 4 ) 292 - 293 .

Signore A, Picarelli A, Annovazzi A, Britton KE, Grossman AB, Bonanno E, Maras B, Barra D et al. ( 2003 ) . 123I-Interleukin-2: biochemical characterization and in vivo use for imaging autoimmune diseases . Nucl Med Commun vol. 24 , ( 3 ) 305 - 316 .

Flohé SB, Wasmuth HE, Kerad JB, Beales PE, Pozzilli P, Elliott RB, Hill JP, Scott FW et al. ( 2003 ) . A wheat-based, diabetes-promoting diet induces a Th1-type cytokine bias in the gut of NOD mice . Cytokine vol. 21 , ( 3 ) 149 - 154 .

Beyan H, Valorani MG, Pozzilli P ( 2003 ) . --to: Gale EAM (2002) A missing link in the hygiene hypothesis? Diabetologia 45:588-592 . Diabetologia vol. 46 , ( 2 ) 301 - 302 .

Pozzilli P, Crinò A, Schiaffini R, Manfrini S, Fioriti E, Coppolino G, Pitocco D, Visalli N et al. ( 2003 ) . A 2-year pilot trial of continuous subcutaneous insulin infusion versus intensive insulin therapy in patients with newly diagnosed type 1 diabetes (IMDIAB 8) . Diabetes Technol Ther vol. 5 , ( 6 ) 965 - 974 .

POZZILLI P, Valdes AM, Noble JA, McGrue Q, Galgani A, Cola SD, Erlich HA, Buzzetti R ( 2003 ) . A study of DR-DQ matched T1D cases and controls in a continental Italian population reveals susceptibility effects of DPB1 and HLA-A alleles . Hum. Immunol. vol. 64 , S143 - S143 .

Picardi A, Pozzilli P ( 2003 ) . Dynamic tests in the clinical management of diabetes . J Endocrinol Invest vol. 26 , ( 7 Suppl ) 99 - 106 .

Monetini L, Barone F, Stefanini L, Petrone A, Walk T, Jung G, Thorpe R, Pozzilli P et al. ( 2003 ) . Establishment of T cell lines to bovine beta-casein and beta-casein-derived epitopes in patients with type 1 diabetes . J Endocrinol vol. 176 , ( 1 ) 143 - 150 .

Signore A, Annovazzi A, Giacalone P, Beales PE, Valorani MG, Vestri AR, Ruberti G, Manfrini S et al. ( 2003 ) . Reduced cumulative incidence of diabetes but not insulitis following administration of chimeric human IL-15-murine IgG2b in NOD mice . Diabetes Metab Res Rev vol. 19 , ( 6 ) 464 - 468 .

Buzzetti R, Pozzilli P, Di Mario U, Ballerini C, Massacesi L ( 2002 ) . Multiple sclerosis and Type I diabetes . Diabetologia vol. 45 , ( 12 ) 1735 - 1736 .

Ou D, Metzger DL, Wang X, Huang J, Pozzilli P, Tingle AJ ( 2002 ) . TNF-related apoptosis-inducing ligand death pathway-mediated human beta-cell destruction . Diabetologia vol. 45 , ( 12 ) 1678 - 1688 .

Beales PE, Elliott RB, Flohé S, Hill JP, Kolb H, Pozzilli P, Wang G-S, Wasmuth H et al. ( 2002 ) . A multi-centre, blinded international trial of the effect of A(1) and A(2) beta-casein variants on diabetes incidence in two rodent models of spontaneous Type I diabetes . Diabetologia vol. 45 , ( 9 ) 1240 - 1246 .

Dorff G, Meyer G, Krone D, Pozzilli P, Zühlke H ( 2002 ) . Neuronal NO synthase and its inhibitor PIN are present and influenced by glucose in the human beta-cell line CM and in rat INS-1 cells . Biol Chem vol. 383 , ( 9 ) 1357 - 1361 .

Petrone A, Battelino T, Krzisnik C, Bugawan T, Erlich H, Di Mario U, Pozzilli P, Buzzetti R ( 2002 ) . Similar incidence of type 1 diabetes in two ethnically different populations (Italy and Slovenia) is sustained by similar HLA susceptible/protective haplotype frequencies . Tissue Antigens vol. 60 , ( 3 ) 244 - 253 .

Beales PE, Castri F, Valiant A, Rosignoli G, Buckley L, Pozzilli P ( 2002 ) . Adrenalitis in the non-obese diabetic mouse . Autoimmunity vol. 35 , ( 5 ) 329 - 333 .

Monetini L, Cavallo MG, Manfrini S, Stefanini L, Picarelli A, Di Tola M, Petrone A, Bianchi M et al. ( 2002 ) . Antibodies to bovine beta-casein in diabetes and other autoimmune diseases . Horm Metab Res vol. 34 , ( 8 ) 455 - 459 .

Klitz W, Bugawan TL, Panelo A, Solfelix CM, Buzzetti R, Pozzilli P, Steiner L, Alejandrino M et al. ( 2002 ) . Association of CTLA-4 variation with type I diabetes in Filipinos . Immunogenetics vol. 54 , ( 5 ) 310 - 313 .

Manfrini S, Coppolino G, Costanza F, Modi P, Montemari A, Pozzilli P ( 2002 ) . Biokinetics of oral spray insulin: comparison with regular and lispro insulin in patients with Type 1 diabetes . DIABETOLOGIA . vol. 45 , A262 - A262 .

Visalli N, Crino A, Schiaffini R, Matteoli M, Patera P, Pitocco D, Ghirlanda G, Manfrini S et al. ( 2002 ) . C-peptide two years after diagnosis of Type 1 diabetes: the effect of nicotinamide and intensive insulin therapy . DIABETOLOGIA . vol. 45 , A119 - A119 .

Coppolino G, Manfrini S, Schiaffini R, Crino A, Merola MK, Valente L, Visalli N, Pozzilli P et al. ( 2002 ) . Leptin levels in the early phases of Type 1 diabetes could explain insulin resistance in the early stages of the disease in female patients . DIABETOLOGIA . vol. 45 , A208 - A209 .

Buzzetti R, Galgani A, Petrone A, Di Mario U, Multari G, Lorini R, Bosi E, Cristaldi A et al. ( 2002 ) . Newborn screening for prediction of Type 1 diabetes genetic risk in continental Italy (Diabfln Study) . DIABETOLOGIA . vol. 45 , A49 - A49 .

Buckley LR, Hawa MI, Beyan H, Pozzilli P, Leslie RDG ( 2002 ) . Role of monocyte cyclooxygenase-2 in Non-Obese Diabetic mice . DIABETOLOGIA . vol. 45 , A116 - A116 .

Manfrini S, Crino A, Fredrickson L, Pozzilli P, IMDIAB Grp ( 2002 ) . CSII versus intensive insulin therapy at onset of type 1 diabetes: The IMDIAB 8 two-year randomised trial . DIABETES vol. 51 , A4 - A4 .

Manfrini S, Modi P, Fioriti E, Coppolino G, Costanza F, Pozzilli P ( 2002 ) . Evaluation of the compliance in the use of oral spray insulin in patients with Type-1 diabetes . DIABETES vol. 51 , A440 - A440 .

Pozzilli P, Cherubini V, Pinelli A, Valente L, Suraci C ( 2002 ) . Low levels of 1,25-dihydroxyvitamin D3 in patients with recent onset type 1 diabetes living in a Mediterranean country . DIABETES vol. 51 , A289 - A289 .

Pozzilli P, Modi P, Manfrini S, Coppolino G, Costanza F, Fioriti E ( 2002 ) . Pharmacokinetics of oral spray insulin vs. regular insulin and lispro insulin in Type-1 diabetes . DIABETES vol. 51 , A48 - A48 .

Visalli N, Suraci C, Leotta S, Pozzilli P, Imdiab Group ( 2002 ) . Residual beta cell function as assessed by baseline C-peptide is an independent factor from glucose levels at the time of blood sampling . DIABETES vol. 51 , A427 - A428 .

Ou DW, Wang XJ, Metzger D, Huang JQ, Pozzilli P, Tingle A ( 2002 ) . TRAIL death signal transduction pathway mediated human beta-cell destruction . DIABETES vol. 51 , A453 - A453 .

Bugawan TL, Klitz W, Alejandrino M, Ching J, Panelo A, Solfelix CM, Petrone A, Buzzetti R et al. ( 2002 ) . The association of specific HLA class I and II alleles with type 1 diabetes among Filipinos . Tissue Antigens vol. 59 , ( 6 ) 452 - 469 .

Nisticò L, Giorgi G, Giordano M, Galgani A, Petrone A, D'Alfonso S, Federici M, Di Mario U et al. ( 2002 ) . IL12B polymorphism and type 1 diabetes in the Italian population: a case-control study . Diabetes vol. 51 , ( 5 ) 1649 - 1650 .

Bottini N, Meloni GF, Borgiani P, Giorgini A, Buzzetti R, Pozzilli P, Lucarelli P, Gloria-Bottini F ( 2002 ) . Genotypes of cytosolic low-molecular-weight protein-tyrosine-phosphatase correlate with age at onset of type 1 diabetes in a sex-specific manner . Metabolism vol. 51 , ( 4 ) 419 - 422 .

Ou D, Metzger DL, Wang X, Pozzilli P, Tingle AJ ( 2002 ) . beta-cell antigen-specific CD56(+) NKT cells from type 1 diabetic patients: autoaggressive effector T cells damage human CD56(+) beta cells by HLA-restricted and non-HLA-restricted pathways . Hum Immunol vol. 63 , ( 4 ) 256 - 270 .

Misani P, Pozzilli P ( 2002 ) . Bather. Fernando Botero--Medellín 1932 . J Endocrinol Invest vol. 25 , ( 2 )

Leslie RDG, Pozzilli P ( 2002 ) . An introduction to new advances in diabetes . Diabetes Metab Res Rev . vol. 18 Suppl 1 , S1 - S6 .

Bugawan TL, Alejandrino M, Panelo A, Solfelix CM, Buzzetti R, Pozzilli P, Mirel D, Reynolds R et al. ( 2002 ) . Genetics of type 1 diabetes among flipinos: Association studies of HLA and non-HLA candidate genes . TISSUE ANTIGENS vol. 59 , 53 - 54 .

Pozzilli P ( 2002 ) . The DPT-1 trial: a negative result with lessons for future type 1 diabetes prevention . Diabetes Metab Res Rev vol. 18 , ( 4 ) 257 - 259 .

Beales PE, Pozzilli P ( 2002 ) . Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: implications for human type 1 diabetes . Diabetes Metab Res Rev vol. 18 , ( 2 ) 114 - 117 .

Bugawan TL, Alejandrino M, Ching J, Klitz W, Panelo A, Solfelix CM, Buzzetti R, Pozzilli P et al. ( 2001 ) . Analysis of the HLA class I and class II susceptibility to type 1 diabetes in filipinos using the PCR-SSOP reverse line blot method . European Journal of Immunogenetics vol. 28 , ( 2 )

Pozzilli P, Mesturino CA, Crino A, Gross TM, Jeng LM, Visalli N, IMDIAB Group ( 2001 ) . Is the process of beta-cell destruction in type 1 diabetes at time of diagnosis more extensive in females than in males? . Eur J Endocrinol vol. 145 , ( 6 ) 757 - 761 .

Bugawan TL, Alejandrino M, Mirel DB, Panelo A, Solfelix CM, Pozzilli P, Buzzetti R, Reynolds RL et al. ( 2001 ) . Association of specific IL4 receptor SNPs with type 1 diabetes in Filipinos . AM J HUM GENET vol. 69 , ( 4 ) 403 - 403 .

Mango R, Guarino S, D'Apice R, Amati F, Sangiuolo F, Pozzilli P, Bottazzo G, Crino A et al. ( 2001 ) . Mutational analysis of AIRE gene in APS2 patients . AM J HUM GENET vol. 69 , ( 4 ) 580 - 580 .

Beales PE, Rosignoli G, Buckley LR, Pozzilli P ( 2001 ) . Admistration of vitamin D3 during pregnancy and early life did not reduce diabetes incidence in NOD/Ba mice . DIABETOLOGIA vol. 44 , A100 - A100 .

Pozzilli P, Di Mario U ( 2001 ) . Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention . Diabetes Care vol. 24 , ( 8 ) 1460 - 1467 .

Monetini L, Cavallo MG, Sentinelli F, Stefanini L, Bonifacio E, Sarugeri E, Bosi E, Pozzilli P et al. ( 2001 ) . Cytokine profiles and IgG-IA subclasses response in type 1 diabetic patients treated with oral insulin . DIABETOLOGIA vol. 44 , A151 - A151 .

Cavallo MG, Coppolino G, Romeo S, Manfrini S, Modi P, Pozzilli P ( 2001 ) . Oral spray insulin in patients with Type 1 diabetes: Comparison with regular insulin . DIABETOLOGIA vol. 44 , A213 - A213 .

Cavallo MG, Coppolino G, Romeo S, Pozzilli P ( 2001 ) . Inhaled insulin in type 1 diabetes . Lancet vol. 357 , ( 9272 )

Baker E, Philips B ( 2001 ) . Inhaled insulin in type 1 diabetes . The Lancet vol. 357 , ( 9272 ) 1979 - 1980 .

Pozzilli P, Mesturino CA, Crino A, Ciampalini P, Cervoni M, Coppolino G, Manfrini S, Suraci MC et al. ( 2001 ) . Nicotinamide and vitamin E versus Nicotinamide alone as adyuvant therapy at onset of Type 1 diabetes (IMDIAB IX trial) . DIABETES vol. 50 , A71 - A71 .

Cavallo MG, Romeo S, Coppolino G, Modi P, Pozzilli P ( 2001 ) . Oral spray insulin in patients with Type 1 diabetes and residual beta cell function . DIABETES vol. 50 , A108 - A108 .

Genovese S, Goncalves D, Cavallo GM, Purrello F, Anello L, Rotella CM, Bardini G, Riccardi G et al. ( 2001 ) . Prevalence and clinical characteristics of adult onset diabetes associated with GAD65 autoantibodies. Screening of a large sample of patients attending diabetic clinics in Italy . DIABETES vol. 50 , A94 - A94 .

Ou DW, Metzger D, Wang XJ, Pozzilli P, Tingle A ( 2001 ) . beta-cell antigen-specific CD56(+) NKT cells from type 1 diabetes patients: Autoaggressive effector T cells damage human CD56+p cells by HLA-Restricted and Non-HLA-Restricted pathways . DIABETES vol. 50 , A264 - A264 .

Crinò A, Cavallo MG, Corbi S, Mesturino CA, Ferrazzoli F, Coppolino G, Bizzarri C, Cervoni M et al. ( 2001 ) . Intradermal skin test with diabetes specific antigens in patients with type 1 diabetes . Clin Exp Immunol vol. 123 , ( 3 ) 382 - 386 .

Pozzilli P ( 2001 ) . A ferocious cretin with voluminous goiter . J ENDOCRINOL INVEST vol. 24 , ( 2 ) 137 - 137 .

Cavallo MG, Romeo S, Coppolino G, Pozzilli P ( 2001 ) . Continuous glucose monitoring during the European Soccer cup semifinal, Italy against Holland . Diabetologia vol. 44 , ( 2 )

Pozzilli P ( 2001 ) . Endocrinology and art. "A ferocious cretin with voluminous goiter". Morazzone, circa 1600 . J Endocrinol Invest vol. 24 , ( 2 )

Multari G, Werner B, Cervoni M, Lubrano R, Costantino F, Demiraj V, Pozzilli P ( 2001 ) . Peritoneal dialysis in an infant with type 1 diabetes and hyperosmolar coma . J Endocrinol Invest vol. 24 , ( 2 ) 104 - 106 .

Pozzilli P, Manfrini S, Monetini L ( 2001 ) . Biochemical markers of type 1 diabetes: clinical use . Scand J Clin Lab Invest Suppl vol. 235 , 38 - 44 .

Monetini L, Cavallo MG, Stefanini L, Ferrazzoli F, Bizzarri C, Marietti G, Curro V, Cervoni M et al. ( 2001 ) . Bovine beta-casein antibodies in breast- and bottle-fed infants: their relevance in Type 1 diabetes . Diabetes Metab Res Rev vol. 17 , ( 1 ) 51 - 54 .

Pozzilli P, Coppolino G, Monetini L, Nisticò L ( 2001 ) . Type 1 Diabetes and Multiple Sclerosis: Similarities and Dissimilarities . New Concepts in Pathology and Treatment of Autoimmune Disorders , Springer Nature

Sebastiani L, Visalli N, Adorisio E, D'Elia R, Conte A, Pozzilli P ( 2001 ) . [Type 1 diabetes in Lazio. Note 2 -- case control study of risk factors] . Ann Ig vol. 13 , ( 6 ) 523 - 530 .

Sebastiani L, Adorisio E, Visalli N, Conte A, D'Elia R, Pozzilli P ( 2001 ) . [Type I diabetes in Lazio. Note 1: incidence in 1989-1998] . Ann Ig vol. 13 , ( 5 ) 393 - 398 .

( 2000 ) . No evidence of rapid onset (Japanese) Type I diabetes in Caucasian patients . Diabetologia vol. 43 , ( 10 ) 1332 - 1332 .

Beales PE, Rosignoli G, Batchelor K, Pozzilli P ( 2000 ) . The prevention of diabetes using rosiglitazone in the non-obese diabetic mouse . Diabetes Research and Clinical Practice vol. 50 ,

Pozzilli P, Pitocco D, Visalli N, Cavallo MG, Buzzetti R, Crinò A, Spera S, Suraci C et al. ( 2000 ) . No effect of oral insulin on residual beta-cell function in recent-onset Type I diabetes (the IMDIAB VII) . Diabetologia vol. 43 , ( 8 ) 1000 - 1004 .

Salvetti M, Ristori G, Bomprezzi R, Pozzilli P, Leslie RDG ( 2000 ) . Twins: mirrors of the immune system . Trends in Immunology vol. 21 , ( 7 ) 342 - 347 .

Chianelli M, Parisella MG, Mather SJ, Visalli N, Annovazzi A, Giacalone P, Capriotti G, Corsetti F et al. ( 2000 ) . 99mTc-IL2 detects insulitis in the pancreas of newly diagnosed type 1 diabetes patients and predicts response to immunotherapy . Nuclear Medicine Communications vol. 21 , ( 6 )

Burkart V, Liu H, Bellmann K, Wissing D, Jäättelä M, Cavallo MG, Pozzilli P, Briviba K et al. ( 2000 ) . Natural Resistance of Human Beta Cells toward Nitric Oxide Is Mediated by Heat Shock Protein 70* . Journal of Biological Chemistry vol. 275 , ( 26 ) 19521 - 19528 .

Group EAS ( 2000 ) . Variation and trends in incidence of childhood diabetes in Europe . The Lancet vol. 355 , ( 9207 ) 873 - 876 .

Signore A, Chianelli M, Annovazzi A, Bonanno E, Spagnoli LG, Pozzilli P, Pallone F, Biancone L ( 2000 ) . 123I-interleukin-2 scintigraphy for in vivo assessment of intestinal mononuclear cell infiltration in Crohn's disease . Journal of Nuclear Medicine vol. 41 , ( 2 ) 242 - 249 .

Visalli N, Sebastiani L, Adorisio E, Castelli MD, Coppolino G, Marietti G, Pozzilli P ( 2000 ) . Caesarean section delivery and vitamin D supplement: Risk and protective factors for Type 1 diabetes . DIABETOLOGIA . vol. 43 , A94 - A94 .

Beales PE, Liddi R, Rosignoli G, Hill J, Pozzilli P ( 2000 ) . Diet and its effect on diabetes incidence in the NOD/Ba mouse . DIABETOLOGIA . vol. 43 , A3 - A3 .

Pozzilli P, Visalli N, Coppolino G, Classen DC, Classen JB ( 2000 ) . Hepatitis B vaccine associated with an increased risk of type 1 diabetes in Italy . DIABETES . vol. 49 , A67 - A67 .

Monetini L, Cavallo MG, Stefanini L, Coppolino G, Walk T, Jung G, Pozzilli P ( 2000 ) . Isolation of specific bovine β-casein T cell lines in Type 1 diabetes . DIABETOLOGIA . vol. 43 , A104 - A104 .

Pugliese G, Buzzetti R, Mellozzi M, Galante V, Parravano C, Pala L, Rotella CM, Di Mario U et al. ( 2000 ) . Low prevalence of diabetic nephropathy in Type 1 diabetes from central Italy . DIABETES . vol. 49 , A158 - A158 .

Pozzilli P, Visalli N, Coppolino G, Leslie D ( 2000 ) . No evidence of rapid onset "Japanese" Type 1 diabetes in Caucasian patients . DIABETOLOGIA . vol. 43 , A103 - A103 .

Pozzilli P, Cavallo MG ( 2000 ) . Oral insulin and the induction of tolerance in man: reality or fantasy? . Diabetes/Metabolism Research and Reviews vol. 16 , ( 5 ) 306 - 307 .

Monetini L, Cavallo MG, Stefanini L, Coppolino G, Walk T, Jung G, Pozzilli P ( 2000 ) . T cell lines to bovine β-casein in Type 1 diabetes . DIABETES . vol. 49 , A323 - A323 .

Visalli N, Cavallo MG, Signore A, Baroni MG, Buzzetti R, Fioriti E, Mesturino C, Fiori R et al. ( 1999 ) . A multi‐centre randomized trial of two different doses of nicotinamide in patients with recent‐onset Type 1 diabetes (the IMDIAB VI) . Diabetes/Metabolism Research and Reviews vol. 15 , ( 3 ) 181 - 185 .

Beales PE, Burr LA, Webb GP, Mansfield KJ, Pozzilli P ( 1999 ) . Diet can influence the ability of nicotinamide to prevent diabetes in the non‐obese diabetic mouse: a preliminary study . Diabetes/Metabolism Research and Reviews vol. 15 , ( 1 ) 21 - 28 .

Schloot NC, Pozzilli P, Mandrup‐Poulsen T ( 1999 ) . Immune markers for monitoring the progression of autoimmune disease . Diabetes/Metabolism Research and Reviews vol. 15 , ( 2 ) 141 - 145 .

Baroni MG, D’Andrea MP, Montali A, Pannitteri G, Barillà F, Campagna F, Mazzei E, Lovari S et al. ( 1999 ) . A Common Mutation of the Insulin Receptor Substrate-1 Gene Is A Risk Factor for Coronary Artery Disease . Arteriosclerosis Thrombosis and Vascular Biology vol. 19 , ( 12 ) 2975 - 2980 .

Medici F, Hawa MI, Giorgini A, Panelo A, Solfelix CM, Leslie RD, Pozzilli P ( 1999 ) . Antibodies to GAD65 and a tyrosine phosphatase-like molecule IA-2ic in Filipino type 1 diabetic patients . Diabetes Care vol. 22 , ( 9 ) 1458 - 1461 .

Melander A, Olsson J, Lindberg G, Salzman A, Howard T, Stang P, Lydick E, Emslie-Smith A et al. ( 1999 ) . 35th Annual Meeting of the European Association for the Study of Diabetes . Diabetologia vol. 42 , ( Suppl 1 ) a1 - a330 .

Mansfield KJ, Wilson JE, Pozzilli P, Beales PE ( 1999 ) . A new substrain of the non-obese diabetic mouse which develops cataracts (NOD/Ba/Lop19) . British Journal of Ophthalmology vol. 83 , ( 6 )

Baroni MG, Cavallo MG, Mark M, Monetini L, Stoehrer B, Pozzilli P ( 1999 ) . Beta-cell gene expression and functional characterisation of the human insulinoma cell line CM . Journal of Endocrinology vol. 161 , ( 1 ) 59 - 68 .

Kolb H, Pozzilli P ( 1999 ) . Cow's milk and type I diabetes: the gut immune system deserves attention . Trends in Immunology vol. 20 , ( 3 ) 108 - 110 .

( 1999 ) . Caution is required with Interferon α as a potential treatment for Type I diabetes . Diabetologia vol. 42 , ( 3 ) 385 - 385 .

Gross T, Visalli N, Fredrickson L, Pozzilli P ( 1999 ) . A new formula for estimating insulin dose at diagnosis of type I diabetes . DIABETES . vol. 48 , A351 - A351 .

Biancone L, Signore A, Ronga G, Pozzilli P, Pallone F ( 1999 ) . Activated intestinal lymphocytes in inactive Crohn's disease (CD) as a subclinical marker of early clinical relapse . GASTROENTEROLOGY . vol. 116 , A791 - A791 .

Pitocco D, Visalli N, Cavallo MG, Bitti MLM, Suraci C, Crinò A, Giordano C, Cervoni M et al. ( 1999 ) . Double blind trial of oral insulin in recent onset type 1 diabetes . DIABETOLOGIA . vol. 42 , A92 - A92 .

Merriman T, Corradu F, Cucca F, Broadley S, Sawcer S, Compston A, Wordsworth P, Bain S et al. ( 1999 ) . Human chromosome 18q12-q21 and distal rodent chromosome 18 are associated with multiple autoimmune phenotypes . AMERICAN JOURNAL OF HUMAN GENETICS . vol. 65 , A59 - A59 .

Monetini L, Cavallo MG, Valente L, Coppolino G, Stefanini L, Corbi S, Spera S, Matteoli MC et al. ( 1999 ) . Raised antibodies to β-casein in type 1 diabetes and coeliac disease but not in other autoimmune diseases . DIABETOLOGIA . vol. 42 , A100 - A100 .

Visalli N, Sabastiani L, Adorisio E, Faldetta MRC, Buzzetti R, Multari G, Casu A, Songini M et al. ( 1999 ) . Sex differences in the incidence of type 1 diabetes in two Italian regions: Lazio and Sardinia . DIABETOLOGIA . vol. 42 , A85 - A85 .

Pozzilli P ( 1998 ) . IDDM preventive trials: what’s new? . Diabetes/Metabolism Research and Reviews vol. 14 , ( 3 ) 260 - 261 .

Pozzilli P ( 1998 ) . Prevention of insulin‐dependent diabetes mellitus 1998 . Diabetes/Metabolism Research and Reviews vol. 14 , ( 1 ) 69 - 84 .

Pozzilli P ( 1996 ) . Prevention of Insulin‐dependent Diabetes: Where Are We Now? . Diabetes/Metabolism Research and Reviews . vol. 12 , 127 - 135 .

Esposito L, Hill NJ, Pritchard LE, Cucca F, Muxworthy C, Merriman ME, Wilson A, Julier C et al. ( 1998 ) . Genetic analysis of chromosome 2 in type 1 diabetes: analysis of putative loci IDDM7, IDDM12, and IDDM13 and candidate genes NRAMP1 and IA-2 and the interleukin-1 gene cluster. IMDIAB Group . Diabetes vol. 47 , ( 11 ) 1797 - 1799 .

Pozzilli P, Visalli N, Buzzetti R, Cavallo MG, Marietti G, Hawa M, Leslie RDG, Group IS ( 1998 ) . Metabolic and immune parameters at clinical onset of insulin-dependent diabetes: A population-based study . Metabolism vol. 47 , ( 10 ) 1205 - 1210 .

Beales PE, Liddi R, Giorgini AE, Signore A, Procaccini E, Batchelor K, Pozzilli P ( 1998 ) . Troglitazone prevents insulin dependent diabetes in the non-obese diabetic mouse . European Journal of Pharmacology vol. 357 , ( 2-3 ) 221 - 225 .

Nakagawa Y, Kawaguchi Y, Twells RCJ, Muxworthy C, Hunter KMD, Wilson A, Merriman ME, Cox RD et al. ( 1998 ) . Fine Mapping of the Diabetes-Susceptibility Locus, IDDM4, on Chromosome 11q13 . American Journal of Human Genetics vol. 63 , ( 2 ) 547 - 556 .

Barone R, Procaccini E, Chianelli M, Annovazzi A, Fiore V, Hawa M, Nardi G, Ronga G et al. ( 1998 ) . Prognostic relevance of pancreatic uptake of technetium-99m labelled human polyclonal immunoglobulins in patients with type 1 diabetes . European Journal of Nuclear Medicine and Molecular Imaging vol. 25 , ( 5 ) 503 - 508 .

Schwingshackl A, Blasko I, Steiner E, Pozzilli P, Cavallo MG, Berger P, Grubeck-Loebenstein B ( 1998 ) . Sex Steroids Do Not Prevent Amylin-Induced Apoptosis in Human Cells . Experimental Cell Research vol. 241 , ( 1 ) 265 - 268 .

Biancone L, Signore A, Ronga G, Pozzilli P, Pallone F ( 1998 ) . Ex-vivo autoradiography and facs-scan analysis demonstration of a specific binding between IL2-receptor positive cells in Crohn's disease gut and 123I-interleukin-2 injected in vivo . Gastroenterology . vol. 114 ,

Baroni MG, D’Andrea MP, Capici F, Buzzetti R, Cavallo MG, Fallucca F, Giovannini C, Pozzilli P ( 1998 ) . High frequency of polymorphism but no mutations found in the GLUT1 glucose transporter gene in NIDDM and familial obesity by SSCP analysis . Human Genetics vol. 102 , ( 4 ) 479 - 482 .

Baroni MG, Arca M, D'Andrea MP, Campagna F, Capici F, Urbinati G, Pozzilli P ( 1998 ) . A common mutation in the Insulin Receptor Substrate-1 gene is a genetic marker for the Insulin Resistance Syndrome in patients with coronary artery disease . DIABETES . vol. 47 , A173 - A173 .

Arca M, D'Andrea MP, Montali A, Mariano E, Campagna F, Ricci G, Pozzilli P, Urbinati G et al. ( 1998 ) . A common mutation in the insulin receptor substrate-1 (IRS-1) gene is a genetic marker for the insulin resistance syndrome . CIRCULATION . vol. 98 , 673 - 673 .

Cavallo MG, Monetini L, Barone F, Valente L, Pozzilli P ( 1998 ) . Cellular immune response to multiple cow milk proteins in IDDM . DIABETES . vol. 47 , A202 - A202 .

Cavallo MG, Monetini L, Tiberi F, Barone F, Valente L, Pozzilli P ( 1998 ) . Cellular immunity to different cow's milk proteins in IDDM . DIABETOLOGIA . vol. 41 , A94 - A94 .

Pozzilli P ( 1998 ) . Erratum: Prevention of Insulin-dependent Diabetes Mellitus 1998 (Diabetes/Metabolism Reviews (1998) 14(1) (69-84)) . Diabetes/Metabolism Reviews vol. 14 , ( 2 )

Nistico L, Pritchard L, Buzzetti R, De Cinti A, Di Genova G, Tosi R, Todd J, Pozzilli P ( 1998 ) . Fine mapping of <i>IDDM12</i> . DIABETES . vol. 47 , A229 - A229 .

Visalli N, Ghirlanda G, Pozzilli P ( 1998 ) . High and standard dose of nicotinamide in recent onset insulin dependent diabetes (the IMDIAB 6 Study) . DIABETOLOGIA . vol. 41 , A89 - A89 .

Signore A, Chianelli M, Visalli N, Barone R, Annovazzi A, Di Leve G, Parisella MG, Pozzilli P ( 1998 ) . Identification of type 1 diabetic patients with insulitis at diagnosis by <SUP>99m</SUP>Tc-IL2 scintigraphy . DIABETOLOGIA . vol. 41 , A95 - A95 .

Beales PE, Liddi R, Matta G, Webb GP, Pozzilli P ( 1998 ) . Incomplete Freund's adjuvant protects NOD mice from type 1 diabetes . DIABETOLOGIA . vol. 41 , A90 - A90 .

Nisticò L, Prichard L, Buzzetti R, De Cinti A, Di Genova G, Tosi R, Serrano-Rios M, Martinez MT et al. ( 1998 ) . Mapping of IDDM 12 in southern European populations . DIABETOLOGIA . vol. 41 , A79 - A79 .

McKinney PA, Rothwell P, Schober E, Ionescu-Tirgoviste C, Neu A, Pozzilli P, Gutnikov S ( 1998 ) . Seasonality of birth in patients with childhood IDDM: The EURODIAB study . DIABETOLOGIA . vol. 41 , A91 - A91 .

Gisella Cavallo M, Pozzilli P ( 1997 ) . Pilot trials in pre-IDDM: yes but... . Diabetes/Metabolism Research and Reviews vol. 13 , ( 4 )

Bennett ST, Wilson AJ, Esposito L, Bouzekri N, Undlien DE, Cucca F, Nisticò L, Buzzetti R et al. ( 1997 ) . Insulin VNTR allele-specific effect in type 1 diabetes depends on identity of untransmitted paternal allele . Nature Genetics vol. 17 , ( 3 ) 350 - 352 .

Sciullo E, Cardellini G, Baroni MG, Torresi P, Buongiorno A, Pozzilli P, Fallucca F ( 1997 ) . Glucose transporter (Glut1, Glut3) mRNA in human placenta of diabetic and non-diabetic pregnancies . American Journal Of Reproductive Immunology vol. 3 , ( 3 ) 172 - 182 .

Pozzilli P, Visalli N, Cavallo MG, Signore A, Baroni MG, Buzzetti R, Fioriti E, Mesturino C et al. ( 1997 ) . Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes (the IMDIAB IV study) . European Journal of Endocrinology vol. 137 , ( 3 ) 234 - 239 .

Hawa M, Rowe R, Lan MS, Notkins AL, Pozzilli P, Christie MR, Leslie RD ( 1997 ) . Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes . Diabetes vol. 46 , ( 8 ) 1270 - 1275 .

Merriman T, Twells R, Merriman M, Eaves I, Cox R, Cucca F, McKinney P, Shield J et al. ( 1997 ) . Evidence by Allelic Association-Dependent Methods for a Type 1 Diabetes Polygene (IDDM6) on Chromosome 18q21 . Human Molecular Genetics vol. 6 , ( 7 ) 1003 - 1010 .

Baroni M, Vialettes B, Pozzilli P ( 1997 ) . The Glucose Evaluation Trial for Remission (GETREM): A European effort to evaluate insulin-dependent diabetes mellitus in the first year after diagnosis . Diabetes & Metabolism vol. 23 , ( 3 ) 264 - 265 .

Pozzilli P, Group OBOTI ( 1997 ) . BCG vaccine in insulin-dependent diabetes mellitus . The Lancet vol. 349 , ( 9064 ) 1520 - 1521 .

Signore A, Biancone L, Pallone F, Bonanno E, Chianelli M, Nardi G, Morrone S, Spagnoli LG et al. ( 1997 ) . SP-5. Radiolabelled interleukin-2 scintigraphy for imaging CD25+ mononuclear cells in chronic inflammation . Nuclear Medicine Communications vol. 18 , ( 5 )

Cavallo MG, Monetini L, Valente L, Barone F, Beales P, Russo M, Pozzilli P ( 1997 ) . Glutaihione protects a human insulinoma cell line from tumor necrosis factors-α-mediated cytotoxicity . International Journal of Clinical and Laboratory Research vol. 27 , ( 1 ) 44 - 47 .

Pozzilli P, Leslie RDG ( 1997 ) . Hyperexpression of GAD in the islets may be relevant but is it sufficient to induce autoimmune insulitis? . Diabetologia vol. 40 , ( 3 ) 357 - 361 .

Pozzilli P ( 1997 ) . Erratum: Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes (European Journal of Endocrinology (1997) 137 (234-239)) . European Journal of Endocrinology vol. 137 , ( 5 )

Sciullo E, Cardellini G, Baroni M, Torresi P, Mazziotti F, Pozzilli P, Fallucca F ( 1997 ) . Glucose transporters (GLUT 1, GLUT 3) mRNA in human placenta of diabetic and non-diabetic pregnancies . Annali dell Istituto Superiore di Sanità vol. 33 , ( 3 ) 361 - 365 .

Signore A, Chianelli M, Picarelli A, Procaccini E, Barone R, Greco M, Annovazzi A, De Vincenzi M et al. ( 1997 ) . In Vivo Detection of Activated Lymphocytes in Immune- Mediated Diseases by 123I-Interleukin-2 Scintigraphy . Radioactive Isotopes in Clinical Medicine and Research , Springer Nature

Muntoni, Fonte M, Stoduto S, Marietti G, Bizzarri C, Crinò A, Ciampalini P, Multari G et al. ( 1997 ) . Incidence of insulin-dependent diabetes mellitus among Sardinianheritage children born in Lazio region, Italy . The Lancet vol. 349 , ( 9046 ) 160 - 162 .

Bellmann K, Liu H, Burkhart V, Pozzilli P, Cavallo MG, Jaatela M, Steensgaard P, Kolb H ( 1997 ) . Nitric oxide and type I diabetes: Low toxicity of NO towards human beta cells due to hsp 70 expression . Immunobiology . vol. 197 ,

Cavallo MG, Leytze G, Buzzetti R, Nistico L, Linsley P, Pozzilli P ( 1997 ) . Study of CTLA-4 gene expression in patients with IDDM . DIABETES . vol. 46 , 1319 - 1319 .

Visalli N, Sebastiani L, Adorisio E, DeCicco AL, Pozzilli P ( 1997 ) . Study on the incidence of insulin-dependent diabetes in the Lazio region (Central Italy) from 1989 to 1995 . DIABETOLOGIA . vol. 40 , 230 - 230 .

Browne PD, Lampeter E, DeLeeuw I, Iafusco D, IonescuTirgoviste C, Kolouskova S, Linn T, Ludvigsson J et al. ( 1997 ) . The GETREM study: New preliminary findings for the clinical remission in IDDM using logistic regression . DIABETOLOGIA . vol. 40 , 1311 - 1311 .

Giorgini A, Scott D, Liddi R, Beales P, Pozzilli P ( 1997 ) . Troglitazone alters the cytokine production of activated lymphocytes from human donors . DIABETOLOGIA . vol. 40 , 363 - 363 .

Beales P, Giorgini A, Batchelor K, Pozzilli P ( 1997 ) . Troglitazone reduces diabetes incidence in NOD mice . DIABETOLOGIA . vol. 40 , 261 - 261 .

Pozzilli P ( 1997 ) . Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes. (vol 137, pg 234, 1997) . EUROPEAN JOURNAL OF ENDOCRINOLOGY vol. 137 , ( 5 ) 558 - 558 .

Gray DW ( 1996 ) . Diabetes and cows' milk . The Lancet vol. 348 , ( 9042 )

Pozzilli P, Browne PD, Kolb H, Trialists TN ( 1996 ) . Meta-Analysis of Nicotinamide Treatment in Patients With Recent-Onset IDDM . Diabetes Care vol. 19 , ( 12 ) 1357 - 1363 .

Pozzilli P, Buzzetti R, Nisticó L, Romiti A, Giovannini C ( 1996 ) . Non-HLA genes and the susceptibility to insulin dependent diabetes: the role of the CTLA-4 gene . Acta Diabetologica . vol. 33 , 250 - 252 .

Pozzilli P ( 1996 ) . Present facts and prospects . Diabetes, Nutrition and Metabolism - Clinical and Experimental vol. 9 , ( 6 ) 306 - 309 .

Cavallo MG, Fava D, Monetini L, Barone F, Pozzilli P ( 1996 ) . Cell-mediated immune response to β casein in recent-onset insulin-dependent diabetes: implications for disease pathogenesis . The Lancet vol. 348 , ( 9032 ) 926 - 928 .

Cavallo MG, Dotta F, Monetini L, Dionisi S, Previti M, Valente L, Toto A, Di Mario U et al. ( 1996 ) . Beta-cell markers and autoantigen expression by a human insulinoma cell line: similarities to native beta cells . Journal of Endocrinology vol. 150 , ( 1 ) 113 - 120 .

Nisticò L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E, Larrad MTM, Rios MS et al. ( 1996 ) . The CTLA-4 Gene Region of Chromosome 2q33 Is Linked to, and Associated with, Type 1 Diabetes . Human Molecular Genetics vol. 5 , ( 7 ) 1075 - 1080 .

Signore A, Fiore V, Chianelli M, Procaccini E, Barone R, Ronga G, Negri M, Pozzilli P ( 1996 ) . The effect of metformin on liver blood flow in vivo in normal subjects and patients with non insulin dependent diabetes . Diabetes Research and Clinical Practice vol. 33 , ( 2 ) 83 - 87 .

Pozzilli P, Lunadei M, Frati L, Leslie RDG, Farthing M ( 1996 ) . From Erasmus to Socrates: should mobility move from students to teachers? . The Lancet vol. 347 , ( 9017 )

Luo D-F, Buzzetti R, Rotter JI, Maclaren NK, Raffel LJ, Nisticô L, Giovannini C, Pozzilli P et al. ( 1996 ) . Confirmation of Three Susceptibility Genes to Insulin-Dependent Diabetes Mellitus: IDDM4, IDDM5 and IDDM8 . Human Molecular Genetics vol. 5 , ( 5 ) 693 - 698 .

Sebastiani L, Visalli N, Adorisio E, Suppa MA, Buzzetti R, De Cicco AL, Giovannini C, Comerci MD et al. ( 1996 ) . A 5-year (1989–1993) Prospective Study of the Incidence of IDDM in Rome and the Lazio Region in the Age-Group 0–14 years . Diabetes Care vol. 19 , ( 1 ) 70 - 73 .

Nistico L, Buzzetti R, Pritchard LE, Martinez MT, SerranoRios M, Barnett AH, Tosi R, Pozzilli P et al. ( 1996 ) . CTLA-4 region predisposes to IDDM and Graves' disease . DIABETOLOGIA . vol. 39 , 292 - 292 .

Leslie D, Hawa M, Rowe R, Lan M, Notkins A, Pozzilli P ( 1996 ) . Characterising islet protein tyrosine phosphatase antibodies association with type 1 diabetes . DIABETES . vol. 45 , 879 - 879 .

Del Prato S, Pozzilli P ( 1996 ) . FIRI: fasting or false insulin resistance index? . The Lancet vol. 347 , ( 8994 )

Faldetta MC, Visalli N, Cavallo MG, Andreani D, Leslie RDG, Hava M, Pozzilli P ( 1996 ) . GAD and IA-2 antibodies in relation to disease presentation and C-peptide secretion . DIABETOLOGIA . vol. 39 , 343 - 343 .

Signore A, Barone R, Procaccini E, Annovazzi A, Chianelli M, Scopinaro F, Ronga G, Multari G et al. ( 1996 ) . In vivo measurement of immunoglobulin accumulation in the pancreas of recent onset type 1 diabetic patients . Clinical and Experimental Rheumatology . vol. 14 Suppl 15 , s41 - s45 .

Pozzilli P, Browne PD, Kolb H ( 1996 ) . Nicotinamide increases C-peptide secretion in recent onset IDDM: Results of an international meta-analysis . DIABETES . vol. 45 , 511 - 511 .

Pozzilli P ( 1996 ) . Prevention of insulin-dependent diabetes - Present facts and prospects . DIABETES NUTRITION & METABOLISM vol. 9 , ( 6 ) 306 - 309 .

Muntoni S, Fonte MT, Stoduto S, Marietti G, Crino A, Bizzarri C, Ciampalini P, Multari G et al. ( 1996 ) . Sardinians living in LAZIO retain their fivefold incidence of type 1 diabetes compared with the host population . DIABETOLOGIA . vol. 39 , 53 - 53 .

Cavallo MG, Monetini L, Russo M, Thorpe R, Pozzilli P ( 1995 ) . Mumps virus infection increases sensitivity to tumour necrosis factor-alpha and gamma-interferon induced cytotoxicity in a human insulinoma cell line . Diabetes, Nutrition and Metabolism - Clinical and Experimental vol. 8 , ( 6 ) 319 - 323 .

Pozzilli P, Visalli N, Signore A, Baroni MG, Buzzetti R, Cavallo MG, Boccuni ML, Fava D et al. ( 1995 ) . Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study) . Diabetologia vol. 38 , ( 7 ) 848 - 852 .

Lévy-Marchal C, Patterson C, Green A, Schober E, Ullreich G, Vandewalle C, Svendsen A, Lounamaa R et al. ( 1995 ) . Variation by age group and seasonally at diagnosis of childhood IDDM in Europe . Diabetologia vol. 38 , ( 7 )

Signore A, Procaccini E, Chianelli M, Pozzilli P ( 1995 ) . Retroviruses and diabetes in animal models: hypotheses for the induction of the disease . Diabetes & Metabolism vol. 21 , ( 3 ) 147 - 155 .

Pozzilli P, Buzzetti R, Giovannini C, Gragnoli C, Leslie RD ( 1995 ) . New and old trends for treating organ-specific autoimmune endocrinopathies . Journal of Endocrinology vol. 145 , ( 2 ) 195 - 199 .

Biancone L, Di Macio L, Marcheggiano A, Di Paolo MC, Paoluzi P, Scopinaro F, Pallone F ( 1995 ) . Usefulness of scintigraphy using 99mTc-EMPAO labelled granulocytes (PMN) as early indicator of postoperative asymptomatic recurrence in Crohn's disease (CD) . Gastroenterology . vol. 108 ,

Beales PE, Hawa M, Williams AJK, Albertini MC, Giorgini A, Pozzilli P ( 1995 ) . Baclofen, a gamma-aminobutyric acid-b receptor agonist, delays diabetes onset in the non-obese diabetic mouse . Acta Diabetologica vol. 32 , ( 1 ) 53 - 56 .

Pozzilli P, Visalli N, Buzzetti R, Baroni MG, Boccuni ML, Fioriti E, Signore A, Mesturino C et al. ( 1995 ) . Adjuvant therapy in recent onset type 1 diabetes at diagnosis and insulin requirement after 2 years . Diabetes & Metabolism vol. 21 , ( 1 ) 47 - 49 .

BROWNE PD, AMODEO BM, DELEEUW I, DUCAJU MVL, IONESCUTIRGOVISTE C, KOLOUSKOVA S, LAMPETER E, LINN T et al. ( 1995 ) . A MULTICENTER EUROPEAN STUDY FOR THE EVALUATION OF SPONTANEOUS CLINICAL REMISSION IN IDDM . DIABETOLOGIA . vol. 38 , A100 - A100 .

BARONI MG, GRAGNOLI C, CAVALLO MG, LATINI L, VALENTE L, ANDREANI D, POZZILLI P ( 1995 ) . HUMAN INSULINOMA CELL-LINE EXPRESSING CONSTITUTIVE BETA-CELL GENES . DIABETOLOGIA . vol. 38 , A46 - A46 .

NISTICO L, BUZZETTI R, POZZILLI P, CONTU L, SERRANORIOS M, LARRAZ MT, TOSI R, GIOVANNINI C ( 1995 ) . IDENTIFICATION OF A NEW REGION LINKED TO IDDM IN AFFECTED MULTIPLEX FAMILIES FROM THE MEDITERRANEAN AREA . DIABETES . vol. 44 , A17 - A17 .

SIGNORE A, CHIANELLI M, PICARELLI A, FERRETTI E, GRECO M, MULTARI M, DEMATTIA G, POZZILLI P ( 1995 ) . IN-VIVO DETECTION OF ACTIVATED LYMPHOCYTES IN THE ENDOCRINE PANCREAS - A NEW TOOL FOR IDDM PREDICTION . DIABETOLOGIA . vol. 38 , A38 - A38 .

BEALES PE, WEBB GP, GIORGINI A, ALBERTINI MC, BURR LA, MANSFIELD KJ, POZZILLI P ( 1995 ) . NICOTINAMIDE TREATMENT IN NOD MICE CAN BE AFFECTED BY SUCROSE IN THE DIET . DIABETOLOGIA . vol. 38 , A97 - A97 .

FALDETTA MC, VISALLI N, BOCCUMI ML, MESTURINO C, MATTEOLI MC, CRINO A, CICCONETTI CA, PACI F et al. ( 1995 ) . NICOTINAMIDE VERSUS VITAMIN-E IN RECENT-ONSET IDDM - A RANDOMIZED TRIAL IN 85 PATIENTS . DIABETOLOGIA . vol. 38 , A99 - A99 .

Pozzilli P, Dupre J ( 1995 ) . New intervention modalities for the prevention of insulin-dependent diabetes . Diabetes, Nutrition and Metabolism - Clinical and Experimental vol. 8 , ( 2 ) 69 - 73 .

Pozzilli P, Buzzetti R, Bottazzo G, Tosi R ( 1995 ) . Response from the authors . Diabetologia vol. 38 , ( 1 ) 126 - 126 .

Letizia C, d'Ambrosio C, De Ciocchis A, Scavo D, Pozzilli P ( 1995 ) . Serum angiotensin-converting enzyme levels in patients with recent-onset insulin-dependent diabetes after one year of low-dose cyclosporin therapy. IMDIAB Study Group . Clinical pharmacology research vol. 15 , ( 5-6 ) 209 - 213 .

BUZZETTI R, NISTICO L, POZZILLI P, SERRANORIOS M, LARRAZ MT, TOSI R, GIOVANNINI C ( 1995 ) . THE CTLA4 MICROSATELLITE IDENTIFIES A NEW REGION ON CHROMOSOME-2 LINKED TO IDDM . DIABETOLOGIA . vol. 38 , A29 - A29 .

Pozzilli P ( 1994 ) . Prevention of Type I diabetes mellitus . Diabetes, Nutrition and Metabolism - Clinical and Experimental vol. 7 , ( 2 ) 57 - 61 .

Fava D, Leslie RDG, Pozzilli P ( 1994 ) . Relationship Between Dairy Product Consumption and Incidence of IDDM in Childhood in Italy . Diabetes Care vol. 17 , ( 12 ) 1488 - 1490 .

Signore A, Chianelli M, Ferretti E, Toscano A, Britton KE, Andreani D, Gale EA, Pozzilli P ( 1994 ) . New approach for in vivo detection of insulitis in type I diabetes: activated lymphocyte targeting with 123I-labelled interleukin 2 . European Journal of Endocrinology vol. 131 , ( 4 ) 431 - 437 .

Leslie RD, Pozzilli P ( 1994 ) . Type I Diabetes Masquerading as Type II Diabetes: Possible implications for prevention and treatment . Diabetes Care vol. 17 , ( 10 ) 1214 - 1219 .

Pozzilli P, Visalli N, Boccuni ML, Baroni MG, Buzzetti R, Fioriti E, Signore A, Cavallo M et al. ( 1994 ) . Combination of Nicotinamide and Steroid Versus Nicotinamide in Recent-Onset IDDM: The IMDIAB II Study . Diabetes Care vol. 17 , ( 8 ) 897 - 900 .

Staines A, Pozzilli P, Buzzetti R, Bottazzo GF, Tosi R ( 1994 ) . Selection of control subjects for case/control analysis of susceptibility to Type 1 (insulin-dependent) diabetes mellitus . Diabetologia vol. 37 , ( 8 ) 845 - 846 .

Baroni MG, Alcolado JC, Gragnoli C, Franciosi AM, Cavallo MG, Fiore V, Pozzilli P, Galton DJ ( 1994 ) . Affected sib-pair analysis of the GLUT1 glucose transporter gene locus in non-insulin-dependent diabetes mellitus (NIDDM): evidence for no linkage . Human Genetics vol. 93 , ( 6 ) 675 - 680 .

Alcolado JC, Pozzilli P ( 1994 ) . Selection of control subjects in genetic studies of diabetes mellitus . Diabetologia vol. 37 , ( 6 ) 639 - 640 .

Signore A, Procaccini E, Toscano AM, Ferretti E, Pozzilli P, Williams AJK, Beales PE, Cugini P ( 1994 ) . Histological study of pancreatic beta-cell loss in relation to the insulitis process in the non-obese diabetic mouse . Histochemistry and Cell Biology vol. 101 , ( 4 ) 263 - 269 .

Chianelli M, Mather SJ, Signore A, Ronga G, Pozzilli P, Fritzberg A ( 1994 ) . 99mTc Labelling of Interleukin-2 for in Vivo Targeting of Activated T-Lymphocytes . Radiolabeled Blood Elements , Springer Nature

CAVALLO MG, MONETINI L, VALENTE L, DESANTIS R, POZZILLI P ( 1994 ) . AUTOANTIBODIES IN NEWLY-DIAGNOSED IDDM SERA DETECTED USING A HUMAN INSULINOMA CELL-LINE AS SUBSTRATE . DIABETES . vol. 43 , A154 - A154 .

Buzzetti R, Nisticò L, Pozzilli P, Giovannini C ( 1994 ) . Analysis of HLA-DQ Alpha and DQ Beta Genes in Type I (Insulin-dependent) Diabetes . Standardization of Epidemiologic Studies of Host Susceptibility , Springer Nature

BARONI MG, FRANCIOSI A, GRAGNOLI C, CAVALLO MG, MONETINI L, POZZILLI P ( 1994 ) . EXPRESSION OF GLUT1, GLUT2 AND INSULIN GENES BY A HUMAN INSULINOMA CELL-LINE . DIABETES . vol. 43 , A250 - A250 .

VISALLI N, SIGNORE A, BARONI MG, BUZZETTI R, CAVALLO MG, BOCCUNI ML, ANDREANI D, LUCENTINI L et al. ( 1994 ) . NICOTINAMIDE AT IDDM DIAGNOSIS - 1 YEAR RESULTS OF A LARGE DOUBLE-BLIND-STUDY . DIABETOLOGIA . vol. 37 , A64 - A64 .

FERRETTI E, BARONE R, MANGO L, MULTARI G, ANDREANI D, POZZILLI P, SIGNORE A ( 1994 ) . RADIOLABELED IMMUNOGLOBULINS FOR IMAGING PANCREATIC INFLAMMATION IN TYPE-1 DIABETES . DIABETOLOGIA . vol. 37 , A91 - A91 .

POZZILLI P, BUZZETTI R, BOTTAZZO GF, TOSI R ( 1994 ) . SELECTION OF CONTROL SUBJECTS FOR CASE/CONTROL ANALYSIS OF SUSCEPTIBILITY TO TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS - RESPONSE . DIABETOLOGIA vol. 37 , ( 8 ) 846 - 846 .

Pozzilli P, Visalli N, Suppa A, Buzzetti R ( 1993 ) . IDDM and rainfall . The Lancet vol. 342 , ( 8885 )

Pozzilli P, Buzzetti R, Bottazzo GF, Tosi R ( 1993 ) . The selection of control subjects for case/control analysis of susceptibility to Type 1 (insulin-dependent) diabetes mellitus . Diabetologia vol. 36 , ( 11 ) 1208 - 1209 .

Beales PE, Williams AJK, Signore A, Procaccini E, Xu S, Pozzilli P ( 1993 ) . The effect of a heparin analogue, ITF-5005, on diabetes incidence and insulitis in the non-obese diabetic mouse . Diabetes Research and Clinical Practice vol. 21 , ( 1 ) 5 - 9 .

Williams AJK, Beales PE, Krug J, Procaccini E, Signore A, Xu S, Gale EAM, Pozzilli P ( 1993 ) . Tolbutamide reduces the incidence of diabetes mellitus, but not insulitis, in the non-obese-diabetic mouse . Diabetologia vol. 36 , ( 6 ) 487 - 492 .

Pozzilli P, Signore A, Williams AJK, Beales PE ( 1993 ) . NOD mouse colonies around the world- recent facts and figures . Trends in Immunology vol. 14 , ( 5 ) 193 - 196 .

Pozzilli P, Maclaren NK ( 1993 ) . Immunotherapy at clinical diagnosis of insulin-dependent diabetes An approach still worth considering . Trends in Endocrinology and Metabolism vol. 4 , ( 3 ) 101 - 105 .

SEBASTIANI ML, SUPPA A, FIORITI E, MATTEOLI MC, PONTE E, GUGLIELMI A, FALDETTA MC, AMORETTI R et al. ( 1993 ) . A RECORD OF TYPE-1 DIABETES OVER 4 CONSECUTIVE YEARS - EVIDENCE FOR CLIMATIC INFLUENCE ON DIABETES INCIDENCE . DIABETOLOGIA . vol. 36 , A175 - A175 .

Visalli N, Boccuni ML, Pozzilli P ( 1993 ) . Acute administration of nicotinamide does not modify C-peptide and insulin secretion in normal subjects . Diabetes, Nutrition and Metabolism - Clinical and Experimental vol. 6 , ( 3 ) 159 - 161 .

SIGNORE A, CHIANELLI M, FERRETTI E, MATHER SJ, GALE EAM, POZZILLI P ( 1993 ) . IN-VIVO IMAGING OF ACTIVATED LYMPHOCYTES IN THE PANCREAS OF NEWLY-DIAGNOSED DIABETIC-PATIENTS . DIABETOLOGIA . vol. 36 , A36 - A36 .

PICARELLI A, FERRETTI E, CIANCAMERLA M, GRECO M, RONGA G, CORAZZIARI E, POZZILLI P, SIGNORE A ( 1993 ) . INVIVO IMAGING OF SMALL-BOWEL LYMPHOCYTIC INFILTRATION IN CELIAC-DISEASE . GASTROENTEROLOGY . vol. 104 , A271 - A271 .

POZZILLI P, KOLB H, ILKOVA HM ( 1993 ) . NEW TRENDS FOR PREVENTION AND IMMUNOTHERAPY OF INSULIN-DEPENDENT DIABETES - PREFACE . DIABETES-METABOLISM REVIEWS vol. 9 , ( 4 ) 237 - 237 .

VISALLI N, BOCCUNI ML, LUCENTINI L, DEMATTIA GC, GHIRLANDA G, CICCONETTI CA, PISANO L, MULTARI G et al. ( 1993 ) . NO DIFFERENCES IN CLINICAL AND METABOLIC CHARACTERISTICS BETWEEN NEWLY-DIAGNOSED IDDM CHILDREN AND ADULTS . DIABETOLOGIA . vol. 36 , A58 - A58 .

FERRETTI E, CHIANELLI M, RONGA G, CIANCAMERIA M, MULTARI G, POZZILLI P, SIGNORE A ( 1993 ) . RADIOLABELED IMMUNOGLOBULINS FOR IMAGING INSULITIS IN PREDIABETES . DIABETOLOGIA . vol. 36 , A36 - A36 .

Baroni MG, Fiore V, Maestripieri PL, Caccamo C, Gragnoli C, Franciosi A, Negri M, Pozzilli P ( 1993 ) . Therapy with a thymic extract and reduced recurrence of low urinary tract infections in patients with diabetes mellitus . Acta Therapeutica vol. 19 , ( 3 ) 283 - 294 .

Baroni MG, Alcolado JC, Needham EWA, Pozzilli P, Stocks J, Galton DJ ( 1992 ) . Sib-Pair Analysis of Adenosine Deaminase Locus in NIDDM . Diabetes vol. 41 , ( 12 ) 1640 - 1643 .

Pozzilli P, Buzzetti R, Dotta F, Andreani D ( 1992 ) . Acute onset of seeming IDDM in an AIDS patient . Diabetes Care vol. 15 , ( 11 ) 1824 - 1825 .

Pozzilli P, Signore A, Andreani D ( 1992 ) . What future for therapeutic prevention of Type I (insulin-dependent) diabetes mellitus? . Diabetologia vol. 35 , ( 11 ) 1093 - 1095 .

SIGNORE A, CHIANELLI M, TOSCANO A, MONETINI L, RONGA G, NIMMON CC, BRITTON KE, POZZILLI P et al. ( 1992 ) . A radiopharmaceutical for imaging areas of lymphocytic infiltration: 123I-interleukin-2. Labelling procedure and animal studies . Nuclear Medicine Communications vol. 13 , ( 10 ) 713 - 722 .

Cugini P, Gasbarrone L, Lucia P, Cianetti A, Canova R, Di Palma L, Sepe FA, Pozzilli P et al. ( 1992 ) . The circadian rhythm of plasma vasoactive intestinal peptide, atrial natriuretic peptide, renin activity, aldosterone and cortisol in heart transplantation. The effects of immunosuppressive therapy . Bollettino Della Societa Italiana Di Cardiologia vol. 37 , ( 10 ) 693 - 699 .

Al Sakkaf L, Pozzilli P, Bingley PJ, Lowdell MW, Thomas JM, Bonifacio E, Gale EAM, Bottazzo GF ( 1992 ) . Early T-cell defects in pre-type 1 diabetes . Acta Diabetologica vol. 28 , ( 3-4 ) 189 - 192 .

Cavallo MG, Baroni MG, Toto A, Gearing AJ, Forsey T, Andreani D, Thorpe R, Pozzilli P ( 1992 ) . Viral infection induces cytokine release by beta islet cells . Immunology vol. 75 , ( 4 ) 664 - 668 .

Baroni MG, Oelbaum RS, Pozzilli P, Stocks J, Li S-R, Fiore V, Galton DJ ( 1992 ) . Polymorphisms at the GLUT1 (HepG2) and GLUT4 (muscle/adipocyte) glucose transporter genes and non-insulin-dependent diabetes mellitus (NIDDM) . Human Genetics vol. 88 , ( 5 ) 557 - 561 .

BEALES PE, TOSCANO A, PETRUZZIELLO R, MASTROMARINO P, SIGNORE A, POZZILLI P ( 1992 ) . ANTICOMPLEMENT ACTIVITY IN NOD MOUSE - PROTECTIVE ROLE IN BETA-CELL AUTOIMMUNITY . DIABETOLOGIA . vol. 35 , A207 - A207 .

BUZZETTI R, NISTICO L, SORRENTINO R, POZZILLI P, GIOVANNINI C, TOSI R ( 1992 ) . COMBINED ANALYSIS OF BOTH DQA1 AND DQB1 GENE POLYMORPHISMS IS REQUIRED TO EVALUATE THE RISK FOR TYPE-1 DIABETES . DIABETOLOGIA . vol. 35 , A138 - A138 .

VISALLI N, LUCENTINI L, CRINO A, CICCONETTI CA, TEODONIO C, AMORETTI R, PISANO L, PENNAFINA MG et al. ( 1992 ) . COMPARISON BETWEEN NICOTINAMIDE AND NICOTINAMIDE + DEFLAZACORT IN RECENT ONSET TYPE-1 DIABETES . DIABETOLOGIA . vol. 35 , A218 - A218 .

SIGNORE A, CHIANELLI M, FERRETTI E, TOMEI E, RONGA G, ANDREANI D, POZZILLI P ( 1992 ) . DETECTION OF PANCREATIC INSULITIS IN TYPE-1 DIABETES BY USING 1231I-LABELED INTERLEUKIN-2 . DIABETOLOGIA . vol. 35 , A214 - A214 .

SIGNORE A, CHIANELLI M, FERRETTI E, TOMEI E, POZZILLI P, RONGA G, CANTARANO G, ANDREANI D ( 1992 ) . DETECTION OF PANCREATIC INSULITIS IN TYPE-1 DIABETES BY USING 123I-LABELED INTERLEUKIN-2 . EUROPEAN JOURNAL OF NUCLEAR MEDICINE . vol. 19 , 583 - 583 .

Beales PE, Williams A, Krug J, Signore A, Chianelli M, Andreani D, Pozzilli P ( 1992 ) . Effect of Tenidap, a novel anti-inflammatory compound on islet lymphocytic infiltration and diabetes incidence in the non obese diabetic (NOD) mouse . Diabetes & Metabolism vol. 18 , ( 1 ) 48 - 53 .

Visalli N, Pozzilli P, Boccuni ML, Suppa MA, Messina R, Buzzetti R, Andreani D ( 1992 ) . Immunointervention in insulin dependent diabetes: implications for the epidemiology of the disease . Annali di Igiene Medicina Preventiva e di Comunità vol. 4 , ( 3 ) 159 - 163 .

Cugini P, Lucia P, Di Palma L, Pozzilli P, Re M, Canova R, Gasbarrone L, Cianetti A ( 1992 ) . Interactions between the circadian rhythm of vasoactive intestinal peptide (VIP) and T lymphocyte subpopulations: Evidence of VIP-induced immunoregulation . Immunologia Clinica vol. 11 , ( 1 ) 15 - 22 .

BARONI MG, ALCOLADO JC, GALTON DJ, ANDREANI D, POZZILLI P ( 1992 ) . SIB-PAIR ANALYSIS OF THE GLUT1 GLUCOSE TRANSPORTER GENE IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS . DIABETOLOGIA vol. 35 , A72 - A72 .

CAVALLO MG, DOTTA F, MONETINI L, TOTO A, ANDREANI D, POZZILLI P ( 1992 ) . STUDY OF BETA-CELL MARKERS AND ANTIGEN EXPRESSION BY A HUMAN INSULINOMA CELL-LINE . DIABETOLOGIA . vol. 35 , A207 - A207 .

Buzzetti R, Pozzilli P, Giovannini C ( 1991 ) . Human lymphocytes and the hypothalamus pituitary secretory axis as seen by an endocrinological point of view . EOS Rivista di Immunologia ed Immunofarmacologia vol. 11 , ( 4 ) 131 - 134 .

Krug J, Williams AJ, Beales PE, Doniach I, Gale EA, Pozzilli P ( 1991 ) . Parathyroiditis in the non-obese diabetic mouse – a new finding . Journal of Endocrinology vol. 131 , ( 2 ) 193 - np .

Cugini P, Lucia P, Di Palma L, Pozzilli P, Re M, Canova R, Gasbarrone L, Cianetti A ( 1991 ) . Vasoactive intestinal peptide: A chronoimmunomodulator? . Molecular Genetics and Metabolism vol. 46 , ( 2 ) 274 - 276 .

Pozzilli P, Visalli N, Signore A, Andreani D, Quatraro A, Minei A, Torella R, Ceriello A et al. ( 1991 ) . Clinical remission in patients with IDDM and family history of NIDDM . The Lancet vol. 337 , ( 8750 )

Pozzilli P, Bottazzo GF ( 1991 ) . Coffee or Sugar: Which is to Blame in IDDM? . Diabetes Care vol. 14 , ( 2 ) 144 - 145 .

Cugini P, Lucia P, Di Palma L, Pozzilli P, Re M, Canova R, Gasbarrone L, Cianetti A ( 1991 ) . Temporal interrelationships between circadian rhythms of vasoactive intestinal peptide and T lymphocyte subpopulations . Journal of Clinical and Laboratory Immunology vol. 34 , ( 2 ) 49 - 54 .

Cugini P, Cavallini M, Pozzilli P, Letizia C, Sepe M, Di Palma L, Battisti P ( 1991 ) . Circadian Rhythm of T-Lymphocyte Subsets, Cortisol and Cyclosporin in Kidney-Transplanted Subjects . Nephrology Dialysis Transplantation vol. 6 , ( 7 ) 512 - 517 .

Cugini P, Battisti P, Di Palma L, Cavallini M, Pozzilli P, Scibilia G, Letizia C, Sepe M et al. ( 1991 ) . Circadian rhythm of the renin-angiotensin-aldosterone system in subjects with kidney and heart transplants . Recenti Progressi in Medicina vol. 82 , ( 1 ) 4 - 8 .

Krug J, Williams A, Beales P, Procaccini E, Chianelli M, Signore A, Negri M, Tonnarini GF et al. ( 1991 ) . Effect of an anti-protein denaturant and immunomodulator (bendazac lysine salt) on the incidence of diabetes and insulitis in the non obese diabetic mouse . Acta Therapeutica vol. 17 , ( 3 ) 245 - 252 .

DORMAN JS, BESSAOUD K, DESEREDAY M, MARTI M, SCHOBER E, FRANCO L, NEGRATO C, RUSSO E et al. ( 1991 ) . FAMILIAL INSULIN-DEPENDENT DIABETES-MELLITUS (IDDM) EPIDEMIOLOGY - STANDARDIZATION OF DATA FOR THE DIAMOND PROJECT . BULLETIN OF THE WORLD HEALTH ORGANIZATION vol. 69 , ( 6 ) 767 - 777 .

Pozzilli P ( 1990 ) . Immunotherapy in pre-Type 1 diabetes mellitus . Diabetologia vol. 33 , ( 12 ) 741 - 741 .

Boccuni ML, De Mattia G, Laurenti O, Bravi C, Messina R, Bruno MR, Visalli N, Pozzilli P ( 1990 ) . Recent advances in pathogenesis and immunotherapy of type 1 diabetes . Folia Allergologica et Immunologica Clinica vol. 37 , ( 2 ) 67 - 76 .

Krug J, Lohmann D, Andreani D, Pozzilli P ( 1990 ) . The immunoregulatory system in Type I (insulin-dependent) diabetes . Diabetes, Nutrition and Metabolism - Clinical and Experimental vol. 3 , ( 4 ) 351 - 358 .

Williams AJK, Krug J, Lampeter EF, Mansfield K, Beales PE, Signore A, Gale EAM, Pozzilli P ( 1990 ) . Raised temperature reduces the incidence of diabetes in the NOD mouse . Diabetologia vol. 33 , ( 10 ) 635 - 637 .

Sensi M, Bruno MR, Valente L, Cioccia GP, Chianelli M, Pozzilli P ( 1990 ) . Retinol binding protein: a short half life determinant of protein non enzymatic glycation in diabetes . Diabetes Research vol. 13 , ( 4 ) 195 - 198 .

Sensi M, Valente L, Casini A, Bruno MR, Cioccia G, Pozzilli P ( 1990 ) . Reduction of the non-enzymic glycation of a short lived protein (retinol binding protein) induced by Bendazac . Medical Science Research vol. 18 , ( 3 ) 107 - 108 .

Lampeter EF, Pozzilli P, Signore A, Williams A, Mansfield K, Gale EAM ( 1990 ) . Ciamexone treatment in the NOD mice — Failure to suppress insulitis . Journal of Autoimmunity vol. 3 , ( 1 )

Cugini P, Cavallini M, Pozzilli P, Scibilia G, Letizia C, Di Palma L, Battisti P, Sepe M et al. ( 1990 ) . Circadian rhythms of T lymphocyte subpopulations and cortisol in kidney and heart transplantation . Progress in Clinical and Biological Research vol. 341A , 543 - 553 .

Signore A, Chianelli M, Ronga G, Pozzilli P, Beverley PC ( 1990 ) . In vivo labelling of activated T lymphocytes by i.v. injection of 123I-IL2 for detection of insulitis in type 1 diabetes . Progress in Clinical and Biological Research vol. 355 , 229 - 238 .

Cugini P, Cavallini M, Pozzilli P, Palestini M, Letizia C, Di Palma L, Sepe M, Battisti P ( 1990 ) . Lymphocyte subpopulations, plasma cortisol and cyclosporine in kidney transplantation . Giornale Italiano di Nefrologia vol. 7 , ( 3 ) 191 - 200 .

Pozzilli P, Buzzetti R, McLoughlin L ( 1989 ) . Bidirectional interaction between the hypophysis-adrenal axis and the immune system . Immunologia Clinica vol. 8 , ( 4 ) 171 - 184 .

Buzzetti R, McLoughlin L, Rees LH, Pozzilli P ( 1989 ) . Human lymphocytes and production of pro-opiomelanocortin (POMC) derived peptides: State of art . Journal of Endocrinological Investigation . vol. 12 , 43 - 48 .

Pagani S, Cruciani L, Chianelli M, Procaccini E, Pozzilli P ( 1989 ) . Thymopentin administration and increase of sero-conversion after B-hepatitis vaccine in diabetic patients . Diabetes Research vol. 12 , ( 4 ) 199 - 201 .

Pozzilli P, Kolb H ( 1989 ) . Immunotherapy in type 1 diabetes: present status . Trends in Immunology vol. 10 , ( 10 ) 321 - 322 .

Lampeter EF, Signore A, Gale EAM, Pozzilli P ( 1989 ) . Lessons from the NOD mouse for the pathogenesis and immunotherapy of human Type 1 (insulin-dependent) diabetes mellitus . Diabetologia vol. 32 , ( 10 ) 703 - 708 .

Kolb H, Bach J-F, Eisenbarth GS, Harrison LC, Maclaren NK, Pozzilli P, Skyler JS, Stiller CR ( 1989 ) . CRITERIA FOR IMMUNE TRIALS IN TYPE I DIABETES . The Lancet vol. 334 , ( 8664 )

Buzzetti R, Valente L, Barletta C, Scavo D, Pozzilli P ( 1989 ) . Thymopentin induces release of ACTH-like immunoreactivity by human lymphocytes . Journal of Clinical and Laboratory Immunology vol. 29 , ( 4 ) 157 - 159 .

Cugini P, Letizia C, Di Palma L, Sepe M, Battisti P, Pozzilli P, Cassisi A, Cioli AR et al. ( 1989 ) . 24-hour behavior of T-lymphocyte subpopulations in patients with stable heart transplants receiving cyclosporin therapy . Bollettino Della Societa Italiana Di Cardiologia vol. 34 , ( 6 ) 537 - 550 .

Al-Sakkaf L, Pozzilli P, Tarn AC, Schwarz G, Gale EAM, Bottazzo GF ( 1989 ) . Persistent reduction of CD4/CD8 lymphocyte ratio amd cell activation before the onset of Type 1 (insulin-dependent) diabetes . Diabetologia vol. 32 , ( 5 ) 322 - 325 .

Signore A, Pozzilli P, Gale EAM, Andreani D, Beverley PCL ( 1989 ) . The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice . Diabetologia vol. 32 , ( 5 ) 282 - 289 .

Buttinelli C, Signore A, Salvetti M, Pozzilli C, Fieschi C, Pozzilli P ( 1989 ) . A longitudinal study of lymphocyte activation in multiple sclerosis . Medical Science Research vol. 17 , ( 14 ) 603 - 604 .

Cavallo MG, Signore A, Baroni MG, Andreani D, Pozzilli P ( 1989 ) . Interleukin 2 (IL2) production and IL2 receptor release in type I diabetes mellitus . Diabetes, Nutrition and Metabolism - Clinical and Experimental vol. 2 , ( 3 ) 179 - 183 .

Signore A, Lampeter E, Cavallo MG, Visalli N, Pozzilli P ( 1989 ) . The immunological network in the pathogenesis of type 1 diabetes mellitus . EOS Rivista di Immunologia ed Immunofarmacologia vol. 9 , ( 2 ) 63 - 67 .

Pozzilli P, Pagani S, Visalli N, Boccuni ML, Cruciani L, Negri M ( 1989 ) . Thymopentin administration and antibody titre following anti-influenza vaccine in diabetic patients . Medical Science Research vol. 17 , ( 13 ) 549 - 550 .

Bruno MR, Sensi M, Cioccia GP, Valente L, Negri M, Ghirlanda G, Pozzilli P ( 1988 ) . Inhibition of protein non-enzymic glycation induced by Bendazac . Diabetes Research vol. 9 , ( 1 ) 11 - 14 .

Pozzilli P, Occhigrossi F, Buzzetti R, Fiore V ( 1988 ) . Record Books and Patients With NIDDM: Waste of Time? . Diabetes Care vol. 11 , ( 3 ) 299 - 300 .

Pozzilli P, Fighi V, Fiore V, Casanica M, Giaccari A, Sbraccia P, Tamburrano G ( 1988 ) . Effects of Acarbose on Insulin Sensitivity and Liver Uptake in Patients with Type I Diabetes . Acarbose for the Treatment of Diabetes Mellitus , Springer Nature

Pozzilli P, Visalli N, Andreani D ( 1988 ) . Immunotherapy of Type I diabetes: Facts and recommendations . Diabetes, Nutrition and Metabolism - Clinical and Experimental vol. 1 , ( 4 ) 269 - 271 .

Signore A, Beverley PC, Negri M, Pozzilli P ( 1988 ) . Labelling of interleukin 2 with 123 iodine and its administration to animals susceptible to diabetes for the visualization of lymphocytic infiltration in the pancreas . Minerva Endocrinologica vol. 13 , ( 4 ) 279 - 285 .

Signore A, Pozzilli P, Tamburrano G, Andreani D ( 1988 ) . The in Vivo Visualization of Insulitis a New Marker of Prediabetes . Advances in Experimental Medicine and Biology vol. 246 , 119 - 125 .

Sensi M, Cioccia GP, Bruno MR, Ghirlanda G, Valente L, Negri M, Tonnarini G, Pozzilli P ( 1988 ) . The in vitro effect of Bendazac on the expression of interleukin 2 receptors and lymphocyte transformation in normal and diabetic patients . Medical Science Research vol. 16 , ( 7 ) 327 - 328 .

Signore A, Cooke A, Pozzilli P, Butcher G, Simpson E, Beverley PCL ( 1987 ) . Class-II and IL 2 receptor positive cells in the pancreas of NOD mice . Diabetologia vol. 30 , ( 11 ) 902 - 905 .

Pozzilli P ( 1987 ) . Immunosuppressive therapy in type 1 diabetes: update . Recenti Progressi in Medicina vol. 78 , ( 11 ) 514 - 516 .

SINCLAIR AJ, SIGNORE A, BOMANJI J, BRITTON KE, POZZILLI P, GALE EAM ( 1987 ) . In vivo kinetics of 1231-labelled insulin . Nuclear Medicine Communications vol. 8 , ( 10 ) 779 - 786 .

Pozzilli P, Visalli N, Cavallo MG, Beales P, Negri M, Ghirlanda G, Papa V, Andreani D ( 1987 ) . Normalization of the CD4/CD8 lymphocyte ratio and increased B lymphocytes in long standing diabetic patients following therapy with thymopentin . Diabetes Research vol. 6 , ( 2 ) 51 - 56 .

Pozzilli P, Arduini P, Visalli N, Sutherland J, Pezzella M, Galli C, Corradini SG, Biasio L et al. ( 1987 ) . Reduced protection against hepatitis B virus following vaccination in patients with Type 1 (insulin-dependent) diabetes . Diabetologia vol. 30 , ( 10 ) 817 - 819 .

Signore A, Pozzilli P, Parman A, Andreani D, Beverley PL ( 1987 ) . DETECTION OF ACTIVATED LYMPHOCYTES IN ENDOCRINE PANCREAS OF BB/W RATS BY INJECTION OF 123I-INTERLEUKIN-2: AN EARLY SIGN OF TYPE 1 DIABETES . The Lancet vol. 330 , ( 8558 ) 537 - 540 .

Pozzilli P, Pagani S, Arduini P, Visalli N, Cioccia GP, Negri M, Andreani D ( 1987 ) . In vivo determination of cell mediated immune response in diabetic patients using a multiple intradermal antigen dispenser . Diabetes Research vol. 6 , ( 1 ) 5 - 8 .

Signore A, Negri M, Pozzilli P ( 1987 ) . Toxicity of indium-111 on lymphocytes . Journal of Nuclear Medicine vol. 28 , ( 8 )

Pallone F, Fais S, Squarcia O, Biancone L, Pozzilli P, Boirivant M ( 1987 ) . Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens . Gut vol. 28 , ( 6 )

Lampeter EF, Krug J, Beales P, Sutherland J, Cossel L, Pozzilli P ( 1987 ) . Ultrastructure of lymphocyte subsets and of activated lymphocytes in type 1 diabetes as defined by monoclonal antibodies and the immunogold technique . Diabetes Research vol. 5 , ( 2 ) 59 - 66 .

Pozzilli P, Signore A, Negri M ( 1987 ) . Immunological markers and immunotherapy in insulin dependent (Type I) diabetes . Medical Science Research vol. 15 , ( 22 ) 1363 - 1365 .

Di Mario U, Crisa L, Pozzilli P, Andreani D ( 1987 ) . Immunotherapy of type 1 diabetes: Utopia or reality? . Giornale Italiano di Diabetologia vol. 7 , ( 4 ) 293 - 297 .

Sensi M, Bruno MR, Pozzilli P ( 1987 ) . In vitro inhibition of non-enzymatic glycosylation induced by aspirin . Medical Science Research vol. 15 , ( 2 ) 99 - 100 .

Casanica M, Busco S, Buzzetti R, Negri M, Beales PE, Pozzilli P ( 1987 ) . Intravenous infusion of thymopentin does not change pituitary and pancreatic hormone secretion in man . Medical Science Research vol. 15 , ( 15 ) 915 - 916 .

Tanzi P, Vitillo M, Mancuso M, Fiore V, Pozzilli P, Di Mario U, Andreani D ( 1987 ) . The Effect of High Doses of Carbimazole in Patients with Graves’disease and in Subjects with Thyroid Antibodies . Thyroid Autoimmunity , Springer Nature

Pozzilli P, Visalli N, Corcos A, Andreani D ( 1987 ) . Why do so few diabetic patients attend dialysis centers in Central Italy? . Journal of Diabetic Complications vol. 1 , ( 1 ) 4 - 6 .

Pozzilli P, Gale EAM, Visallil N, Baroni M, Crovari P, Frighi V, Cavallo MG, Andreani D ( 1986 ) . The immune response to influenza vaccination in diabetic patients . Diabetologia vol. 29 , ( 12 ) 850 - 854 .

Pozzilli P, Ghirlanda G, Manna R, Alfano G, Greco AV, Andreani D ( 1986 ) . White cells transfusion in recent onset type 1 diabetes . Diabetes Research vol. 3 , ( 5 ) 273 - 276 .

Pozzilli P, Signore A, Andreani D ( 1986 ) . Does the current knowledge on the pathogenesis of type 1 diabetes justify immunotherapeutic intervention? . Recenti Progressi in Medicina vol. 77 , ( 5 ) 245 - 248 .

Pozzilli P, Signore A, Pozzilli C ( 1986 ) . Development and applications of the marking technique of lymphocytes with Indium-111 in the study of the organ pathology . EOS Rivista di Immunologia ed Immunofarmacologia vol. 6 , ( 1 ) 47 - 50 .

Pozzilli P, Negri M, Visalli N ( 1986 ) . Impaired CD4/CD8 lymphocyte ratio in patients with long standing diabetes mellitus . IRCS Medical Science vol. 14 , ( 7 ) 648 - 649 .

Pozzilli P, Colletti F, Tarentini M ( 1986 ) . Mechanisms of damage to the islands of Langerhans in type I diabetes . Minerva Endocrinologica vol. 11 , ( 1 ) 45 - 48 .

Al-Sakkaf L, Pozzilli P, Sensi M, Irving WL, Bottazzo GF ( 1985 ) . A cell surface monoclonal antibody (H366) helps to discriminate human cytotoxic from suppressor T cells . Clinical & Experimental Immunology vol. 62 , ( 3 ) 594 - 599 .

Pozzilli P, Tarn A, Gale EAM ( 1985 ) . HLA-DR3 AND ACTIVATED LYMPHOCYTES: SIGNIFICANCE IN AUTOIMMUNITY . The Lancet vol. 326 , ( 8461 ) 954 - 955 .

Signore A, Sensi M, Pozzilli C, Negri M, Lenzi GL, Pozzilli P ( 1985 ) . Effect of unlabeled indium oxine and indium tropolone on the function of isolated human lymphocytes . Journal of Nuclear Medicine vol. 26 , ( 6 ) 612 - 615 .

Signore A, Cugini P, Letizia C, Lucia P, Murano G, Pozzilli P ( 1985 ) . Study of the diurnal variation of human lymphocyte subsets . Journal of Clinical and Laboratory Immunology vol. 17 , ( 1 ) 25 - 28 .

Signore A, Pozzilli P, Di Mario U, Sensi M, Beales P, Andreani D ( 1985 ) . Inhibition of the receptor for interleukin-2 induced by carbimazole: relevance for the therapy of autoimmune thyroid disease . Clinical & Experimental Immunology vol. 60 , ( 1 ) 111 - 116 .

Frighi V, Pozzilli P ( 1985 ) . Current problems in diabetic cardiopathy . Bollettino Della Societa Italiana Di Cardiologia vol. 30 , ( 3 ) 177 - 182 .

Pozzilli C, Lenzi GL, Argentino C, Carolei A, Rasura M, Signore A, Bozzao L, Pozzilli P ( 1985 ) . Imaging of leukocytic infiltration in human cerebral infarcts . Stroke vol. 16 , ( 2 ) 251 - 255 .

Kennedy R, Di Mario U, Pozzilli P, Guy K, Leonardi M, Sensi M, Andreani D ( 1985 ) . Activated T cells in Graves' disease before treatment . Clinical & Experimental Immunology vol. 59 , ( 2 ) 377 - 382 .

Zuccarini O, Sensi M, Gargiulo P, Pozzilli P, Tiberti C, Pachi A, Fallucca F ( 1985 ) . Sera from diabetic pregnant women contain reduced titres of inhibiting factors on killer cell activity . Diabetologia vol. 28 , ( 2 ) 95 - 98 .

Fais S, Pallone F, Squarcia O, Boirivant M, Pozzilli P ( 1985 ) . T cell early activation antigens expressed by peripheral lymphocytes in Crohn's disease . Journal of Clinical and Laboratory Immunology vol. 16 , ( 2 ) 75 - 76 .

Pozzilli P, Signore A, Andreani D ( 1985 ) . Does the present knowledge of the pathogenesis of type 1 diabetes justify an immunotherapeutic approach? . Italian Journal of Medicine vol. 1 , ( 2-3 ) 92 - 95 .

Signore A, Pozzilli C, Negri M, Lenzi GL, Pozzilli P ( 1985 ) . Homing and circulation of indium-111-labelled leucocytes. A post-mortem study . Bildgebung vol. 54 , ( 6 ) 315 - 317 .

Pozzilli P, Corcos A ( 1985 ) . Immunology in the natural history of diabetes mellitus . Minerva Endocrinologica vol. 10 , ( 2 ) 71 - 78 .

Sensi M, Zuccarini O, Spencer KM, Beales P, Pujol-Borrell R, Pozzilli P ( 1985 ) . In vitro inhibition of insulin release mediated by sera with complement-fixing islet cell antibodies belonging to normal first degree relatives of patients with type 1 diabetes . Diabetes Research vol. 2 , ( 1 ) 1 - 4 .

Lenzi GL, Fazio F, Pozzilli C, Negri M, Bozzao L, Fantozzi LM, Gerundini P, Colombo F et al. ( 1985 ) . New Approaches to the Study of Cerebral Ischemia in Man Using Single Photon Labeled Indicators . Cerebral Blood Flow and Metabolism Measurement , Springer Nature

Pozzilli P, Signore A, Pozzilli C ( 1984 ) . Detrimental effect of indium-111 on human lymphocytes . Journal of Nuclear Medicine vol. 25 , ( 7 )

Pozzilli P, Sensi M, Al-Sakkaf L, Tarn A, Zuccarini O, Bottazzo GF ( 1984 ) . Prospective study of lymphocyte subsets in subjects genetically susceptible to Type 1 (insulin-dependent) diabetes . Diabetologia vol. 27 , ( Suppl 1 ) 132 - 135 .

Sensi M, Pozzilli P, Di Mario U ( 1984 ) . A method to facilitate the reading of up to 60 samples of monoclonal antibody-fluorescence stained cells using Medicell HLA-DR plates . Journal of Clinical and Laboratory Immunology vol. 13 , ( 2 ) 101 - 102 .

Pozzilli P, Sensi M ( 1984 ) . Alpha-2-macroglobulin levels in Type 1 diabetes at diagnosis and in subjects at risk for the disease . IRCS Medical Science vol. 12 , ( 10 ) 947 - 948 .

Pozzilli P, Zuccarini O, Sensi M, Spencer KM, Bottazzo G ( 1984 ) . Cell-mediated immunity in the aetiopathogenesis of insulin-dependent (type I) diabetes mellitus . Biomedica Biochimica Acta vol. 43 , ( 5 ) 621 - 625 .

Andreani D, Di Mario U, Zuccarini O, Franco M, Sensi M, Iavicoli M, Pozzilli P ( 1984 ) . Lymphocyte subsets and immune complexes in long standing diabetic patients: Relation with the presence of microangiopathy . Immunology Letters vol. 8 , ( 1 ) 17 - 21 .

FAIS S, SQUARCIA O, MONTANO S, BOIRIVANT M, POZZILLI P, TONIETTI G, PALLONE F ( 1984 ) . STUDIES ON PERIPHERAL-BLOOD LYMPHOCYTES IN CROHNS-DISEASE - CIRCULATING ACTIVATED T-CELLS . GASTROENTEROLOGY . vol. 86 , 1072 - 1072 .

Signore A, Beales P, Sensi M, Zuccarini O, Pozzilli P ( 1983 ) . Labelling of lymphocytes with indium 111 oxine: Effect on cell surface phenotype and antibody-dependent cellular cytotoxicity . Immunology Letters vol. 6 , ( 3 ) 151 - 154 .

Sensi M, Di Mario U, Pozzilli P ( 1983 ) . Inhibition of antibody dependent cellular cytotoxicity induced by sera from patients with insulin dependent (Type I) diabetes . IRCS Medical Science vol. 11 , ( 7 )

MONTANO S, POZZILLI P, FAIS S, BOIRIVANT M, TARICIOTTI D, PALLONE F ( 1983 ) . LYMPHOCYTE SUBPOPULATION IN CROHNS-DISEASE (CD) . ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY . vol. 15 , 216 - 216 .

Tamburrano G, Pozzilli P ( 1983 ) . Metabolic and hormonal effect of 19-norandrostenolone in type 2 (insulin independent) diabetes mellitus . Acta Therapeutica vol. 9 , ( 3 ) 253 - 262 .

Pozzilli P, Zuccarini O, Iavicoli M, Andreani D, Sensi M, Spencer KM, Bottazzo GF, Beverley PCL et al. ( 1983 ) . Monoclonal Antibodies Defined Abnormalities of T-Lymphocytes in Type I (Insulin-dependent) Diabetes . Diabetes vol. 32 , ( 1 ) 91 - 94 .

Pozzilli P, Zuccarini O, Iavicoli M, Andreani D, Sensi M, Spencer KM, Bottazzo GF, Beverley PC et al. ( 1983 ) . Monoclonal antibodies defined abnormalities of T-lymphocytes in type I (insulin-dependent) diabetes . Diabetes vol. 32 , ( 1 ) 91 - 94 .

Pozzilli P, Di Mario U, Andreani D ( 1982 ) . Cell-mediated immunity and immune complexes in the pathogenesis of type 1 (insulin-dependent) diabetes . Acta Diabetologica vol. 19 , ( 4 ) 295 - 300 .

Sensi M, Pozzilli P, Ventriglia L, Doniach I, Cudworth AG ( 1982 ) . Histology of the islets of Langerhans following administration of human lymphocytes into athymic mice . Clinical & Experimental Immunology vol. 49 , ( 1 ) 81 - 86 .

Pozzilli P, Cudworth AG, Andreani D ( 1982 ) . Cell mediated immunity in the pathogenesis of insulin dependent (type I) diabetes mellitus . Giornale Italiano di Diabetologia vol. 2 , ( 2 ) 157 - 163 .

Iavicoli M, Mario UD, Pozzilli P, Canalese J, Ventriglia L, Galfo C, Andreani D ( 1982 ) . Impaired Phagocytic Function and Increased Immune Complexes in Diabetics with Severe Microangiopathy . Diabetes vol. 31 , ( 1 ) 7 - 11 .

Iavicoli M, Di Mario U, Pozzilli P, Canalese J, Ventriglia L, Galfo C, Andreani D ( 1982 ) . Impaired phagocytic function and increased immune complexes in diabetics with severe microangiopathy . Diabetes vol. 31 , ( 1 ) 7 - 11 .

Sensi M, Pozzilli P, Cudworth AG ( 1981 ) . Antibody-dependent and natural killer cytotoxicity in type 1 diabetes . Acta Diabetologica vol. 18 , ( 4 ) 339 - 344 .

Sensi M, Pozzilli P, Gorsuch AN, Bottazzo GF, Cudworth AG ( 1981 ) . Increased killer cell activity in insulin dependent (Type 1) diabetes mellitus . Diabetologia vol. 20 , ( 2 ) 106 - 109 .

Pozzilli P, Sensi M, Meschini C ( 1981 ) . Low affinity and high affinity E-rosetting cells: A study with the 3A1 monoclonal antibody . IRCS Medical Science vol. 9 , ( 11 ) 1047 - 1048 .

Negri M, Tamburrano G, Pozzilli P ( 1981 ) . Prolactin (PRL) and cortisol dynamic secretion in hirsute females treated with 12 mg cyproterone acetate (CA) . Progresso Medico vol. 37 , ( 17 ) 747 - 749 .

Pozzilli P, Sensi M, Dean B, Gorsuch A, Cudworth A ( 1980 ) . The importance of measuring Fc+ (killer) cells in insulin-dependent (type 1) diabetes . Acta Diabetologica vol. 17 , ( 2 ) 119 - 122 .

Sensi M, Pozzilli P, Cattell WR ( 1980 ) . Gentamicin nephrotoxicity in experimental acute renal failure . Acta Therapeutica vol. 6 , ( 1 ) 65 - 73 .

Pozzilli P, Sensi M, Cudworth AG ( 1980 ) . Identification of high risk subjects for Type 1 diabetes by means of HLA family study and leucocyte migration inhibition test . Diabetologia Croatica vol. 9 , ( Suppl 1 ) 132 - 135 .

Pozzilli P, Di Mario U, Javicoli M, Menzinger G, Andreani D ( 1980 ) . Inhibition of allogeneic lymphocyte E-rosettes induced by sera from newly diagnosed type I diabeticsPresented in part at the 14th Meeting of the European Association for the Study of Diabetes (EASD), Zagreb 28–30 September, 1978 . European Journal of Endocrinology vol. 93 , ( 1 ) 49 - 53 .

Pozzilli P ( 1980 ) . The cell-mediated immunity in juvenile onset-insulin dependent (type I) diabetes . Rassegna di Medicina Interna vol. 1 , ( 2 ) 211 - 218 .

Pozzilli P, Gorsuch A, Sensi M, Bottazzo GF, Cudworth AG ( 1979 ) . EVIDENCE FOR RAISED K-CELL LEVELS IN TYPE-I DIABETES . The Lancet vol. 314 , ( 8135 ) 173 - 175 .

Iavicoli M, Pozzilli P, Di Mario U ( 1979 ) . Increased lymphocyte transformation by insulin induced hypoglycaemia in normal subjects . Journal of Clinical and Laboratory Immunology vol. 1 , ( 4 ) 351 - 353 .

Tamburrano G, Pozzilli P, Gaspardone A, Mazzei E ( 1979 ) . Hormonal changes induced by undecilate 19-norandrostenolone in normal subjects . Policlinico - Sezione Medica vol. 86 , ( 6 ) 480 - 490 .

Irvine WJ, Di Mario U, Guy K, Iavicoli M, Pozzilli P, Lumbroso B, Andreani D ( 1978 ) . Immune complexes and diabetic microangiopathy . Journal of Clinical and Laboratory Immunology vol. 1 , ( 3 ) 187 - 191 .

Puddu PE, Pozzilli P, Rulli V ( 1978 ) . Cycloergometric stress test, coronarography and metabolic parameters in patients with high coronary risk . Cardiologia Pratica vol. 29 , ( 2 ) 81 - 84 .

Pozzilli P, Di Mario U, Pintor A, Javicoli M ( 1978 ) . Hyperglycaemia-induced lymphocyte reactivity depression in normal subjects . Folia Allergologica et Immunologica Clinica vol. 25 , ( 1 ) 53 - 56 .

Negri M, Pozzilli P, Pozzi V, Aragona C ( 1977 ) . Correlations between serum levels of prolactin and dynamic testosterone changes in selected cases of hirsutism . Patologia e Clinica Ostetrica e Ginecologica vol. 5 , ( 6 ) 267 - 270 .

Die Mario U, Pozzilli P, Scarsella M ( 1977 ) . Depressed lymphocyte transformation to phytohemagglutinin in normal subjects by intravenous glucose administration (IVGA) . Diabetologia vol. 13 , ( 4 )